Background	Background	NN	B-NP
Whole-genome	Whole-genome	JJ	I-NP
expression	expression	NN	I-NP
profiling	profiling	NN	I-NP
exemplified	exemplified	NN	I-NP
by	by	IN	0
the	the	DT	0
development	development	NN	0
of	of	IN	0
dna	dna	NN	B-NP
microarray	microarray	NN	I-NP
represents	represents	VBZ	0
a	a	DT	0
major	major	JJ	0
advance	advance	NN	0
in	in	IN	0
genome-wide	genome-wide	JJ	B-NP
functional	functional	JJ	I-NP
analysis	analysis	NN	I-NP
[	[	-LRB-	0
1	1	CD	0
2	2	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
a	a	DT	0
single	single	JJ	0
assay	assay	NN	B-NP
,	,	,	0
the	the	DT	0
transcriptional	transcriptional	JJ	B-NP
response	response	NN	I-NP
of	of	IN	0
each	each	DT	0
gene	gene	NN	0
to	to	TO	0
a	a	DT	0
change	change	NN	0
in	in	IN	0
cellular	cellular	JJ	B-NP
state	state	NN	I-NP
can	can	MD	0
be	be	VB	0
measured	measured	VBN	0
,	,	,	0
whether	whether	IN	0
it	it	PRP	0
is	is	VBZ	0
a	a	DT	0
viral	viral	JJ	B-NP
infection	infection	NN	I-NP
,	,	,	0
host	host	NN	B-NP
cell	cell	NN	I-NP
cycle	cycle	NN	I-NP
change	change	NN	I-NP
,	,	,	0
chemical	chemical	JJ	B-NP
treatment	treatment	NN	I-NP
,	,	,	0
or	or	CC	0
genetic	genetic	JJ	B-NP
perturbation	perturbation	NN	I-NP
.	.	.	0
Specifically	Specifically	RB	0
,	,	,	0
systematic	systematic	JJ	B-NP
approach	approach	NN	I-NP
for	for	IN	0
identifying	identifying	VBG	0
the	the	DT	0
cellular	cellular	JJ	B-NP
gene	gene	NN	I-NP
biological	biological	JJ	I-NP
function	function	NN	I-NP
altered	altered	VBN	0
during	during	IN	0
these	these	DT	0
changes	changes	NNS	0
,	,	,	0
such	such	JJ	0
as	as	IN	0
HIV-1	HIV-1	NNP	B-NP
infection	infection	NN	I-NP
,	,	,	0
are	are	VBP	0
needed	needed	VBN	0
to	to	TO	0
ensure	ensure	VB	0
rapid	rapid	JJ	B-NP
progress	progress	NN	I-NP
in	in	IN	0
defining	defining	JJ	0
significant	significant	JJ	0
host	host	NN	0
and	and	CC	0
viral	viral	JJ	B-NP
genome	genome	JJ	I-NP
sequence	sequence	NN	I-NP
in	in	IN	0
directed	directed	JJ	0
experimentation	experimentation	NN	B-NP
and	and	CC	0
application	application	NN	B-NP
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
host	host	NN	0
cellular	cellular	JJ	B-NP
state	state	NN	I-NP
can	can	MD	0
be	be	VB	0
inferred	inferred	VBN	0
from	from	IN	0
the	the	DT	0
expression	expression	NN	B-NP
profile	profile	NN	I-NP
,	,	,	0
and	and	CC	0
the	the	DT	0
notion	notion	NN	0
that	that	IN	0
the	the	DT	0
global	global	JJ	0
transcriptional	transcriptional	JJ	B-NP
response	response	NN	I-NP
constitutes	constitutes	VBZ	0
a	a	DT	0
detailed	detailed	JJ	0
molecular	molecular	JJ	B-NP
phenotype	phenotype	NN	I-NP
,	,	,	0
such	such	JJ	0
as	as	IN	0
class	class	NN	B-NP
discovery	discovery	NN	I-NP
,	,	,	0
class	class	NN	B-NP
prediction	prediction	NN	I-NP
,	,	,	0
drug	drug	NN	B-NP
target	target	NN	I-NP
validation	validation	NN	I-NP
,	,	,	0
and	and	CC	0
the	the	DT	0
classification	classification	NN	B-NP
of	of	IN	0
tumors	tumors	NNS	0
by	by	IN	0
expression	expression	NN	B-NP
profiling	profiling	NN	I-NP
has	has	VBZ	0
begun	begun	VBN	0
to	to	TO	0
receive	receive	VB	0
considerable	considerable	JJ	0
attention	attention	NN	0
[	[	-LRB-	0
3	3	CD	0
4	4	CD	0
5	5	CD	0
6	6	CD	0
7	7	CD	0
8	8	CD	0
9	9	CD	0
10	10	CD	0
11	11	CD	0
]	]	-RRB-	0
.	.	.	0
Since	Since	IN	0
its	its	PRP$	0
discovery	discovery	NN	0
,	,	,	0
much	much	RB	0
of	of	IN	0
the	the	DT	0
mainstream	mainstream	JJ	0
human	human	JJ	B-NP
immunodeficiency	immunodeficiency	JJ	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	CD	I-NP
(	(	-LRB-	0
human	human	JJ	B-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
)	)	-RRB-	0
Tat	Tat	NNP	0
research	research	NN	0
has	has	VBZ	0
focused	focused	VBN	0
on	on	IN	0
its	its	PRP$	0
ability	ability	NN	B-NP
to	to	TO	0
activate	activate	VB	0
the	the	DT	0
HIV-1	HIV-1	NNP	B-NP
LTR	LTR	NNP	I-NP
.	.	.	0
However	However	RB	0
,	,	,	0
to	to	TO	0
date	date	NN	0
,	,	,	0
besides	besides	IN	0
the	the	DT	0
transactivation	transactivation	JJ	B-NP
activity	activity	NN	I-NP
on	on	IN	0
the	the	DT	0
HIV-1	HIV-1	NNP	B-NP
promoter	promoter	NN	I-NP
,	,	,	0
few	few	JJ	0
other	other	JJ	0
effects	effects	NNS	0
exerted	exerted	VBN	0
by	by	IN	0
HIV-1	HIV-1	NNP	B-NP
Tat	Tat	NNP	I-NP
on	on	IN	0
cellular	cellular	JJ	0
and	and	CC	0
viral	viral	JJ	B-NP
gene	gene	NN	I-NP
has	has	VBZ	0
also	also	RB	0
been	been	VBN	0
observed	observed	VBN	0
.	.	.	0
The	The	DT	0
Tat	Tat	JJ	B-NP
protein	protein	NN	I-NP
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
transcriptionally	transcriptionally	VB	0
repress	repress	JJ	0
host	host	NN	0
cellular	cellular	JJ	B-NP
gene	gene	NN	I-NP
and	and	CC	0
be	be	VB	0
involved	involved	VBN	0
in	in	IN	0
the	the	DT	0
immunosuppression	immunosuppression	NN	B-NP
associated	associated	VBN	0
with	with	IN	0
viral	viral	JJ	B-NP
infection	infection	NN	I-NP
.	.	.	0
For	For	IN	0
instance	instance	NN	0
,	,	,	0
HIV-1	HIV-1	NNP	B-NP
infection	infection	NN	I-NP
is	is	VBZ	0
able	able	JJ	0
to	to	TO	0
down-regulate	down-regulate	JJ	0
major	major	JJ	B-NP
histocompatibility	histocompatibility	JJ	I-NP
complex	complex	JJ	I-NP
type	type	NN	I-NP
I	I	PRP	I-NP
(	(	-LRB-	0
major	major	JJ	B-NP
histocompatibility	histocompatibility	NN	I-NP
complex	complex	JJ	I-NP
type	type	NN	I-NP
i	i	NN	I-NP
)	)	-RRB-	0
by	by	IN	0
various	various	JJ	0
different	different	JJ	0
viral	viral	JJ	B-NP
protein	protein	NN	I-NP
,	,	,	0
including	including	VBG	B-NP
Tat	Tat	NNP	I-NP
which	which	WDT	0
represses	represses	VBZ	0
the	the	DT	0
major	major	JJ	B-NP
histocompatibility	histocompatibility	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
complex	complex	JJ	I-NP
type	type	NN	I-NP
i	i	NN	I-NP
transcription	transcription	NN	I-NP
,	,	,	0
Vpu	Vpu	NNP	B-NP
which	which	WDT	0
retains	retains	VBZ	0
nascent	nascent	JJ	0
mhc-i	mhc-i	NN	B-NP
chain	chain	NN	I-NP
in	in	IN	0
the	the	DT	0
endoplasmic	endoplasmic	JJ	B-NP
reticulum	reticulum	NN	I-NP
,	,	,	0
and	and	CC	0
Nef	Nef	NNP	B-NP
which	which	WDT	0
can	can	MD	0
mediate	mediate	VB	0
mhc-i	mhc-i	NN	B-NP
molecule	molecule	NN	I-NP
selective	selective	JJ	I-NP
internalization	internalization	NN	I-NP
from	from	IN	0
the	the	DT	0
plasma	plasma	JJ	0
membrane	membrane	NN	0
.	.	.	0
gene	gene	NN	B-NP
expression	expression	NN	I-NP
mhc	mhc	NN	I-NP
class	class	NN	I-NP
i	i	NN	I-NP
has	has	VBZ	0
also	also	RB	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
be	be	VB	0
reduced	reduced	VBN	0
upon	upon	IN	0
infection	infection	NN	B-NP
with	with	IN	0
the	the	DT	0
wild-type	wild-type	JJ	B-NP
LAI	LAI	NNP	I-NP
virus	virus	NN	I-NP
or	or	CC	0
a	a	DT	0
Tat	Tat	NNP	B-NP
exon	exon	VBD	I-NP
one	one	CD	0
recombinant	recombinant	JJ	0
virus	virus	NN	0
[	[	-LRB-	0
12	12	CD	0
13	13	CD	0
]	]	-RRB-	0
.	.	.	0
Tat	Tat	NNP	0
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
down-regulate	down-regulate	JJ	0
mannose	mannose	JJ	B-NP
receptor	receptor	NN	I-NP
,	,	,	0
EDF-1	EDF-1	NNP	B-NP
,	,	,	0
CD3-gamma	CD3-gamma	NNP	B-NP
,	,	,	0
and	and	CC	0
TCR	TCR	NNP	B-NP
/	/	NNP	0
CD3	CD3	NNP	B-NP
surface	surface	NN	I-NP
receptor	receptor	NN	I-NP
[	[	-LRB-	0
14	14	CD	0
]	]	-RRB-	0
.	.	.	0
Tat	Tat	NNP	0
reduces	reduces	VBZ	0
mannose	mannose	JJ	B-NP
receptor	receptor	NN	I-NP
level	level	JJ	I-NP
and	and	CC	0
promoter	promoter	JJ	B-NP
activity	activity	NN	I-NP
in	in	IN	0
mature	mature	JJ	0
macrophage	macrophage	NN	B-NP
and	and	CC	0
dendritic	dendritic	JJ	B-NP
cell	cell	NN	I-NP
by	by	IN	0
interfering	interfering	VBG	0
with	with	IN	0
the	the	DT	0
host	host	NN	B-NP
transcriptional	transcriptional	NN	I-NP
machinery	machinery	NN	I-NP
;	;	:	0
resulting	resulting	VBG	0
in	in	IN	0
decreased	decreased	JJ	0
levels	levels	NNS	0
of	of	IN	0
surface	surface	NN	B-NP
mannosa	mannosa	NN	I-NP
receptor	receptor	VBP	0
needed	needed	VBN	0
for	for	IN	0
Ag	Ag	NNP	B-NP
(	(	-LRB-	0
mannosylated	mannosylated	FW	0
albumin	albumin	NN	B-NP
uptake	uptake	NN	I-NP
)	)	-RRB-	0
or	or	CC	0
pathogen	pathogen	JJ	B-NP
capture	capture	NN	I-NP
(	(	-LRB-	0
pneumocysti	pneumocysti	NN	B-NP
carinii	carinii	NN	I-NP
phagocytosi	phagocytosi	NN	I-NP
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
eventual	eventual	JJ	B-NP
delivery	delivery	NN	I-NP
to	to	TO	0
MHC	MHC	NNP	B-NP
class	class	NN	I-NP
II-containing	II-containing	FW	0
intracellular	intracellular	NN	B-NP
compartment	compartment	NN	I-NP
[	[	-LRB-	0
15	15	CD	0
]	]	-RRB-	0
.	.	.	0
EDF-1	EDF-1	NNP	B-NP
,	,	,	0
a	a	DT	0
gene	gene	NN	0
down-regulated	down-regulated	NN	0
when	when	WRB	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
are	are	VBP	0
induced	induced	VBN	0
to	to	TO	0
differentiate	differentiate	VB	0
in	in	IN	0
vitro	vitro	NN	B-NP
,	,	,	0
was	was	VBD	0
shown	shown	VBN	0
to	to	TO	0
be	be	VB	0
down-regulated	down-regulated	JJ	0
by	by	IN	0
Tat	Tat	NNP	0
at	at	IN	0
the	the	DT	0
transcriptional	transcriptional	JJ	B-NP
level	level	NN	I-NP
,	,	,	0
resulting	resulting	VBG	0
in	in	IN	0
the	the	DT	0
inhibition	inhibition	NN	0
of	of	IN	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
growth	growth	NN	I-NP
and	and	CC	0
in	in	IN	0
the	the	DT	0
transition	transition	NN	0
from	from	IN	0
a	a	DT	0
nonpolar	nonpolar	JJ	B-NP
cobblestone	cobblestone	JJ	I-NP
phenotype	phenotype	NN	I-NP
to	to	TO	0
a	a	DT	0
polar	polar	JJ	B-NP
fibroblast-like	fibroblast-like	JJ	I-NP
phenotypa	phenotypa	NN	I-NP
[	[	-LRB-	0
16	16	CD	0
]	]	-RRB-	0
.	.	.	0
When	When	WRB	0
examining	examining	VBG	0
the	the	DT	0
in	in	IN	0
hiv-1	hiv-1	NN	B-NP
tat	tat	NN	I-NP
protein	protein	NN	I-NP
vivo	vivo	JJ	I-NP
effect	effect	NN	I-NP
in	in	IN	0
the	the	DT	0
Xenopus	Xenopus	JJ	B-NP
embryo	embryo	NN	I-NP
,	,	,	0
it	it	PRP	0
was	was	VBD	0
found	found	VBN	0
that	that	IN	0
upon	upon	IN	0
synthetic	synthetic	JJ	B-NP
tat	tat	NN	I-NP
mrna	mrna	NN	I-NP
injection	injection	NN	I-NP
into	into	IN	0
zygote	zygote	NN	B-NP
,	,	,	0
a	a	DT	0
marked	marked	JJ	0
delay	delay	NN	0
in	in	IN	0
gastrulation	gastrulation	NN	B-NP
occurred	occurred	VBD	0
.	.	.	0
This	This	DT	0
led	led	VBN	0
to	to	TO	0
the	the	DT	0
altered	altered	JJ	0
anterior-posterior	anterior-posterior	JJ	B-NP
axis	axis	NN	I-NP
specification	specification	NN	I-NP
and	and	CC	0
partial	partial	JJ	0
loss	loss	NN	0
of	of	IN	0
the	the	DT	0
anterior	anterior	JJ	0
embryo	embryo	NN	B-NP
structure	structure	NN	I-NP
.	.	.	0
Mechanistically	Mechanistically	NNP	0
,	,	,	0
HIV-1	HIV-1	NNP	B-NP
Tat	Tat	NNP	I-NP
elicited	elicited	VBD	0
a	a	DT	0
general	general	JJ	0
suppression	suppression	NN	0
of	of	IN	0
gene	gene	NN	B-NP
expression	expression	NN	I-NP
,	,	,	0
including	including	VBG	0
that	that	IN	0
of	of	IN	0
Xbra	Xbra	NNP	B-NP
and	and	CC	0
gsc	gsc	NN	B-NP
,	,	,	0
two	two	CD	0
early	early	JJ	0
genes	genes	NNS	0
whose	whose	WP$	0
expression	expression	NNS	0
are	are	VBP	0
required	required	VBN	0
for	for	IN	0
proper	proper	JJ	0
gastrulation	gastrulation	NN	B-NP
[	[	-LRB-	0
17	17	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
relation	relation	NN	0
to	to	TO	0
the	the	DT	0
cell	cell	NN	B-NP
cycle	cycle	NN	I-NP
,	,	,	0
Tat	Tat	NNP	0
has	has	VBZ	0
also	also	RB	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
bind	bind	VB	0
to	to	TO	0
p53	p53	NN	B-NP
and	and	CC	0
inhibit	inhibit	VB	0
the	the	DT	0
p53	p53	NN	B-NP
responsive	responsive	JJ	I-NP
element	element	NN	I-NP
transcription	transcription	NN	I-NP
,	,	,	0
such	such	JJ	0
as	as	IN	0
the	the	DT	0
p21	p21	CD	B-NP
/	/	CD	0
Waf1	Waf1	CD	B-NP
gene	gene	NN	I-NP
promoter	promoter	NN	I-NP
.	.	.	0
Consequently	Consequently	RB	0
,	,	,	0
upon	upon	IN	0
stress	stress	NN	B-NP
signal	signal	JJ	I-NP
introduction	introduction	NN	I-NP
(	(	-LRB-	0
e.g.	e.g.	NNP	0
,	,	,	0
gamma	gamma	JJ	B-NP
irradiation	irradiation	NN	I-NP
)	)	-RRB-	0
,	,	,	0
hiv-1-infected	hiv-1-infected	NN	B-NP
cell	cell	NN	I-NP
lose	lose	VBP	0
their	their	PRP$	0
G1	G1	NNP	0
/	/	NNP	0
S	S	NNP	B-NP
checkpoint	checkpoint	NN	I-NP
,	,	,	0
enter	enter	VB	0
the	the	DT	0
S-phase	S-phase	JJ	B-NP
inappropriately	inappropriately	NN	0
,	,	,	0
and	and	CC	0
apoptosa	apoptosa	NN	B-NP
[	[	-LRB-	0
18	18	CD	0
19	19	CD	0
20	20	CD	0
]	]	-RRB-	0
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
the	the	DT	0
inhibition	inhibition	NN	0
of	of	IN	0
Tat	Tat	NNP	0
on	on	IN	0
translational	translational	JJ	B-NP
machinery	machinery	NN	I-NP
has	has	VBZ	0
also	also	RB	0
been	been	VBN	0
noted	noted	VBN	0
.	.	.	0
The	The	DT	0
tar	tar	NN	B-NP
rna	rna	NN	I-NP
region	region	NN	I-NP
potential	potential	JJ	I-NP
translational	translational	JJ	I-NP
inhibitory	inhibitory	JJ	I-NP
effect	effect	NN	I-NP
is	is	VBZ	0
mediated	mediated	VBN	0
by	by	IN	0
the	the	DT	0
p68	p68	NNP	B-NP
activation	activation	NN	I-NP
(	(	-LRB-	0
the	the	DT	0
interferon-induced	interferon-induced	JJ	0
68-kilodalton	68-kilodalton	CD	0
protein	protein	NN	0
kinase	kinase	NN	0
)	)	-RRB-	0
kinase	kinase	NN	B-NP
,	,	,	0
which	which	WDT	0
was	was	VBD	0
down-regulated	down-regulated	JJ	0
by	by	IN	0
Tat	Tat	NNP	0
during	during	IN	0
productive	productive	JJ	B-NP
HIV-1	HIV-1	NNP	I-NP
infection	infection	NN	I-NP
[	[	-LRB-	0
22	22	CD	0
]	]	-RRB-	0
.	.	.	0
Although	Although	IN	0
the	the	DT	0
mechanism	mechanism	NN	0
of	of	IN	0
the	the	DT	0
host	host	NN	0
cellular	cellular	JJ	B-NP
down-regulation	down-regulation	NN	I-NP
remains	remains	VBZ	0
largely	largely	RB	0
unknown	unknown	JJ	0
,	,	,	0
few	few	JJ	0
reports	reports	NNS	0
have	have	VBP	0
attempted	attempted	VBN	0
to	to	TO	0
decipher	decipher	VB	0
the	the	DT	0
mechanism	mechanism	NN	0
of	of	IN	0
the	the	DT	0
observed	observed	JJ	0
inhibition	inhibition	NN	0
.	.	.	0
For	For	IN	0
instance	instance	NN	0
,	,	,	0
the	the	DT	0
addition	addition	NN	B-NP
of	of	IN	0
Tat	Tat	NNP	0
to	to	TO	0
pc12	pc12	NN	B-NP
cell	cell	NN	I-NP
up-regulated	up-regulated	JJ	0
the	the	DT	0
expression	expression	NN	0
of	of	IN	0
the	the	DT	0
inducible	inducible	JJ	B-NP
cAMP	cAMP	JJ	I-NP
early	early	JJ	I-NP
repressor	repressor	NN	I-NP
(	(	-LRB-	0
inducible	inducible	NN	B-NP
camp	camp	JJ	I-NP
early	early	JJ	I-NP
repressor	repressor	NN	I-NP
)	)	-RRB-	0
,	,	,	0
a	a	DT	0
specific	specific	JJ	0
member	member	NN	0
of	of	IN	0
the	the	DT	0
cAMP-responsive	cAMP-responsive	JJ	B-NP
element	element	NN	I-NP
modulator	modulator	VBZ	0
transcription	transcription	JJ	B-NP
factor	factor	NN	I-NP
family	family	NN	I-NP
,	,	,	0
in	in	IN	0
a	a	DT	0
cAMP-dependent	cAMP-dependent	JJ	B-NP
manner	manner	NN	I-NP
.	.	.	0
In	In	IN	0
turn	turn	NN	0
,	,	,	0
inducible	inducible	NN	B-NP
camp	camp	JJ	I-NP
early	early	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
repressor	repressor	NN	I-NP
overexpression	overexpression	VBZ	0
abrogated	abrogated	VBG	0
the	the	DT	0
th	th	NN	B-NP
promoter	promoter	NN	I-NP
transcriptional	transcriptional	JJ	I-NP
activity	activity	NN	I-NP
,	,	,	0
strongly	strongly	RB	0
suggesting	suggesting	VBG	B-NP
ICER	ICER	NNP	I-NP
's	's	POS	I-NP
involvement	involvement	NN	0
in	in	IN	0
Tat-mediated	Tat-mediated	JJ	0
inhibition	inhibition	NN	0
of	of	IN	0
gene	gene	NN	B-NP
expression	expression	NN	I-NP
[	[	-LRB-	0
23	23	CD	0
]	]	-RRB-	0
.	.	.	0
Aside	Aside	RB	0
from	from	IN	0
inducible	inducible	NN	B-NP
camp	camp	JJ	I-NP
early	early	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
repressor	repressor	NN	I-NP
induction	induction	NN	I-NP
,	,	,	0
Tat	Tat	NNP	0
is	is	VBZ	0
capable	capable	JJ	0
of	of	IN	0
forming	forming	VBG	0
complex	complex	JJ	0
(	(	-LRB-	0
e	e	NN	B-NP
)	)	-RRB-	0
with	with	IN	0
a	a	DT	0
component	component	NN	0
of	of	IN	0
TFIID	TFIID	NNP	B-NP
,	,	,	0
TAF	TAF	NNP	B-NP
II	II	NNP	I-NP
250	250	CD	0
[	[	-LRB-	0
24	24	CD	0
]	]	-RRB-	0
and	and	CC	0
Tip60	Tip60	NNP	B-NP
[	[	-LRB-	0
25	25	CD	0
]	]	-RRB-	0
both	both	CC	0
of	of	IN	0
which	which	WDT	0
contain	contain	VBP	0
histone	histone	JJ	B-NP
acetyltransferasa	acetyltransferasa	NN	I-NP
(	(	-LRB-	0
histone	histone	NN	B-NP
acetyltransferase	acetyltransferase	NN	I-NP
)	)	-RRB-	0
activity	activity	NN	0
.	.	.	0
In	In	IN	0
these	these	DT	0
cases	cases	NNS	0
,	,	,	0
Tat-TAF	Tat-TAF	NNP	B-NP
II	II	NNP	I-NP
250	250	CD	0
and	and	CC	0
Tat-Tip60	Tat-Tip60	NNP	B-NP
do	do	VBP	0
not	not	RB	0
affect	affect	VB	0
the	the	DT	0
transcription	transcription	NN	B-NP
from	from	IN	0
the	the	DT	0
HIV-1	HIV-1	NNP	B-NP
LTR	LTR	NNP	I-NP
,	,	,	0
but	but	CC	0
interfere	interfere	VB	0
with	with	IN	0
the	the	DT	0
cellular	cellular	JJ	B-NP
gene	gene	NN	I-NP
transcription	transcription	JJ	I-NP
activity	activity	NN	I-NP
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
postulated	postulated	VBN	0
that	that	IN	0
different	different	JJ	0
targets	targets	NNS	0
of	of	IN	0
HATs	HATs	JJ	0
by	by	IN	0
Tat	Tat	NNP	0
have	have	VBP	0
different	different	JJ	0
consequence	consequence	NN	B-NP
.	.	.	0
The	The	DT	0
interaction	interaction	NN	0
of	of	IN	0
Tat	Tat	NNP	0
with	with	IN	0
p300	p300	NNP	B-NP
/	/	NNP	0
CBP	CBP	NNP	B-NP
and	and	CC	0
P	P	NNP	B-NP
/	/	NNP	I-NP
CAF	CAF	NNP	I-NP
stimulates	stimulates	VBD	0
its	its	PRP$	0
ability	ability	NN	B-NP
to	to	TO	0
transactivate	transactivate	VB	0
LTR-dependent	LTR-dependent	JJ	B-NP
transcription	transcription	NN	I-NP
,	,	,	0
while	while	IN	0
Tat-TAF	Tat-TAF	NNP	B-NP
II	II	NNP	I-NP
250	250	CD	0
or	or	CC	0
tat-tip60	tat-tip60	NN	B-NP
interaction	interaction	NN	I-NP
control	control	VBP	0
the	the	DT	0
cellular	cellular	JJ	B-NP
gene	gene	NN	I-NP
transcription	transcription	NN	I-NP
.	.	.	0
Here	Here	RB	0
to	to	TO	0
better	better	RB	0
understand	understand	VB	0
the	the	DT	0
host	host	NN	B-NP
response	response	NN	I-NP
to	to	TO	0
Tat	Tat	NNP	0
,	,	,	0
we	we	PRP	0
have	have	VBP	0
performed	performed	VBN	0
microarray	microarray	JJ	B-NP
experiment	experiment	NN	I-NP
on	on	IN	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
infected	infected	JJ	0
cells	cells	NNS	0
expressing	expressing	VBG	0
the	the	DT	0
Tat	Tat	JJ	B-NP
protein	protein	NN	I-NP
.	.	.	0
To	To	TO	0
our	our	PRP$	0
surprise	surprise	NN	0
many	many	JJ	0
host	host	NN	0
cellular	cellular	JJ	B-NP
gene	gene	NN	I-NP
were	were	VBD	0
down-regulated	down-regulated	JJ	0
when	when	WRB	0
comparing	comparing	VBG	B-NP
HIV-1	HIV-1	NNP	I-NP
infected	infected	VBD	0
latent	latent	JJ	0
cells	cells	NNS	0
to	to	TO	0
uninfected	uninfected	VB	0
parental	parental	JJ	0
cells	cells	NNS	0
.	.	.	0
Because	Because	IN	0
most	most	JJS	0
,	,	,	0
if	if	IN	0
not	not	RB	0
all	all	RB	0
,	,	,	0
latent	latent	JJ	0
infected	infected	JJ	0
cells	cells	NNS	0
available	available	JJ	0
to	to	TO	0
date	date	VB	0
(	(	-LRB-	0
e.g.	e.g.	NNP	0
,	,	,	0
ACH2	ACH2	NNP	B-NP
,	,	,	0
U1	U1	NNP	0
,	,	,	0
J1.1	J1.1	NNP	0
,	,	,	0
OM.10	OM.10	CD	B-NP
)	)	-RRB-	0
have	have	VBP	0
various	various	JJ	0
expression	expression	NN	B-NP
level	level	JJ	I-NP
of	of	IN	0
doubly	doubly	FW	0
spliced	spliced	FW	0
viral	viral	JJ	B-NP
mrna	mrna	NN	I-NP
,	,	,	0
including	including	VBG	B-NP
Tat	Tat	NNP	I-NP
,	,	,	0
Rev	Rev	NNP	B-NP
,	,	,	0
Nef	Nef	NNP	B-NP
,	,	,	0
Vpr	Vpr	NNP	B-NP
,	,	,	0
and	and	CC	0
other	other	JJ	0
accessory	accessory	JJ	B-NP
protein	protein	NN	I-NP
,	,	,	0
we	we	PRP	0
decided	decided	VBD	0
to	to	TO	0
perform	perform	VB	0
the	the	DT	0
microarray	microarray	NN	B-NP
in	in	IN	0
a	a	DT	0
system	system	NN	0
where	where	WRB	0
Tat	Tat	NNP	0
was	was	VBD	0
constitutively	constitutively	VBN	0
expressed	expressed	VBN	0
;	;	:	0
asking	asking	VBG	0
whether	whether	IN	0
Tat	Tat	NNP	0
by	by	IN	0
itself	itself	PRP	0
,	,	,	0
or	or	CC	0
in	in	IN	0
the	the	DT	0
absence	absence	NN	B-NP
of	of	IN	0
other	other	JJ	0
accessory	accessory	JJ	B-NP
protein	protein	NN	I-NP
,	,	,	0
could	could	MD	0
still	still	RB	0
down-regulate	down-regulate	JJ	0
host	host	NN	0
cellular	cellular	JJ	B-NP
gene	gene	NN	I-NP
.	.	.	0
Consistent	Consistent	JJ	0
with	with	IN	0
latently	latently	JJ	B-NP
infected	infected	JJ	I-NP
cell	cell	NN	I-NP
,	,	,	0
we	we	PRP	0
found	found	VBD	0
many	many	JJ	0
cellular	cellular	JJ	B-NP
gene	gene	NN	I-NP
to	to	TO	0
be	be	VB	0
down-regulated	down-regulated	JJ	0
in	in	IN	0
Tat	Tat	NNP	0
expressing	expressing	VBG	B-NP
lymphocyte	lymphocyte	NN	I-NP
.	.	.	0
The	The	DT	0
down-regulation	down-regulation	NN	B-NP
is	is	VBZ	0
most	most	RBS	0
apparent	apparent	JJ	0
on	on	IN	0
cellular	cellular	JJ	B-NP
receptor	receptor	NN	I-NP
that	that	WDT	0
have	have	VBP	0
intrinsic	intrinsic	JJ	B-NP
receptor	receptor	NN	I-NP
tyrosine	tyrosine	NN	I-NP
kinase	kinase	NN	I-NP
(	(	-LRB-	0
receptor	receptor	NN	B-NP
tyrosine	tyrosine	NN	I-NP
kinase	kinase	NN	I-NP
)	)	-RRB-	0
activity	activity	NN	0
and	and	CC	0
signal	signal	VB	0
transduction	transduction	JJ	B-NP
member	member	NN	I-NP
that	that	IN	0
mediate	mediate	JJ	0
RTK	RTK	NNP	B-NP
function	function	NN	I-NP
;	;	:	0
including	including	VBG	0
the	the	DT	0
Ras-Raf-MEK	Ras-Raf-MEK	JJ	B-NP
pathway	pathway	NN	I-NP
,	,	,	0
and	and	CC	0
co-activator	co-activator	NN	B-NP
such	such	JJ	0
as	as	IN	0
p300	p300	NNP	B-NP
/	/	NNP	0
CBP	CBP	NNP	B-NP
and	and	CC	0
SRC-1	SRC-1	NNP	B-NP
,	,	,	0
which	which	WDT	0
mediate	mediate	JJ	0
gene	gene	NN	B-NP
expression	expression	NN	I-NP
related	related	VBN	0
to	to	TO	0
hormone	hormone	VB	0
receptor	receptor	JJ	B-NP
gene	gene	NN	I-NP
.	.	.	0
Interestingly	Interestingly	RB	0
,	,	,	0
we	we	PRP	0
also	also	RB	0
s-phase	s-phase	NN	B-NP
gene	gene	NN	I-NP
observed	observed	VBD	I-NP
up-regulation	up-regulation	JJ	I-NP
,	,	,	0
as	as	RB	0
well	well	RB	0
as	as	IN	0
ribosomal	ribosomal	JJ	B-NP
gene	gene	NN	I-NP
involved	involved	VBN	0
in	in	IN	0
translation	translation	NN	0
.	.	.	0
Functionally	Functionally	NNP	0
,	,	,	0
receptor	receptor	NN	B-NP
down-regulation	down-regulation	JJ	I-NP
may	may	MD	0
allow	allow	VB	0
latent	latent	CD	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
infected	infected	JJ	0
cells	cells	NNS	0
to	to	TO	0
either	either	RB	0
hide	hide	VB	0
from	from	IN	0
the	the	DT	0
immune	immune	JJ	0
system	system	NN	0
or	or	CC	0
avoid	avoid	VB	0
extracellular	extracellular	JJ	B-NP
differentiation	differentiation	NN	I-NP
signals	signals	VBZ	0
normally	normally	RB	0
regulated	regulated	VBN	0
by	by	IN	0
receptor	receptor	NN	B-NP
.	.	.	0
s-phase	s-phase	NN	B-NP
up-regulation	up-regulation	NN	I-NP
and	and	CC	0
translation	translation	NN	B-NP
gene	gene	NN	I-NP
may	may	MD	0
allow	allow	VB	0
speeding	speeding	VBG	0
of	of	IN	0
cells	cells	NNS	0
through	through	IN	0
the	the	DT	0
S-phase	S-phase	JJ	B-NP
and	and	CC	0
subsequent	subsequent	JJ	0
accumulation	accumulation	NN	B-NP
at	at	IN	0
the	the	DT	0
G2	G2	JJ	B-NP
phase	phase	NN	I-NP
,	,	,	0
where	where	WRB	0
most	most	JJS	0
of	of	IN	0
the	the	DT	0
cellular	cellular	JJ	0
and	and	CC	0
viral	viral	JJ	B-NP
translation	translation	NN	I-NP
may	may	MD	0
take	take	VB	0
place	place	NN	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
Tat	Tat	NNP	0
may	may	MD	0
not	not	RB	0
only	only	RB	0
control	control	VB	0
activated	activated	VBN	B-NP
transcription	transcription	VBN	I-NP
on	on	IN	0
HIV-1	HIV-1	NNP	B-NP
LTR	LTR	NNP	I-NP
,	,	,	0
but	but	CC	0
also	also	RB	0
aid	aid	VB	0
in	in	IN	0
the	the	DT	0
subsequent	subsequent	JJ	0
translation	translation	NN	0
of	of	IN	0
viral	viral	JJ	B-NP
mRNA	mRNA	NN	I-NP
in	in	IN	0
the	the	DT	0
cytoplasm	cytoplasm	NN	B-NP
.	.	.	0
Results	Results	NNS	0
and	and	CC	0
discussion	discussion	NN	0
receptor	receptor	NN	B-NP
family	family	NN	I-NP
member	member	NN	I-NP
It	It	PRP	0
has	has	VBZ	0
long	long	RB	0
been	been	VBN	0
known	known	VBN	0
that	that	IN	0
infection	infection	NN	B-NP
by	by	IN	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
commonly	commonly	RB	0
leads	leads	VBZ	0
to	to	TO	0
the	the	DT	0
down-regulation	down-regulation	JJ	B-NP
and	and	CC	0
the	the	DT	0
cd4	cd4	NN	B-NP
receptor	receptor	NN	I-NP
disappearance	disappearance	NN	I-NP
from	from	IN	0
the	the	DT	0
plasma	plasma	JJ	0
membrane	membrane	NN	0
,	,	,	0
a	a	DT	0
phenomenon	phenomenon	NN	0
referred	referred	VBD	0
to	to	TO	0
as	as	RB	0
receptor	receptor	JJ	B-NP
down-modulation	down-modulation	NN	I-NP
.	.	.	0
This	This	DT	0
,	,	,	0
in	in	IN	0
turn	turn	NN	0
,	,	,	0
renders	renders	JJ	0
cells	cells	NNS	0
refractory	refractory	VBP	0
to	to	TO	0
subsequent	subsequent	JJ	0
infection	infection	NN	B-NP
by	by	IN	0
the	the	DT	0
same	same	JJ	0
or	or	CC	0
other	other	JJ	0
viruses	viruses	NN	0
that	that	WDT	0
use	use	VBP	0
the	the	DT	0
CD4	CD4	JJ	B-NP
receptor	receptor	NN	I-NP
for	for	IN	0
entry	entry	NN	0
;	;	:	0
thus	thus	RB	0
creating	creating	VBG	0
a	a	DT	0
state	state	NN	0
of	of	IN	0
super-infection	super-infection	JJ	B-NP
immunity	immunity	NN	I-NP
.	.	.	0
Results	Results	NNS	0
in	in	IN	0
Table	Table	NNP	0
1indicate	1indicate	NNP	0
that	that	IN	0
although	although	IN	0
few	few	JJ	0
receptor	receptor	NN	B-NP
gene	gene	NN	I-NP
were	were	VBD	0
up-regulated	up-regulated	JJ	0
,	,	,	0
most	most	JJS	0
of	of	IN	0
the	the	DT	0
cellular	cellular	JJ	B-NP
receptor	receptor	NN	I-NP
in	in	IN	0
general	general	JJ	0
,	,	,	0
were	were	VBD	0
down-regulated	down-regulated	JJ	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
the	the	DT	0
Tat	Tat	JJ	B-NP
protein	protein	NN	I-NP
.	.	.	0
Most	Most	JJS	0
of	of	IN	0
these	these	DT	0
receptor	receptor	NN	B-NP
or	or	CC	0
membranous	membranous	JJ	B-NP
protein	protein	NN	I-NP
were	were	VBD	0
initially	initially	RB	0
discovered	discovered	VBN	0
from	from	IN	0
immune	immune	JJ	0
or	or	CC	0
neuronal	neuronal	JJ	B-NP
cell	cell	NN	I-NP
,	,	,	0
hence	hence	RB	0
they	they	PRP	0
were	were	VBD	0
given	given	VBN	0
names	names	NNS	0
related	related	VBN	0
to	to	TO	0
the	the	DT	0
immune	immune	JJ	0
or	or	CC	0
nervous	nervous	JJ	0
system	system	NN	0
.	.	.	0
For	For	IN	0
instance	instance	NN	0
,	,	,	0
mRNA	mRNA	JJ	0
for	for	IN	0
the	the	DT	0
neuropeptide	neuropeptide	JJ	B-NP
Y-like	Y-like	JJ	I-NP
receptor	receptor	NN	I-NP
(	(	-LRB-	0
Acc	Acc	UH	B-NP
#	#	#	0
X71635	X71635	CD	0
)	)	-RRB-	0
,	,	,	0
which	which	WDT	0
was	was	VBD	0
up-regulated	up-regulated	JJ	0
in	in	IN	0
Tat	Tat	NNP	0
expressing	expressing	VBG	B-NP
cell	cell	NN	I-NP
,	,	,	0
was	was	VBD	0
initially	initially	RB	0
discovered	discovered	VBN	0
as	as	IN	0
a	a	DT	0
G-protein	G-protein	JJ	B-NP
coupled	coupled	JJ	0
neuropeptide	neuropeptide	JJ	B-NP
Y	Y	NN	I-NP
receptor	receptor	NN	I-NP
,	,	,	0
and	and	CC	0
later	later	RB	0
found	found	VBN	0
to	to	TO	0
be	be	VB	0
homologous	homologous	VBN	0
to	to	TO	0
the	the	DT	0
co-receptor	co-receptor	JJ	B-NP
CCR5	CCR5	NN	I-NP
needed	needed	VBN	0
for	for	IN	0
monocyte/macrophage	monocyte/macrophage	NN	B-NP
cell	cell	NN	I-NP
hiv-1	hiv-1	NN	I-NP
infection	infection	NN	I-NP
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
most	most	JJS	0
of	of	IN	0
the	the	DT	0
receptor	receptor	NN	B-NP
listed	listed	VBN	0
in	in	IN	0
Table	Table	NNP	0
1may	1may	NNP	0
in	in	IN	0
fact	fact	NN	0
be	be	VB	0
expressed	expressed	VBN	0
in	in	IN	0
various	various	JJ	0
tissues	tissues	NNS	0
and	and	CC	0
have	have	VBP	0
multiple	multiple	JJ	0
functions	functions	NNS	0
.	.	.	0
Consistent	Consistent	JJ	0
with	with	IN	0
our	our	PRP$	0
microarray	microarray	JJ	B-NP
result	result	NN	I-NP
on	on	IN	0
CCR5	CCR5	NNP	B-NP
up-regulation	up-regulation	NNP	I-NP
,	,	,	0
experiments	experiments	NNS	0
performed	performed	VBN	0
in	in	IN	0
peripheral	peripheral	JJ	B-NP
blood	blood	NN	I-NP
mononuclear	mononuclear	NN	I-NP
cell	cell	NN	I-NP
(	(	-LRB-	0
peripheral	peripheral	JJ	B-NP
blood	blood	NN	I-NP
mononuclear	mononuclear	NN	I-NP
cell	cell	NN	I-NP
)	)	-RRB-	0
with	with	IN	0
soluble	soluble	JJ	0
Tat	Tat	NNP	0
has	has	VBZ	0
shown	shown	VBN	0
selective	selective	JJ	B-NP
entry	entry	NN	I-NP
and	and	CC	0
ccr5	ccr5	NN	B-NP
virus	virus	NN	I-NP
replication	replication	NN	I-NP
into	into	IN	0
cells	cells	NNS	0
[	[	-LRB-	0
27	27	CD	0
28	28	CD	0
]	]	-RRB-	0
.	.	.	0
hiv-1	hiv-1	NN	B-NP
coreceptor	coreceptor	NN	I-NP
up-regulation	up-regulation	NN	I-NP
by	by	IN	0
Tat	Tat	NNP	0
has	has	VBZ	0
also	also	RB	0
been	been	VBN	0
reported	reported	VBN	0
,	,	,	0
where	where	WRB	0
a	a	DT	0
synthetic	synthetic	JJ	B-NP
Tat	Tat	JJ	I-NP
protein	protein	NN	I-NP
that	that	WDT	0
was	was	VBD	0
immobilized	immobilized	VBN	0
on	on	IN	0
a	a	DT	0
solid	solid	JJ	0
substrate	substrate	NN	0
,	,	,	0
up-regulated	up-regulated	JJ	0
the	the	DT	0
surface	surface	NN	0
expression	expression	NN	0
of	of	IN	0
the	the	DT	0
chemokine	chemokine	JJ	B-NP
receptor	receptor	NN	I-NP
in	in	IN	0
purified	purified	JJ	0
populations	populations	NNS	0
of	of	IN	0
primary	primary	JJ	B-NP
resting	resting	NN	I-NP
CD4+	CD4+	CD	I-NP
t	t	NN	B-NP
cell	cell	NN	I-NP
.	.	.	0
Also	Also	RB	0
,	,	,	0
a	a	DT	0
similar	similar	JJ	0
result	result	NN	0
was	was	VBD	0
seen	seen	VBN	0
from	from	IN	0
Tat	Tat	NNP	B-NP
protein	protein	NN	I-NP
actively	actively	RB	0
released	released	VBN	0
by	by	IN	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
infected	infected	JJ	0
cells	cells	NNS	0
,	,	,	0
implying	implying	VBG	0
a	a	DT	0
potentially	potentially	RB	0
important	important	JJ	0
role	role	NN	0
for	for	IN	0
extracellular	extracellular	JJ	B-NP
Tat	Tat	NN	I-NP
in	in	IN	0
rendering	rendering	VBG	0
the	the	DT	0
bystander	bystander	JJ	B-NP
CD4+	CD4+	CD	I-NP
t	t	NN	B-NP
cell	cell	NN	I-NP
more	more	RBR	0
susceptible	susceptible	JJ	0
to	to	TO	0
infection	infection	VB	B-NP
[	[	-LRB-	0
28	28	CD	0
]	]	-RRB-	0
.	.	.	0
We	We	PRP	0
therefore	therefore	RB	0
tested	tested	VBN	0
whether	whether	IN	0
H9	H9	NNP	0
/	/	NNP	0
Tat	Tat	NNP	0
cells	cells	NNS	0
,	,	,	0
which	which	WDT	0
showed	showed	VBD	0
an	an	DT	0
increase	increase	NN	0
in	in	IN	0
CCR5	CCR5	CD	B-NP
expression	expression	NN	I-NP
,	,	,	0
could	could	MD	0
in	in	IN	0
fact	fact	NN	0
allow	allow	VB	0
better	better	JJR	0
entry	entry	NN	0
and	and	CC	0
ccr5	ccr5	NN	B-NP
infection	infection	NN	I-NP
(	(	-LRB-	0
R5	R5	NNP	0
)	)	-RRB-	0
virus	virus	NN	0
into	into	IN	0
cells	cells	NNS	0
.	.	.	0
Figure	Figure	NN	0
3Ashows	3Ashows	VBZ	0
the	the	DT	0
result	result	NN	0
of	of	IN	0
such	such	PDT	0
an	an	DT	0
experiment	experiment	NN	0
,	,	,	0
where	where	WRB	0
H9	H9	NNP	0
/	/	NNP	0
Tat	Tat	NNP	0
cells	cells	NNS	0
allowed	allowed	VBD	0
a	a	DT	0
better	better	RBR	0
replication	replication	JJ	B-NP
profile	profile	NN	I-NP
of	of	IN	0
the	the	DT	0
R5	R5	NN	0
than	than	IN	0
the	the	DT	0
CXCR4	CXCR4	NNP	B-NP
(	(	-LRB-	0
X4	X4	NNP	0
)	)	-RRB-	0
virus	virus	NN	0
.	.	.	0
The	The	DT	0
increase	increase	NN	0
in	in	IN	0
viral	viral	JJ	B-NP
titer	titer	NN	I-NP
peaked	peaked	VBN	0
after	after	IN	0
some	some	DT	0
18	18	CD	0
days	days	NNS	0
of	of	IN	0
infection	infection	NN	B-NP
with	with	IN	0
the	the	DT	0
R5	R5	JJ	B-NP
virus	virus	NN	I-NP
,	,	,	0
further	further	RB	0
implying	implying	VBG	0
that	that	IN	0
the	the	DT	0
CCR5	CCR5	NNP	B-NP
co-receptor	co-receptor	NNP	I-NP
allowed	allowed	VBD	0
a	a	DT	0
better	better	JJR	0
selection	selection	NN	0
of	of	IN	0
R5	R5	CD	B-NP
virus	virus	NN	I-NP
in	in	IN	0
Tat	Tat	NNP	0
expressing	expressing	VBG	B-NP
cell	cell	NN	I-NP
.	.	.	0
Another	Another	DT	0
example	example	NN	0
of	of	IN	0
co-receptor	co-receptor	NN	B-NP
with	with	IN	0
multiple	multiple	JJ	0
functions	functions	NNS	0
is	is	VBZ	0
the	the	DT	0
leukotriene	leukotriene	JJ	B-NP
family	family	NN	I-NP
member	member	NN	I-NP
B4	B4	NN	I-NP
,	,	,	0
which	which	WDT	0
was	was	VBD	0
down-regulated	down-regulated	JJ	0
in	in	IN	0
Tat	Tat	NNP	0
expressing	expressing	VBG	B-NP
cell	cell	NN	I-NP
(	(	-LRB-	0
Acc	Acc	UH	B-NP
#	#	#	0
D89078	D89078	CD	0
,	,	,	0
Table	Table	NNP	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
cysteinyl	cysteinyl	JJ	B-NP
leukotriene	leukotriene	NN	I-NP
(	(	-LRB-	0
cysteinyl	cysteinyl	NN	B-NP
leukotriene	leukotriene	NN	I-NP
)	)	-RRB-	0
,	,	,	0
LTC	LTC	NNP	B-NP
,	,	,	0
LTD	LTD	NNP	0
,	,	,	0
and	and	CC	0
LTE	LTE	NNP	B-NP
,	,	,	0
were	were	VBD	0
first	first	RB	0
shown	shown	VBN	0
to	to	TO	0
be	be	VB	0
essential	essential	JJ	B-NP
mediator	mediator	NN	I-NP
in	in	IN	0
asthma	asthma	NN	B-NP
[	[	-LRB-	0
29	29	CD	0
]	]	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
when	when	WRB	0
the	the	DT	0
mouse	mouse	NN	B-NP
leukotriene	leukotriene	NN	I-NP
B4	B4	NN	I-NP
receptor	receptor	NN	I-NP
(	(	-LRB-	0
m-BLTR	m-BLTR	NNP	B-NP
)	)	-RRB-	0
gene	gene	NN	0
,	,	,	0
was	was	VBD	0
cloned	cloned	VBN	0
it	it	PRP	0
was	was	VBD	0
shown	shown	VBN	0
to	to	TO	0
have	have	VB	0
significant	significant	JJ	0
sequence	sequence	NN	B-NP
homology	homology	NN	I-NP
with	with	IN	0
chemokine	chemokine	JJ	B-NP
receptor	receptor	NN	I-NP
(	(	-LRB-	0
CCR5	CCR5	NNP	B-NP
and	and	CC	0
CXCR4	CXCR4	CD	B-NP
)	)	-RRB-	0
,	,	,	0
co-receptor	co-receptor	NN	B-NP
for	for	IN	0
many	many	JJ	0
different	different	JJ	0
hiv-1	hiv-1	NN	B-NP
clade	clade	NN	I-NP
[	[	-LRB-	0
30	30	CD	0
]	]	-RRB-	0
.	.	.	0
Along	Along	IN	0
the	the	DT	0
same	same	JJ	0
lines	lines	NNS	0
,	,	,	0
when	when	WRB	0
cells	cells	NNS	0
were	were	VBD	0
infected	infected	VBN	0
with	with	IN	0
10	10	CD	0
primary	primary	JJ	B-NP
clinical	clinical	JJ	I-NP
isolates	isolates	NN	0
of	of	IN	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
,	,	,	0
leukotriene	leukotriene	CD	B-NP
B4	B4	CD	I-NP
receptor	receptor	NN	I-NP
was	was	VBD	0
primarily	primarily	RB	0
utilized	utilized	VBN	0
for	for	IN	0
efficient	efficient	JJ	0
entry	entry	NN	0
into	into	IN	0
cells	cells	NNS	0
which	which	WDT	0
were	were	VBD	0
mainly	mainly	RB	0
of	of	IN	0
the	the	DT	0
syncytium-inducing	syncytium-inducing	JJ	B-NP
phenotypa	phenotypa	NN	I-NP
[	[	-LRB-	0
31	31	CD	0
]	]	-RRB-	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
neuropeptide	neuropeptide	JJ	B-NP
y-like	y-like	NN	I-NP
receptor	receptor	NN	I-NP
up-regulation	up-regulation	JJ	I-NP
and	and	CC	0
leukotriene	leukotriene	CD	B-NP
b4	b4	NN	I-NP
receptor	receptor	NN	I-NP
down-regulation	down-regulation	JJ	I-NP
in	in	IN	0
Tat	Tat	NNP	0
expressing	expressing	VBG	B-NP
cell	cell	NN	I-NP
indicates	indicates	VBZ	0
a	a	DT	0
selective	selective	JJ	B-NP
advantage	advantage	NN	I-NP
of	of	IN	0
one	one	CD	0
class	class	NN	0
of	of	IN	0
virus	virus	NN	0
(	(	-LRB-	0
CCR5	CCR5	NNP	B-NP
)	)	-RRB-	0
over	over	IN	0
another	another	DT	0
(	(	-LRB-	0
CXCR4	CXCR4	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
Other	Other	JJ	0
examples	examples	NNS	0
of	of	IN	0
consistency	consistency	NN	0
between	between	IN	0
our	our	PRP$	0
microarray	microarray	JJ	B-NP
result	result	NN	I-NP
on	on	IN	0
receptor	receptor	NN	B-NP
and	and	CC	0
the	the	DT	0
HIV-1	HIV-1	NNP	B-NP
Tat	Tat	NNP	I-NP
literature	literature	NN	I-NP
,	,	,	0
include	include	VBP	0
the	the	DT	0
gene	gene	NN	B-NP
expression	expression	NN	I-NP
down-regulation	down-regulation	JJ	I-NP
in	in	IN	0
urokinase	urokinase	NN	B-NP
type	type	NN	I-NP
plasminogen	plasminogen	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
activator	activator	NN	I-NP
receptor	receptor	NN	I-NP
(	(	-LRB-	0
Acc	Acc	UH	B-NP
#	#	#	0
X74039	X74039	CD	0
)	)	-RRB-	0
,	,	,	0
IP3	IP3	NNP	B-NP
(	(	-LRB-	0
Acc	Acc	UH	B-NP
#	#	#	0
D26070	D26070	CD	0
,	,	,	0
D26351	D26351	CD	0
)	)	-RRB-	0
,	,	,	0
Glu	Glu	NNP	B-NP
R	R	NNP	I-NP
flop	flop	NNS	0
(	(	-LRB-	0
Acc	Acc	UH	B-NP
#	#	#	0
U10302	U10302	CD	0
)	)	-RRB-	0
,	,	,	0
PPAR	PPAR	NNP	B-NP
(	(	-LRB-	0
Acc	Acc	UH	B-NP
#	#	#	0
L07592	L07592	CD	0
)	)	-RRB-	0
,	,	,	0
alpha-2	alpha-2	NN	B-NP
macroglobulin	macroglobulin	NN	I-NP
receptor	receptor	NN	I-NP
protein	protein	NN	I-NP
(	(	-LRB-	0
Acc	Acc	UH	B-NP
#	#	#	0
M63959	M63959	CD	0
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
receptor	receptor	NN	B-NP
tyrosine	tyrosine	NN	I-NP
kinase	kinase	NN	I-NP
(	(	-LRB-	0
Acc	Acc	UH	B-NP
#	#	#	0
L36645	L36645	CD	0
,	,	,	0
U66406	U66406	CD	0
)	)	-RRB-	0
genes	genes	NNS	0
.	.	.	0
The	The	DT	0
transmembranou	transmembranou	NN	B-NP
urokinase-type	urokinase-type	NN	I-NP
plasminogen	plasminogen	NN	I-NP
activator	activator	NN	I-NP
receptor	receptor	NN	I-NP
(	(	-LRB-	0
urokinase	urokinase	NN	B-NP
type	type	NN	I-NP
plasminogen	plasminogen	NN	I-NP
activator	activator	NN	I-NP
receptor	receptor	NN	I-NP
;	;	:	0
CD87	CD87	CD	0
)	)	-RRB-	0
focuses	focuses	VBZ	0
the	the	DT	0
formation	formation	NN	0
of	of	IN	0
active	active	JJ	0
plasmin	plasmin	NN	B-NP
at	at	IN	0
the	the	DT	0
cell	cell	NN	0
surface	surface	NN	0
,	,	,	0
thus	thus	RB	0
enhancing	enhancing	VBG	0
directional	directional	JJ	B-NP
extracellular	extracellular	JJ	I-NP
proteolysi	proteolysi	NN	I-NP
.	.	.	0
Interestingly	Interestingly	RB	0
,	,	,	0
the	the	DT	0
cd87	cd87	NN	B-NP
gene	gene	NN	I-NP
promoter	promoter	NN	I-NP
activity	activity	NN	I-NP
was	was	VBD	0
shown	shown	VBN	0
to	to	TO	0
decline	decline	VB	0
after	after	IN	0
infection	infection	NN	B-NP
[	[	-LRB-	0
32	32	CD	0
]	]	-RRB-	0
,	,	,	0
implying	implying	VBG	0
that	that	DT	0
post	post	NN	0
integration	integration	NN	0
of	of	IN	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
may	may	MD	0
in	in	IN	0
fact	fact	NN	0
down-regulate	down-regulate	JJ	0
CD87	CD87	CD	B-NP
gene	gene	NN	I-NP
expression	expression	NN	I-NP
.	.	.	0
Similarly	Similarly	RB	0
,	,	,	0
inositol	inositol	NN	B-NP
1,4,5-trisphosphate	1,4,5-trisphosphate	FW	0
receptors	receptors	FW	0
(	(	-LRB-	0
IP3R	IP3R	NNP	0
)	)	-RRB-	0
are	are	VBP	0
intracellular	intracellular	JJ	B-NP
calcium	calcium	NN	I-NP
release	release	NN	I-NP
channel	channel	NN	I-NP
involved	involved	VBN	0
in	in	IN	0
diverse	diverse	JJ	B-NP
signaling	signaling	JJ	I-NP
pathway	pathway	NN	I-NP
and	and	CC	0
are	are	VBP	0
required	required	VBN	0
for	for	IN	0
the	the	DT	0
t	t	NN	B-NP
lymphocyte	lymphocyte	NN	I-NP
activation	activation	NN	I-NP
[	[	-LRB-	0
33	33	CD	0
]	]	-RRB-	0
.	.	.	0
Tat	Tat	NNP	0
(	(	-LRB-	0
also	also	RB	0
implicated	implicated	VBN	0
as	as	IN	0
a	a	DT	0
neurotoxin	neurotoxin	NN	B-NP
)	)	-RRB-	0
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
release	release	VB	0
calcium	calcium	VBN	B-NP
from	from	IN	0
inositol	inositol	CD	B-NP
1,4	1,4	CD	0
,	,	,	0
5-trisphosphate	5-trisphosphate	NNP	0
(	(	-LRB-	0
IP3	IP3	NNP	B-NP
)	)	-RRB-	0
receptor-regulated	receptor-regulated	JJ	B-NP
store	store	NN	I-NP
in	in	IN	0
neuron	neuron	NN	B-NP
and	and	CC	0
astrocytes	astrocytes	VBP	0
causing	causing	VBG	0
premature	premature	JJ	0
apoptosi	apoptosi	NN	B-NP
[	[	-LRB-	0
34	34	CD	0
]	]	-RRB-	0
.	.	.	0
Down-regulation	Down-regulation	JJ	B-NP
of	of	IN	0
IP3	IP3	NNP	B-NP
may	may	MD	0
therefore	therefore	RB	0
contribute	contribute	VB	0
to	to	TO	0
viral	viral	JJ	B-NP
latency	latency	NN	I-NP
and	and	CC	0
maintenance	maintenance	NN	0
of	of	IN	0
an	an	DT	0
anti-apoptotic	anti-apoptotic	JJ	B-NP
state	state	NN	I-NP
in	in	IN	0
cells	cells	NNS	0
.	.	.	0
HIV-1	HIV-1	NNP	B-NP
infection	infection	NN	I-NP
can	can	MD	0
cause	cause	VB	0
extensive	extensive	JJ	B-NP
neuronal	neuronal	JJ	I-NP
loss	loss	NN	I-NP
and	and	CC	0
clinically	clinically	RB	0
,	,	,	0
a	a	DT	0
severe	severe	JJ	0
dementia	dementia	NN	B-NP
.	.	.	0
The	The	DT	0
cause	cause	NN	0
of	of	IN	0
the	the	DT	0
neurotoxicity	neurotoxicity	NN	B-NP
remains	remains	VBZ	0
unclear	unclear	JJ	0
as	as	IN	0
neuron	neuron	NN	B-NP
are	are	VBP	0
not	not	RB	0
infected	infected	VBN	0
,	,	,	0
but	but	CC	0
the	the	DT	0
disturbance	disturbance	NN	0
of	of	IN	0
glutamate-linked	glutamate-linked	JJ	0
calcium	calcium	NN	B-NP
entry	entry	NN	I-NP
has	has	VBZ	0
been	been	VBN	0
implicated	implicated	VBN	0
.	.	.	0
It	It	PRP	0
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
that	that	IN	0
HIV-infected	HIV-infected	JJ	B-NP
brain	brain	NN	I-NP
has	has	VBZ	0
a	a	DT	0
decrease	decrease	NN	0
of	of	IN	0
mRNA	mRNA	JJ	0
and	and	CC	0
glur-a	glur-a	NN	B-NP
protein	protein	NN	I-NP
flop	flop	JJ	0
alpha-amino-3-hydroxy-5-methyl-4-isoxazole	alpha-amino-3-hydroxy-5-methyl-4-isoxazole	CD	B-NP
propionic	propionic	JJ	I-NP
acid	acid	NN	I-NP
subtype	subtype	NN	I-NP
(	(	-LRB-	0
AMPA	AMPA	NNP	B-NP
)	)	-RRB-	0
glutamate	glutamate	JJ	B-NP
receptor	receptor	NN	I-NP
in	in	IN	0
cerebellar	cerebellar	JJ	B-NP
purkinje	purkinje	NN	I-NP
cell	cell	NN	I-NP
.	.	.	0
The	The	DT	0
observed	observed	JJ	0
disturbance	disturbance	NN	0
of	of	IN	0
ampa	ampa	NN	B-NP
receptor	receptor	NN	I-NP
may	may	MD	0
contribute	contribute	VB	0
to	to	TO	0
the	the	DT	0
neurotoxic	neurotoxic	JJ	B-NP
process	process	NN	I-NP
in	in	IN	0
other	other	JJ	0
vulnerable	vulnerable	JJ	0
brain	brain	NN	0
regions	regions	NNS	0
and	and	CC	0
clinically	clinically	RB	0
to	to	TO	0
the	the	DT	0
development	development	NN	0
of	of	IN	0
dementia	dementia	NN	B-NP
[	[	-LRB-	0
35	35	CD	0
]	]	-RRB-	0
.	.	.	0
Interestingly	Interestingly	RB	0
,	,	,	0
in	in	IN	0
a	a	DT	0
mouse	mouse	NN	B-NP
model	model	NN	I-NP
ampa	ampa	NN	I-NP
receptor	receptor	NN	I-NP
in	in	IN	0
the	the	DT	0
cortex	cortex	NN	0
,	,	,	0
striatum	striatum	NN	B-NP
,	,	,	0
hippocampus	hippocampus	NN	B-NP
,	,	,	0
and	and	CC	0
cerebellum	cerebellum	NN	B-NP
declined	declined	VBD	0
by	by	IN	0
29-50	29-50	CD	0
%	%	NN	0
as	as	IN	0
early	early	JJ	0
as	as	IN	0
8	8	CD	0
weeks	weeks	NNS	0
post-retroviral	post-retroviral	JJ	B-NP
inoculation	inoculation	NN	I-NP
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
the	the	DT	0
reduction	reduction	NN	0
in	in	IN	0
AMPA	AMPA	NNP	B-NP
receptor	receptor	NN	I-NP
density	density	NN	I-NP
may	may	MD	0
contribute	contribute	VB	0
to	to	TO	0
the	the	DT	0
development	development	NN	0
of	of	IN	0
the	the	DT	0
cognitive	cognitive	JJ	B-NP
abnormality	abnormality	NN	I-NP
associated	associated	VBN	0
with	with	IN	0
HIV-1	HIV-1	NNP	B-NP
infection	infection	NN	I-NP
[	[	-LRB-	0
36	36	CD	0
]	]	-RRB-	0
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
patients	patients	NNS	0
with	with	IN	0
AIDS	AIDS	NNP	0
who	who	WP	0
are	are	VBP	0
receiving	receiving	VBG	B-NP
therapy	therapy	NN	I-NP
with	with	IN	0
hiv-1	hiv-1	NN	B-NP
protease	protease	CD	I-NP
inhibitor	inhibitor	NN	I-NP
have	have	VBP	0
been	been	VBN	0
reported	reported	VBN	0
to	to	TO	0
be	be	VB	0
afflicted	afflicted	VBN	0
with	with	IN	0
a	a	DT	0
syndrome	syndrome	NN	0
characterized	characterized	VBN	0
by	by	IN	0
lipodystrophy	lipodystrophy	NN	B-NP
(	(	-LRB-	0
fat	fat	JJ	0
redistribution	redistribution	NN	B-NP
favoring	favoring	VBG	0
the	the	DT	0
accumulation	accumulation	NN	B-NP
of	of	IN	0
abdominal	abdominal	NN	0
and	and	CC	0
cervical	cervical	JJ	B-NP
adipose	adipose	JJ	I-NP
tissue	tissue	NN	I-NP
)	)	-RRB-	0
,	,	,	0
hyperlipidemia	hyperlipidemia	NN	B-NP
,	,	,	0
and	and	CC	0
insulin	insulin	NN	0
resistance	resistance	NN	0
.	.	.	0
potential	potential	JJ	B-NP
mechanism	mechanism	NN	I-NP
for	for	IN	0
altered	altered	JJ	0
adipocyte	adipocyte	JJ	B-NP
function	function	NN	I-NP
include	include	VBP	0
,	,	,	0
direct	direct	JJ	0
binding	binding	NN	0
to	to	TO	0
PPARgamma	PPARgamma	JJ	0
or	or	CC	0
inhibition	inhibition	NN	0
of	of	IN	0
ppargamma	ppargamma	NN	B-NP
promoter	promoter	NN	I-NP
transcription	transcription	NN	I-NP
[	[	-LRB-	0
37	37	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
lipodystrophy	lipodystrophy	JJ	B-NP
syndrome	syndrome	NN	I-NP
may	may	MD	0
be	be	VB	0
a	a	DT	0
result	result	NN	0
of	of	IN	0
the	the	DT	0
inhibition	inhibition	NN	0
of	of	IN	0
2	2	CD	0
proteins	proteins	NNS	0
involved	involved	VBN	0
in	in	IN	0
lipid	lipid	JJ	B-NP
metabolism	metabolism	NN	I-NP
that	that	WDT	0
have	have	VBP	0
significant	significant	JJ	0
homology	homology	NN	B-NP
to	to	TO	0
the	the	DT	0
catalytic	catalytic	JJ	B-NP
site	site	NN	I-NP
of	of	IN	0
HIV	HIV	NNP	B-NP
proteases	proteases	NN	0
;	;	:	0
namely	namely	FW	0
binding	binding	JJ	B-NP
protein	protein	NN	I-NP
type	type	NN	I-NP
cytoplasmic	cytoplasmic	NN	I-NP
retinoic	retinoic	NN	I-NP
acid	acid	JJ	I-NP
1	1	CD	0
and	and	CC	0
low	low	JJ	0
density	density	JJ	B-NP
lipoprotein-receptor-related	lipoprotein-receptor-related	JJ	I-NP
protein	protein	NN	I-NP
[	[	-LRB-	0
38	38	CD	0
]	]	-RRB-	0
.	.	.	0
An	An	DT	0
additional	additional	JJ	0
mechanism	mechanism	NN	0
of	of	IN	0
PPAR	PPAR	NNP	B-NP
down-regulation	down-regulation	NNP	I-NP
may	may	MD	0
be	be	VB	0
related	related	VBN	0
to	to	TO	0
Tat	Tat	NNP	0
expression	expression	NN	0
in	in	IN	0
latent	latent	JJ	0
cells	cells	NNS	0
.	.	.	0
Translation	Translation	NN	0
associated	associated	VBN	B-NP
factor	factor	NN	I-NP
Viruses	Viruses	NNS	0
have	have	VBP	0
evolved	evolved	VBN	0
a	a	DT	0
remarkable	remarkable	JJ	0
variety	variety	NN	0
of	of	IN	0
strategies	strategies	NNS	0
to	to	TO	0
modulate	modulate	VB	0
the	the	DT	0
host	host	NN	B-NP
cell	cell	NN	I-NP
translation	translation	NN	I-NP
apparatus	apparatus	NN	I-NP
with	with	IN	0
the	the	DT	0
aim	aim	NN	0
of	of	IN	0
optimizing	optimizing	JJ	B-NP
viral	viral	JJ	I-NP
mRNA	mRNA	JJ	I-NP
translation	translation	NN	I-NP
and	and	CC	0
replication	replication	NN	B-NP
.	.	.	0
For	For	IN	0
instance	instance	NN	0
,	,	,	0
viruses	viruses	VBZ	0
simplex	simplex	JJ	B-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
including	including	VBG	I-NP
herpes	herpes	NN	I-NP
1	1	CD	0
(	(	-LRB-	0
herpes	herpes	NN	B-NP
simplex	simplex	NN	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
)	)	-RRB-	0
have	have	VBP	0
been	been	VBN	0
known	known	VBN	0
to	to	TO	0
induce	induce	VB	0
severe	severe	JJ	0
alterations	alterations	NN	0
of	of	IN	0
the	the	DT	0
host	host	NN	B-NP
translational	translational	NN	I-NP
apparatus	apparatus	NN	I-NP
,	,	,	0
including	including	VBG	0
the	the	DT	0
ribosomal	ribosomal	JJ	B-NP
protein	protein	NN	I-NP
up-regulation	up-regulation	JJ	I-NP
and	and	CC	0
the	the	DT	0
progressive	progressive	JJ	B-NP
association	association	NN	I-NP
of	of	IN	0
several	several	JJ	0
nonribosomal	nonribosomal	JJ	B-NP
protein	protein	NN	I-NP
,	,	,	0
such	such	JJ	0
as	as	IN	0
VP19C	VP19C	NNP	0
,	,	,	0
VP26	VP26	NNP	B-NP
,	,	,	0
and	and	CC	0
the	the	DT	0
poly	poly	NN	B-NP
(	(	-LRB-	I-NP
A	A	NNP	I-NP
)	)	-RRB-	I-NP
-binding	-binding	JJ	I-NP
protein	protein	NN	I-NP
1	1	CD	0
(	(	-LRB-	0
PAB1P	PAB1P	NNP	0
)	)	-RRB-	0
to	to	TO	0
ribosomes	ribosomes	VB	0
[	[	-LRB-	0
39	39	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
the	the	DT	0
case	case	NN	0
of	of	IN	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
,	,	,	0
approximately	approximately	RB	0
one	one	CD	0
infectious	infectious	CD	B-NP
HIV-1	HIV-1	CD	I-NP
genome	genome	NN	I-NP
in	in	IN	0
an	an	DT	0
infected	infected	JJ	0
cell	cell	NN	0
could	could	MD	0
be	be	VB	0
transcribed	transcribed	NNS	0
and	and	CC	0
translated	translated	VBN	0
into	into	IN	0
50,000	50,000	CD	0
to	to	TO	0
100,000	100,000	CD	0
physical	physical	JJ	B-NP
particle	particle	NN	I-NP
[	[	-LRB-	0
40	40	CD	0
]	]	-RRB-	0
.	.	.	0
This	This	DT	0
poses	poses	VBZ	0
an	an	DT	0
immense	immense	JJ	0
challenge	challenge	NN	0
for	for	IN	0
the	the	DT	0
virus	virus	NN	0
to	to	TO	0
be	be	VB	0
able	able	JJ	0
to	to	TO	0
transcribe	transcribe	VB	0
,	,	,	0
splice	splice	NN	0
,	,	,	0
transport	transport	NN	0
,	,	,	0
and	and	CC	0
translate	translate	VB	0
its	its	PRP$	0
RNA	RNA	NNP	B-NP
into	into	IN	0
fully	fully	RB	0
packaged	packaged	VBN	0
virions	virions	VBN	0
in	in	IN	0
a	a	DT	0
timely	timely	JJ	0
fashion	fashion	NN	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
it	it	PRP	0
would	would	MD	0
be	be	VB	0
advantageous	advantageous	VBN	0
for	for	IN	0
the	the	DT	0
virus	virus	NN	0
to	to	TO	0
set	set	VB	0
the	the	DT	0
stage	stage	NN	0
for	for	IN	0
each	each	DT	0
successive	successive	JJ	0
step	step	NN	0
necessary	necessary	JJ	0
for	for	IN	0
viral	viral	JJ	B-NP
progeny	progeny	JJ	I-NP
formation	formation	NN	I-NP
.	.	.	0
One	One	CD	0
such	such	JJ	0
event	event	NN	0
is	is	VBZ	0
Tat	Tat	NNP	0
's	's	POS	0
ability	ability	NN	B-NP
to	to	TO	0
control	control	VB	0
genes	genes	NNS	0
that	that	IN	0
aid	aid	NN	0
in	in	IN	0
translational	translational	JJ	B-NP
machinery	machinery	NN	I-NP
.	.	.	0
As	As	RB	0
seen	seen	VBN	0
in	in	IN	0
Table	Table	NNP	0
2	2	CD	0
,	,	,	0
many	many	JJ	0
of	of	IN	0
the	the	DT	0
functional	functional	JJ	B-NP
ribosome	ribosome	NN	I-NP
critical	critical	JJ	I-NP
component	component	JJ	I-NP
,	,	,	0
including	including	VBG	0
large	large	JJ	0
subunits	subunits	JJ	0
L	L	NNP	0
3	3	CD	0
,	,	,	0
6	6	CD	0
,	,	,	0
26	26	CD	0
,	,	,	0
31	31	CD	0
,	,	,	0
38	38	CD	0
,	,	,	0
and	and	CC	0
41	41	CD	0
,	,	,	0
as	as	RB	0
well	well	RB	0
as	as	IN	0
S	S	NNP	0
6	6	CD	0
,	,	,	0
12	12	CD	0
,	,	,	0
20	20	CD	0
,	,	,	0
and	and	CC	0
24	24	CD	0
,	,	,	0
and	and	CC	0
many	many	JJ	0
of	of	IN	0
the	the	DT	0
translation	translation	NN	B-NP
initiation	initiation	NN	I-NP
factor	factor	NN	I-NP
are	are	VBP	0
up-regulated	up-regulated	JJ	0
by	by	IN	0
Tat	Tat	NNP	0
.	.	.	0
This	This	DT	0
would	would	MD	0
imply	imply	VB	0
that	that	IN	0
Tat	Tat	NNP	0
up-regulates	up-regulates	JJ	0
many	many	JJ	0
ribosomal	ribosomal	JJ	B-NP
gene	gene	NN	I-NP
that	that	WDT	0
may	may	MD	0
be	be	VB	0
necessary	necessary	JJ	0
to	to	TO	0
produce	produce	VB	0
functional	functional	JJ	B-NP
ribosome	ribosome	NN	I-NP
needed	needed	VBN	0
for	for	IN	0
viral	viral	JJ	B-NP
mRNA	mRNA	JJ	I-NP
translation	translation	NN	I-NP
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
interfering	interfering	VBG	0
with	with	IN	0
translation	translation	NN	0
could	could	MD	0
provide	provide	VB	0
a	a	DT	0
new	new	JJ	0
strategy	strategy	NN	0
for	for	IN	0
anti-HIV	anti-HIV	JJ	B-NP
treatment	treatment	NN	I-NP
.	.	.	0
Along	Along	IN	0
these	these	DT	0
lines	lines	NNS	0
,	,	,	0
when	when	WRB	0
the	the	DT	0
aminogylcoside	aminogylcoside	NN	B-NP
(	(	-LRB-	0
kanamycin	kanamycin	UH	0
,	,	,	0
hygromycin	hygromycin	VBG	0
B	B	NNP	0
,	,	,	0
paromycin	paromycin	NN	B-NP
and	and	CC	0
neomycin	neomycin	CD	B-NP
)	)	-RRB-	0
due	due	JJ	0
to	to	TO	0
their	their	PRP$	0
ability	ability	NN	B-NP
to	to	TO	0
inhibit	inhibit	VB	0
protein	protein	NN	B-NP
synthesis	synthesis	NN	I-NP
by	by	IN	0
affecting	affecting	VBG	0
ribosomal	ribosomal	JJ	B-NP
fidelity	fidelity	NN	I-NP
,	,	,	0
or	or	CC	0
puromycin	puromycin	NN	B-NP
because	because	IN	0
of	of	IN	0
its	its	PRP$	0
competing	competing	JJ	0
ability	ability	NN	B-NP
with	with	IN	0
tRNAs	tRNAs	JJ	0
for	for	IN	0
binding	binding	VBG	0
on	on	IN	0
the	the	DT	0
large	large	JJ	0
ribosomal	ribosomal	JJ	B-NP
subunit	subunit	NN	I-NP
,	,	,	0
or	or	CC	0
cycloheximida	cycloheximida	NN	B-NP
which	which	WDT	0
inhibit	inhibit	VBP	0
the	the	DT	0
large	large	JJ	0
ribosomal	ribosomal	JJ	B-NP
subunit	subunit	NN	I-NP
by	by	IN	0
preventing	preventing	VBG	0
ribosomal	ribosomal	JJ	B-NP
movement	movement	NN	I-NP
along	along	IN	0
the	the	DT	0
mRNA	mRNA	JJ	0
,	,	,	0
were	were	VBD	0
used	used	VBN	0
in	in	IN	0
active	active	JJ	0
HIV-1	HIV-1	NNP	B-NP
infection	infection	NN	I-NP
,	,	,	0
it	it	PRP	0
was	was	VBD	0
found	found	VBN	0
that	that	IN	0
both	both	DT	0
cycloheximide	cycloheximide	NN	B-NP
and	and	CC	0
puromycin	puromycin	NN	B-NP
produced	produced	VBD	0
the	the	DT	0
greatest	greatest	JJS	0
decrease	decrease	NN	0
in	in	IN	0
HIV-1	HIV-1	NNP	B-NP
inhibition	inhibition	NN	I-NP
,	,	,	0
presumably	presumably	RB	0
by	by	IN	0
inhibiting	inhibiting	VBG	0
the	the	DT	0
large	large	JJ	0
ribosome	ribosome	NN	B-NP
subunit	subunit	NN	I-NP
[	[	-LRB-	0
41	41	CD	0
]	]	-RRB-	0
.	.	.	0
Translation	Translation	NN	0
of	of	IN	0
hiv-1	hiv-1	NN	B-NP
rna	rna	NN	I-NP
pose	pose	VBD	0
a	a	DT	0
challenge	challenge	NN	0
since	since	IN	0
they	they	PRP	0
all	all	RB	0
contain	contain	VB	0
a	a	DT	0
TAR	TAR	NNP	0
sequence	sequence	NN	0
at	at	IN	0
their	their	PRP$	0
5	5	CD	0
'	'	POS	0
end	end	NN	0
.	.	.	0
The	The	DT	0
Tat-responsive	Tat-responsive	JJ	B-NP
region	region	NN	I-NP
(	(	-LRB-	0
TAR	TAR	NNP	0
)	)	-RRB-	0
of	of	IN	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
exhibits	exhibits	VBZ	0
a	a	DT	0
trans-inhibitory	trans-inhibitory	JJ	B-NP
effect	effect	NN	I-NP
on	on	IN	0
translation	translation	NN	0
by	by	IN	0
activating	activating	VBG	0
the	the	DT	0
interferon-induced	interferon-induced	JJ	0
68-kilodalton	68-kilodalton	CD	0
protein	protein	NN	0
kinase	kinase	NN	0
.	.	.	0
Productive	Productive	JJ	B-NP
infection	infection	NN	I-NP
by	by	IN	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
result	result	VB	0
in	in	IN	0
a	a	DT	0
significant	significant	JJ	0
decrease	decrease	NN	0
in	in	IN	0
the	the	DT	0
amount	amount	NN	0
of	of	IN	0
cellular	cellular	JJ	B-NP
p68	p68	CD	I-NP
kinasa	kinasa	NN	I-NP
.	.	.	0
The	The	DT	0
p68	p68	CD	B-NP
kinase	kinase	NNS	I-NP
steady-state	steady-state	JJ	I-NP
amount	amount	NN	I-NP
was	was	VBD	0
found	found	VBN	0
to	to	TO	0
be	be	VB	0
reduced	reduced	VBN	0
in	in	IN	0
cells	cells	NNS	0
stably	stably	VBP	0
expressing	expressing	VBG	B-NP
Tat	Tat	NNP	I-NP
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
the	the	DT	0
tar	tar	NN	B-NP
rna	rna	NN	I-NP
region	region	NN	I-NP
potential	potential	JJ	I-NP
translational	translational	JJ	I-NP
inhibitory	inhibitory	JJ	I-NP
effect	effect	NN	I-NP
,	,	,	0
mediated	mediated	VBG	0
by	by	IN	0
p68	p68	CD	B-NP
kinase	kinase	NN	I-NP
activation	activation	NN	I-NP
,	,	,	0
may	may	MD	0
be	be	VB	0
down-regulated	down-regulated	JJ	0
by	by	IN	0
Tat	Tat	NNP	0
during	during	IN	0
activation	activation	NN	B-NP
of	of	IN	0
the	the	DT	0
latent	latent	JJ	0
virus	virus	NN	0
[	[	-LRB-	0
22	22	CD	0
]	]	-RRB-	0
.	.	.	0
Along	Along	IN	0
these	these	DT	0
lines	lines	NNS	0
,	,	,	0
a	a	DT	0
Tat	Tat	JJ	0
peptide	peptide	JJ	B-NP
antagonist	antagonist	NN	I-NP
,	,	,	0
which	which	WDT	0
bound	bound	VBP	0
specifically	specifically	RB	0
to	to	TO	0
TAR	TAR	NNP	B-NP
RNA	RNA	NNP	I-NP
and	and	CC	0
competed	competed	VBN	0
with	with	IN	0
Tat	Tat	NNP	0
for	for	IN	0
binding	binding	JJ	0
,	,	,	0
reduced	reduced	VBD	B-NP
Tat-dependent	Tat-dependent	JJ	I-NP
translation	translation	NN	I-NP
[	[	-LRB-	0
42	42	CD	0
]	]	-RRB-	0
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
upregulation	upregulation	VBG	0
of	of	IN	0
translation	translation	NN	B-NP
gene	gene	NN	I-NP
in	in	IN	0
Tat	Tat	NNP	0
expressing	expressing	VBG	B-NP
cell	cell	NN	I-NP
is	is	VBZ	0
specially	specially	RB	0
intriguing	intriguing	JJ	0
in	in	IN	0
light	light	NN	0
of	of	IN	0
the	the	DT	0
recent	recent	JJ	0
discovery	discovery	NN	0
of	of	IN	0
internal	internal	JJ	B-NP
ribosome	ribosome	JJ	I-NP
entry	entry	NN	I-NP
site	site	NN	I-NP
(	(	-LRB-	0
ire	ire	NN	B-NP
)	)	-RRB-	0
in	in	IN	0
HIV-1	HIV-1	NNP	B-NP
gag	gag	NN	I-NP
ORF	ORF	NNP	I-NP
[	[	-LRB-	0
43	43	CD	0
]	]	-RRB-	0
.	.	.	0
ire	ire	NN	B-NP
are	are	VBP	0
thought	thought	VBN	0
to	to	TO	0
promote	promote	VB	0
initiation	initiation	VBN	0
of	of	IN	0
translation	translation	NN	0
by	by	IN	0
directly	directly	RB	0
binding	binding	VBG	0
to	to	TO	0
ribosomes	ribosomes	VB	0
,	,	,	0
in	in	IN	0
a	a	DT	0
manner	manner	NN	0
independent	independent	JJ	0
of	of	IN	0
the	the	DT	0
mRNA	mRNA	JJ	B-NP
cap	cap	NN	I-NP
or	or	CC	0
of	of	IN	0
scanning	scanning	VBG	0
through	through	IN	0
upstream	upstream	JJ	0
sequences	sequences	NN	0
.	.	.	0
Since	Since	IN	0
,	,	,	0
the	the	DT	0
TAR	TAR	NNP	0
is	is	VBZ	0
located	located	VBN	0
at	at	IN	0
the	the	DT	0
5	5	CD	0
'	'	POS	0
end	end	NN	0
of	of	IN	0
all	all	DT	0
hiv-1	hiv-1	NN	B-NP
rna	rna	NN	I-NP
transcript	transcript	NN	I-NP
and	and	CC	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
secondary	secondary	JJ	B-NP
structure	structure	NN	I-NP
at	at	IN	0
or	or	CC	0
near	near	IN	0
the	the	DT	0
5	5	CD	0
'	'	POS	0
end	end	NN	0
of	of	IN	0
rna	rna	NN	B-NP
reduces	reduces	VBZ	0
the	the	DT	0
accessibility	accessibility	NN	0
of	of	IN	0
the	the	DT	0
5	5	CD	0
'	'	POS	0
cap	cap	NN	0
to	to	TO	0
eIF4F	eIF4F	CD	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
thought	thought	VBN	0
that	that	IN	0
this	this	DT	0
feature	feature	NN	0
of	of	IN	0
hiv-1	hiv-1	NN	B-NP
mrna	mrna	NN	I-NP
can	can	MD	0
inhibit	inhibit	VB	0
their	their	PRP$	0
cap-dependent	cap-dependent	JJ	B-NP
translation	translation	NN	I-NP
[	[	-LRB-	0
44	44	CD	0
45	45	CD	0
46	46	CD	0
]	]	-RRB-	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
a	a	DT	0
possible	possible	JJ	0
function	function	NN	0
of	of	IN	0
the	the	DT	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
gag	gag	VBD	0
IRES	IRES	NNP	0
might	might	MD	0
be	be	VB	0
to	to	TO	0
serve	serve	VB	0
as	as	IN	0
a	a	DT	0
mechanism	mechanism	NN	0
to	to	TO	0
bypass	bypass	VB	0
the	the	DT	0
structural	structural	JJ	B-NP
barrier	barrier	NN	I-NP
to	to	TO	0
cap-dependent	cap-dependent	JJ	B-NP
translation	translation	NN	I-NP
by	by	IN	0
recruiting	recruiting	VBG	B-NP
ribosome	ribosome	NN	I-NP
easily	easily	RB	0
and	and	CC	0
directly	directly	RB	0
to	to	TO	0
the	the	DT	0
gag	gag	JJ	B-NP
orf	orf	NNP	I-NP
.	.	.	0
IRES	IRES	NNP	0
entirely	entirely	RB	0
contained	contained	VBN	0
within	within	IN	0
a	a	DT	0
translated	translated	VBN	B-NP
ORF	ORF	NNP	I-NP
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
in	in	IN	0
the	the	DT	0
MMLV	MMLV	NNP	0
gag	gag	NNS	0
[	[	-LRB-	0
47	47	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
encoding	encoding	VBG	B-NP
p110	p110	NN	I-NP
pitslreand	pitslreand	NN	I-NP
p58	p58	NN	I-NP
pitslre	pitslre	NN	I-NP
host	host	NN	I-NP
mrna	mrna	NN	I-NP
[	[	-LRB-	0
48	48	CD	0
]	]	-RRB-	0
.	.	.	0
Along	Along	IN	0
these	these	DT	0
lines	lines	NNS	0
,	,	,	0
cap-dependent	cap-dependent	JJ	B-NP
translation	translation	NN	I-NP
may	may	MD	0
be	be	VB	0
cell	cell	NN	B-NP
cycle	cycle	NN	I-NP
regulated	regulated	VBN	0
,	,	,	0
especially	especially	RB	0
when	when	WRB	0
cells	cells	NNS	0
are	are	VBP	0
arrested	arrested	VBN	0
at	at	IN	0
the	the	DT	0
cell	cell	NN	B-NP
cycle	cycle	NN	I-NP
g2	g2	NN	I-NP
phase	phase	NN	I-NP
,	,	,	0
where	where	WRB	0
the	the	DT	0
cap-dependent	cap-dependent	JJ	B-NP
translation	translation	NN	I-NP
of	of	IN	0
most	most	RBS	0
cellular	cellular	JJ	B-NP
host	host	NN	I-NP
cell	cell	NN	I-NP
mrna	mrna	NN	I-NP
is	is	VBZ	0
inhibited	inhibited	JJ	0
[	[	-LRB-	0
49	49	CD	0
50	50	CD	0
51	51	CD	0
]	]	-RRB-	0
.	.	.	0
Modulation	Modulation	NNP	B-NP
of	of	IN	0
signal	signal	NN	0
transduction	transduction	VBZ	0
pathway	pathway	JJ	B-NP
result	result	NN	I-NP
in	in	IN	0
Table	Table	NNP	0
3indicate	3indicate	NNP	0
that	that	IN	0
many	many	JJ	0
seemingly	seemingly	RB	0
different	different	JJ	0
pathways	pathways	NNS	0
are	are	VBP	0
being	being	VBG	0
regulated	regulated	VBN	0
by	by	IN	0
Tat	Tat	NNP	0
.	.	.	0
However	However	RB	0
,	,	,	0
the	the	DT	0
signal	signal	NN	B-NP
transduction	transduction	NN	I-NP
pathway	pathway	NN	I-NP
,	,	,	0
mitogen	mitogen	NN	B-NP
activated	activated	VBN	I-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
,	,	,	0
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
control	control	VB	0
and	and	CC	0
be	be	VB	0
upstream	upstream	RB	0
of	of	IN	0
DNA-replication	DNA-replication	NNP	B-NP
,	,	,	0
transcription	transcription	NN	B-NP
,	,	,	0
and	and	CC	0
cell	cell	NN	0
cycle	cycle	NN	0
pathways	pathways	NNS	0
[	[	-LRB-	0
52	52	CD	0
53	53	CD	0
54	54	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
mitogen-activated	mitogen-activated	JJ	B-NP
protein	protein	NN	I-NP
kinasa	kinasa	NN	I-NP
(	(	-LRB-	0
map	map	NN	B-NP
kinase	kinase	NN	I-NP
)	)	-RRB-	0
pathway	pathway	NN	0
,	,	,	0
consisting	consisting	VBG	0
of	of	IN	0
the	the	DT	0
map	map	NN	B-NP
kinase	kinase	NN	I-NP
kinas	kinas	NNP	I-NP
(	(	-LRB-	0
map	map	NN	B-NP
kinase	kinase	NN	I-NP
kinase	kinase	NN	I-NP
)	)	-RRB-	0
1	1	CD	0
and	and	CC	0
2	2	CD	0
,	,	,	0
and	and	CC	0
extracellular	extracellular	JJ	B-NP
signal-regulated	signal-regulated	JJ	I-NP
kinas	kinas	NNP	I-NP
(	(	-LRB-	0
extracellular	extracellular	NN	B-NP
signal	signal	JJ	I-NP
regulated	regulated	VBN	I-NP
kinase	kinase	NN	I-NP
)	)	-RRB-	0
1	1	CD	0
and	and	CC	0
2	2	CD	0
,	,	,	0
which	which	WDT	0
have	have	VBP	0
been	been	VBN	0
implicated	implicated	VBN	0
in	in	IN	0
including	including	VBG	B-NP
proliferation	proliferation	NN	I-NP
diverse	diverse	JJ	I-NP
cellular	cellular	JJ	I-NP
process	process	NN	I-NP
,	,	,	0
transformation	transformation	NN	B-NP
,	,	,	0
and	and	CC	0
cell	cell	NN	0
differentiation	differentiation	NNS	0
[	[	-LRB-	0
53	53	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
MAP	MAP	NNP	B-NP
kinasa	kinasa	NN	I-NP
(	(	-LRB-	0
map	map	NN	B-NP
kinase	kinase	NN	I-NP
)	)	-RRB-	0
pathway	pathway	NN	0
has	has	VBZ	0
emerged	emerged	VBN	0
as	as	IN	0
a	a	DT	0
crucial	crucial	JJ	0
route	route	NN	0
between	between	IN	0
membrane-bound	membrane-bound	NNP	0
Ras	Ras	NNP	0
and	and	CC	0
the	the	DT	0
nucleus	nucleus	NN	B-NP
.	.	.	0
This	This	DT	0
MAPK	MAPK	NNP	B-NP
pathway	pathway	VBZ	I-NP
encompasses	encompasses	VBG	0
a	a	DT	0
cascade	cascade	NN	0
of	of	IN	0
phosphorylation	phosphorylation	JJ	B-NP
event	event	NN	I-NP
involving	involving	VBG	0
three	three	CD	0
key	key	JJ	B-NP
kinas	kinas	NNP	I-NP
,	,	,	0
namely	namely	RB	0
Raf	Raf	NNP	B-NP
,	,	,	0
MEK	MEK	NNP	B-NP
(	(	-LRB-	0
MAP	MAP	NN	B-NP
kinase	kinase	NN	I-NP
kinase	kinase	NN	I-NP
)	)	-RRB-	0
and	and	CC	0
ERK	ERK	NNP	B-NP
(	(	-LRB-	0
MAP	MAP	UH	B-NP
kinase	kinase	UH	I-NP
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
MAPK	MAPK	NNP	B-NP
pathway	pathway	NN	I-NP
controls	controls	VBZ	0
ERKs	ERKs	JJ	0
1	1	CD	0
and	and	CC	0
2	2	CD	0
,	,	,	0
c-Jun	c-Jun	JJ	B-NP
N-terminal	N-terminal	JJ	I-NP
kinasa	kinasa	NN	I-NP
(	(	-LRB-	0
jun	jun	NNP	B-NP
n	n	NN	I-NP
terminal	terminal	JJ	I-NP
kinase	kinase	NN	I-NP
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
p38	p38	NNP	B-NP
.	.	.	0
These	These	DT	0
signaling	signaling	JJ	0
pathways	pathways	NN	0
in	in	IN	0
turn	turn	NN	0
,	,	,	0
activate	activate	VBG	0
a	a	DT	0
variety	variety	NN	0
of	of	IN	0
including	including	VBG	B-NP
nf-kappab	nf-kappab	NN	I-NP
transcription	transcription	JJ	I-NP
factor	factor	NN	I-NP
(	(	-LRB-	0
p50	p50	CD	B-NP
/	/	CD	0
p65	p65	CD	B-NP
)	)	-RRB-	0
,	,	,	0
AP-1	AP-1	NNP	B-NP
(	(	-LRB-	0
c-Fos	c-Fos	NNP	B-NP
/	/	NNP	I-NP
c-Jun	c-Jun	NNP	I-NP
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
CREB	CREB	NNP	B-NP
phosphorylation	phosphorylation	NN	I-NP
,	,	,	0
which	which	WDT	0
in	in	RB	0
turn	turn	VB	0
coordinate	coordinate	VB	0
the	the	DT	0
induction	induction	NN	B-NP
of	of	IN	0
many	many	JJ	0
genes	genes	NNS	0
encoding	encoding	VBP	0
inflammatory	inflammatory	JJ	B-NP
mediator	mediator	NN	I-NP
.	.	.	0
cytokine	cytokine	NN	B-NP
receptor	receptor	NN	I-NP
such	such	JJ	0
as	as	IN	0
IL-3	IL-3	NNP	B-NP
,	,	,	0
GM-CSF	GM-CSF	NNP	B-NP
,	,	,	0
and	and	CC	0
the	the	DT	0
interferons	interferons	NN	0
transmit	transmit	VBD	0
their	their	PRP$	0
regulatory	regulatory	JJ	B-NP
signal	signal	JJ	I-NP
primarily	primarily	RB	0
by	by	IN	0
the	the	DT	0
tyrosine	tyrosine	JJ	B-NP
kinas	kinas	NNP	I-NP
receptor-associated	receptor-associated	JJ	I-NP
jak	jak	NN	I-NP
family	family	NN	I-NP
,	,	,	0
and	and	CC	0
activate	activate	JJ	0
stat	stat	NN	B-NP
transcription	transcription	NN	I-NP
factor	factor	NN	I-NP
.	.	.	0
activated	activated	VBN	B-NP
stat5	stat5	NN	I-NP
protein	protein	NN	I-NP
are	are	VBP	0
detected	detected	VBN	0
in	in	IN	0
reduced	reduced	JJ	0
levels	levels	NNS	0
in	in	IN	0
lymphocyte	lymphocyte	NN	B-NP
recovered	recovered	VBD	0
from	from	IN	0
hiv-infected	hiv-infected	NN	B-NP
patient	patient	JJ	I-NP
and	and	CC	0
immunocompromised	immunocompromised	JJ	B-NP
mouse	mouse	NN	I-NP
.	.	.	0
Both	Both	DT	0
of	of	IN	0
these	these	DT	0
types	types	NNS	0
of	of	IN	0
signaling	signaling	VBG	B-NP
pathway	pathway	NN	I-NP
receptor	receptor	NN	I-NP
have	have	VBP	0
recently	recently	RB	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
interact	interact	VB	0
with	with	IN	0
serine/threonine	serine/threonine	NN	B-NP
kinas	kinas	NNP	I-NP
such	such	JJ	0
as	as	IN	0
map	map	NN	B-NP
kinas	kinas	NNP	I-NP
.	.	.	0
A	A	DT	0
common	common	JJ	0
intermediate	intermediate	JJ	0
pathway	pathway	JJ	B-NP
initiating	initiating	NN	I-NP
from	from	IN	0
receptor	receptor	NN	B-NP
to	to	TO	0
the	the	DT	0
nucleus	nucleus	NN	B-NP
is	is	VBZ	0
the	the	DT	0
Ras	Ras	NNP	B-NP
/	/	NNP	I-NP
Raf	Raf	NNP	I-NP
/	/	NNP	I-NP
MEK	MEK	NNP	I-NP
/	/	NNP	I-NP
ERK	ERK	NNP	I-NP
(	(	-LRB-	0
mitogen	mitogen	NN	B-NP
activated	activated	VBN	I-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
)	)	-RRB-	0
cascade	cascade	NN	0
,	,	,	0
which	which	WDT	0
can	can	MD	0
result	result	VB	0
in	in	IN	0
the	the	DT	0
phosphorylation	phosphorylation	NN	B-NP
and	and	CC	0
activation	activation	NN	B-NP
of	of	IN	0
additional	additional	JJ	0
downstream	downstream	JJ	0
kinas	kinas	NNP	B-NP
and	and	CC	0
transcription	transcription	JJ	B-NP
factor	factor	NN	I-NP
such	such	JJ	0
as	as	IN	0
p90Rsk	p90Rsk	NNP	0
,	,	,	0
CREB	CREB	NNP	B-NP
,	,	,	0
Elk	Elk	NNP	0
,	,	,	0
and	and	CC	0
Egr-1	Egr-1	NNP	B-NP
[	[	-LRB-	0
55	55	CD	0
56	56	CD	0
]	]	-RRB-	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
intriguing	intriguing	VBN	0
that	that	IN	0
Tat	Tat	NNP	0
expressing	expressing	VBG	B-NP
cell	cell	NN	I-NP
show	show	VBP	0
mapk	mapk	NN	B-NP
component	component	JJ	I-NP
down-regulation	down-regulation	JJ	I-NP
(	(	-LRB-	0
Table	Table	NNP	0
3	3	CD	0
,	,	,	0
Figure	Figure	NNP	0
3Band	3Band	NNP	0
3C	3C	NNP	0
)	)	-RRB-	0
,	,	,	0
essential	essential	JJ	B-NP
mediator	mediator	NN	I-NP
between	between	IN	0
receptor	receptor	NN	B-NP
and	and	CC	0
nuclear	nuclear	JJ	0
transcription	transcription	JJ	B-NP
factor	factor	NN	I-NP
.	.	.	0
This	This	DT	0
would	would	MD	0
imply	imply	VB	0
that	that	DT	0
latently	latently	JJ	B-NP
infected	infected	JJ	I-NP
cell	cell	NN	I-NP
that	that	WDT	0
express	express	VBP	0
Tat	Tat	NNP	0
(	(	-LRB-	0
doubly	doubly	FW	0
spliced	spliced	VBN	B-NP
RNA	RNA	NNP	I-NP
)	)	-RRB-	0
and	and	CC	0
not	not	RB	0
the	the	DT	0
whole	whole	JJ	0
virus	virus	NN	0
(	(	-LRB-	0
all	all	DT	0
three	three	CD	0
classes	classes	NNS	0
of	of	IN	0
the	the	DT	0
RNA	RNA	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
can	can	MD	0
control	control	VB	0
signal	signal	NN	0
transduction	transduction	VBZ	0
related	related	VBN	0
to	to	TO	0
membrane	membrane	VB	0
and	and	CC	0
transcriptional	transcriptional	JJ	0
signaling	signaling	NNS	0
(	(	-LRB-	0
Figure	Figure	NNP	0
6	6	CD	0
)	)	-RRB-	0
.	.	.	0
Interestingly	Interestingly	RB	0
,	,	,	0
Tat	Tat	NNP	0
,	,	,	0
through	through	IN	0
the	the	DT	0
RGD	RGD	NNP	B-NP
motif	motif	NN	I-NP
,	,	,	0
which	which	WDT	0
controls	controls	VBZ	0
integrin-based	integrin-based	JJ	B-NP
cell	cell	NN	I-NP
signaling	signaling	NN	I-NP
,	,	,	0
has	has	VBZ	0
been	been	VBN	0
reported	reported	VBN	0
to	to	TO	0
mediate	mediate	VB	0
the	the	DT	0
activity	activity	NN	0
of	of	IN	0
phosphotyrosine	phosphotyrosine	JJ	B-NP
phosphatase	phosphatase	NNS	I-NP
.	.	.	0
This	This	DT	0
in	in	IN	0
turn	turn	NN	0
which	which	WDT	0
would	would	MD	0
lead	lead	VB	0
to	to	TO	0
a	a	DT	0
decrease	decrease	NN	0
in	in	IN	0
the	the	DT	0
levels	levels	NNS	0
of	of	IN	0
phosphotyrosine-containing	phosphotyrosine-containing	JJ	B-NP
protein	protein	NN	I-NP
such	such	JJ	0
as	as	IN	0
ERK-2	ERK-2	CD	B-NP
/	/	CD	0
p42MAPK	p42MAPK	CD	0
kinases	kinases	NNS	0
[	[	-LRB-	0
57	57	CD	0
]	]	-RRB-	0
.	.	.	0
Cysteine-rich	Cysteine-rich	NNP	B-NP
and	and	CC	0
basic	basic	JJ	0
tat	tat	NN	B-NP
peptide	peptide	NN	I-NP
have	have	VBP	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
inhibit	inhibit	VB	0
VEGF-induced	VEGF-induced	JJ	B-NP
ERK	ERK	NNP	I-NP
activation	activation	NN	I-NP
and	and	CC	0
mitogenesi	mitogenesi	NN	B-NP
.	.	.	0
These	These	DT	0
peptide	peptide	NN	B-NP
also	also	RB	0
inhibited	inhibited	JJ	0
proliferation	proliferation	NN	B-NP
,	,	,	0
angiogenesi	angiogenesi	NN	B-NP
,	,	,	0
and	and	CC	0
ERK	ERK	NNP	B-NP
activation	activation	VBD	I-NP
induced	induced	VBN	0
by	by	IN	0
basic	basic	JJ	0
fibroblast	fibroblast	JJ	B-NP
growth	growth	NN	I-NP
factor	factor	NN	I-NP
with	with	IN	0
similar	similar	JJ	0
potency	potency	NN	0
and	and	CC	0
efficacy	efficacy	NNS	0
[	[	-LRB-	0
58	58	CD	0
]	]	-RRB-	0
.	.	.	0
Consistent	Consistent	JJ	0
with	with	IN	0
this	this	DT	0
model	model	NN	0
,	,	,	0
it	it	PRP	0
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
that	that	IN	0
treatment	treatment	NN	0
of	of	IN	0
neural	neural	JJ	B-NP
cell	cell	NN	I-NP
with	with	IN	0
culture	culture	NN	B-NP
supernatant	supernatant	NN	I-NP
from	from	IN	0
haart-treated	haart-treated	NN	B-NP
subject	subject	JJ	I-NP
,	,	,	0
which	which	WDT	0
presumably	presumably	RB	0
contain	contain	VB	0
extracellular	extracellular	JJ	B-NP
Tat	Tat	NNP	I-NP
,	,	,	0
resulted	resulted	VBD	0
in	in	IN	0
jun	jun	NNP	B-NP
n	n	NN	I-NP
terminal	terminal	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
kinase	kinase	NN	I-NP
down-regulation	down-regulation	JJ	I-NP
,	,	,	0
AKT	AKT	NNP	B-NP
,	,	,	0
and	and	CC	0
erk	erk	NN	B-NP
kinas	kinas	NNP	I-NP
[	[	-LRB-	0
59	59	CD	0
]	]	-RRB-	0
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
mapk	mapk	NN	B-NP
activation	activation	VBG	I-NP
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
activate	activate	VB	0
the	the	DT	0
singly	singly	JJ	0
spliced	spliced	NN	0
and	and	CC	0
unspliced	unspliced	NNS	0
(	(	-LRB-	0
genomic	genomic	LS	B-NP
)	)	-RRB-	0
latent	latent	VBD	0
HIV-1	HIV-1	CD	B-NP
virus	virus	NN	I-NP
.	.	.	0
For	For	IN	0
instance	instance	NN	0
,	,	,	0
the	the	DT	0
signal	signal	NN	B-NP
transduction	transduction	NN	I-NP
pathway	pathway	NN	I-NP
that	that	WDT	0
regulate	regulate	VBZ	0
the	the	DT	0
switch	switch	NN	0
from	from	IN	0
latent	latent	VBG	0
to	to	TO	0
productive	productive	JJ	B-NP
infection	infection	NN	I-NP
have	have	VBP	0
been	been	VBN	0
linked	linked	VBN	0
to	to	TO	0
mitogen	mitogen	NN	B-NP
activated	activated	VBN	I-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
.	.	.	0
The	The	DT	0
induction	induction	NN	B-NP
of	of	IN	0
latent	latent	CD	0
HIV-1	HIV-1	CD	B-NP
expression	expression	NN	I-NP
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
be	be	VB	0
inhibited	inhibited	VBN	0
by	by	IN	0
PD98059	PD98059	NNP	0
and	and	CC	0
U0126	U0126	NNP	0
,	,	,	0
specific	specific	JJ	0
inhibitors	inhibitors	NN	0
of	of	IN	0
MAPK	MAPK	NNP	B-NP
activation	activation	NN	I-NP
.	.	.	0
The	The	DT	0
mitogen	mitogen	NN	B-NP
activated	activated	VBN	I-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
acts	acts	VBZ	0
by	by	IN	0
stimulating	stimulating	VBG	B-NP
AP-1	AP-1	NNP	I-NP
and	and	CC	0
a	a	DT	0
subsequent	subsequent	JJ	0
physical	physical	JJ	0
and	and	CC	0
ap-1	ap-1	NN	B-NP
functional	functional	JJ	I-NP
interaction	interaction	NN	I-NP
with	with	IN	0
NF-κB	NF-κB	NNP	B-NP
,	,	,	0
resulting	resulting	VBG	0
in	in	IN	0
a	a	DT	0
complex	complex	NN	0
that	that	WDT	0
synergistically	synergistically	VBP	0
transactivates	transactivates	VBG	0
the	the	DT	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
[	[	-LRB-	0
60	60	CD	0
]	]	-RRB-	0
.	.	.	0
At	At	IN	0
the	the	DT	0
level	level	NN	0
of	of	IN	0
infection	infection	NN	B-NP
and	and	CC	0
entry	entry	NN	0
,	,	,	0
the	the	DT	0
mitogen	mitogen	NN	B-NP
activated	activated	VBN	I-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
activation	activation	NN	I-NP
through	through	IN	0
the	the	DT	0
Ras	Ras	NNP	B-NP
/	/	NNP	I-NP
Raf	Raf	NNP	I-NP
/	/	NNP	I-NP
MEK	MEK	NNP	I-NP
(	(	-LRB-	0
MAPK	MAPK	UH	B-NP
kinase	kinase	UH	I-NP
)	)	-RRB-	0
signaling	signaling	VBG	B-NP
pathway	pathway	NN	I-NP
enhances	enhances	VBZ	0
the	the	DT	0
hiv-1	hiv-1	NN	B-NP
virion	virion	NN	I-NP
infectivity	infectivity	NN	I-NP
.	.	.	0
Virus	Virus	NN	B-NP
infectivity	infectivity	NN	I-NP
can	can	MD	0
be	be	VB	0
enhanced	enhanced	VBN	0
by	by	IN	0
treatment	treatment	NN	0
of	of	IN	0
cells	cells	NNS	0
with	with	IN	0
mapk	mapk	NN	B-NP
stimulator	stimulator	NN	I-NP
,	,	,	0
such	such	JJ	0
as	as	IN	0
serum	serum	NN	B-NP
and	and	CC	0
phorbol	phorbol	JJ	B-NP
myristate	myristate	JJ	I-NP
acetate	acetate	NN	I-NP
,	,	,	0
as	as	RB	0
well	well	RB	0
as	as	RB	0
by	by	IN	0
coexpression	coexpression	NN	B-NP
of	of	IN	0
constitutively	constitutively	JJ	0
activated	activated	JJ	0
Ras	Ras	NNP	0
,	,	,	0
Raf	Raf	NNP	B-NP
,	,	,	0
or	or	CC	0
MEK	MEK	NNP	B-NP
in	in	IN	0
the	the	DT	0
extracellular	extracellular	JJ	B-NP
stimulation	stimulation	NN	I-NP
absence	absence	NN	I-NP
[	[	-LRB-	0
61	61	CD	0
]	]	-RRB-	0
.	.	.	0
Also	Also	RB	0
,	,	,	0
following	following	VBG	0
infection	infection	NN	B-NP
,	,	,	0
efficient	efficient	JJ	0
reverse	reverse	JJ	B-NP
transcription	transcription	JJ	I-NP
complex	complex	NN	I-NP
disengagement	disengagement	NN	I-NP
from	from	IN	0
the	the	DT	0
cell	cell	NN	0
membrane	membrane	NNS	0
and	and	CC	0
subsequent	subsequent	JJ	0
nuclear	nuclear	JJ	0
translocation	translocation	NN	B-NP
,	,	,	0
requires	requires	VBZ	0
phosphorylation	phosphorylation	VBN	0
of	of	IN	0
the	the	DT	0
reverse	reverse	JJ	B-NP
transcription	transcription	JJ	I-NP
complex	complex	JJ	0
components	components	NNS	0
by	by	IN	0
ERK	ERK	NNP	B-NP
/	/	NNP	I-NP
MAPK	MAPK	NNP	I-NP
;	;	:	0
demonstrating	demonstrating	VBG	0
a	a	DT	0
critical	critical	JJ	B-NP
regulation	regulation	NN	I-NP
of	of	IN	0
an	an	DT	0
early	early	JJ	0
step	step	NN	0
in	in	IN	0
HIV-1	HIV-1	NNP	B-NP
infection	infection	NN	I-NP
by	by	IN	0
the	the	DT	0
host	host	NN	B-NP
cell	cell	NN	I-NP
MAPK	MAPK	NN	I-NP
signal	signal	JJ	I-NP
transduction	transduction	NN	I-NP
pathway	pathway	NN	I-NP
[	[	-LRB-	0
62	62	CD	0
]	]	-RRB-	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
mapk	mapk	NN	B-NP
pathway	pathway	NN	I-NP
tat	tat	NN	I-NP
down-regulation	down-regulation	NNP	I-NP
in	in	IN	0
latent	latent	JJ	0
cells	cells	NNS	0
implies	implies	VBZ	0
that	that	DT	0
much	much	JJ	0
of	of	IN	0
the	the	DT	0
host	host	NN	B-NP
signal	signal	NN	I-NP
transductions	transductions	VBZ	0
connected	connected	VBN	0
to	to	TO	0
activation	activation	NN	B-NP
are	are	VBP	0
down-regulated	down-regulated	JJ	0
,	,	,	0
and	and	CC	0
at	at	IN	0
the	the	DT	0
same	same	JJ	0
time	time	NN	0
,	,	,	0
these	these	DT	0
cells	cells	NNS	0
may	may	MD	0
be	be	VB	0
refractory	refractory	VBN	0
to	to	TO	0
subsequent	subsequent	JJ	0
infection	infection	NN	B-NP
by	by	IN	0
other	other	JJ	0
viruses	viruses	NN	0
.	.	.	0
thymosin	thymosin	NN	B-NP
family	family	NN	I-NP
member	member	NN	I-NP
,	,	,	0
and	and	CC	0
cell	cell	NN	0
cycle	cycle	NN	0
Prothymosin	Prothymosin	NN	B-NP
α	α	NN	I-NP
(	(	-LRB-	0
prothymosin	prothymosin	NN	B-NP
α	α	NN	I-NP
)	)	-RRB-	0
belongs	belongs	VBZ	0
to	to	TO	0
the	the	DT	0
α-Thymosin	α-Thymosin	JJ	B-NP
family	family	NN	I-NP
which	which	WDT	0
comprises	comprises	VBZ	0
different	different	JJ	0
polypeptide	polypeptide	NN	B-NP
widely	widely	RB	0
distributed	distributed	VBN	0
within	within	IN	0
animal	animal	JJ	0
tissues	tissues	NNS	0
.	.	.	0
Although	Although	IN	0
its	its	PRP$	0
role	role	NN	0
has	has	VBZ	0
remained	remained	VBN	0
controversial	controversial	JJ	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
involved	involved	VBN	0
in	in	IN	0
the	the	DT	0
increase	increase	NN	0
of	of	IN	0
immediate	immediate	JJ	0
early	early	JJ	0
genes	genes	NNS	0
such	such	JJ	0
as	as	IN	0
c-myc	c-myc	NNP	B-NP
[	[	-LRB-	0
63	63	CD	0
]	]	-RRB-	0
,	,	,	0
which	which	WDT	0
is	is	VBZ	0
upstream	upstream	RB	0
of	of	IN	0
cyclin	cyclin	JJ	0
D	D	NNP	0
synthesis	synthesis	NN	0
and	and	CC	0
necessary	necessary	JJ	0
for	for	IN	0
cell	cell	NN	0
division	division	NN	0
[	[	-LRB-	0
64	64	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
humans	humans	NNS	0
,	,	,	0
prothymosin	prothymosin	NN	B-NP
α	α	NN	I-NP
is	is	VBZ	0
coded	coded	VBN	0
by	by	IN	0
a	a	DT	0
gene	gene	NN	B-NP
family	family	NN	I-NP
of	of	IN	0
six	six	CD	0
members	members	NNS	0
.	.	.	0
One	One	CD	0
of	of	IN	0
them	them	PRP	0
contains	contains	VBZ	0
introns	introns	VBN	0
,	,	,	0
exon	exon	NNP	B-NP
and	and	CC	0
classic	classic	JJ	B-NP
regulatory	regulatory	JJ	I-NP
signal	signal	JJ	I-NP
,	,	,	0
while	while	IN	0
the	the	DT	0
remaining	remaining	JJ	0
five	five	CD	0
are	are	VBP	0
intronless	intronless	JJ	B-NP
gene	gene	NN	I-NP
[	[	-LRB-	0
59	59	CD	0
]	]	-RRB-	0
located	located	VBN	0
on	on	IN	0
chromosome	chromosome	CD	0
2	2	CD	0
[	[	-LRB-	0
66	66	CD	0
]	]	-RRB-	0
.	.	.	0
There	There	EX	0
are	are	VBP	0
two	two	CD	0
mrna	mrna	NN	B-NP
transcript	transcript	NN	I-NP
,	,	,	0
which	which	WDT	0
arise	arise	VBP	0
in	in	IN	0
a	a	DT	0
ratio	ratio	NN	0
of	of	IN	0
9	9	CD	0
:	:	:	0
1	1	CD	0
(	(	-LRB-	0
shorter	shorter	CD	B-NP
/	/	CD	I-NP
longer	longer	JJR	I-NP
form	form	NN	I-NP
)	)	-RRB-	0
,	,	,	0
where	where	WRB	0
only	only	RB	0
the	the	DT	0
long	long	JJ	0
transcript	transcript	NN	0
is	is	VBZ	0
regulated	regulated	VBN	0
by	by	IN	0
extracellular	extracellular	JJ	B-NP
signal	signal	JJ	I-NP
.	.	.	0
It	It	PRP	0
has	has	VBZ	0
been	been	VBN	0
demonstrated	demonstrated	VBN	0
that	that	IN	0
malignant	malignant	JJ	0
tissues	tissues	NNS	0
with	with	IN	0
accelerated	accelerated	JJ	0
cell	cell	NN	B-NP
cycle	cycle	NN	I-NP
show	show	VBP	0
higher	higher	JJR	0
levels	levels	NNS	0
of	of	IN	0
ProTα	ProTα	JJ	B-NP
expression	expression	NN	I-NP
than	than	IN	0
normal	normal	JJ	0
or	or	CC	0
surrounding	surrounding	VBG	0
healthy	healthy	JJ	0
tissues	tissues	NNS	0
[	[	-LRB-	0
67	67	CD	0
]	]	-RRB-	0
.	.	.	0
prothymosin	prothymosin	NN	B-NP
α	α	NN	I-NP
was	was	VBD	0
shown	shown	VBN	0
as	as	IN	0
a	a	DT	0
marker	marker	NN	0
for	for	IN	0
breast	breast	JJ	0
cancer	cancer	NN	0
[	[	-LRB-	0
68	68	CD	0
]	]	-RRB-	0
,	,	,	0
hepatocarcinomum	hepatocarcinomum	NN	B-NP
[	[	-LRB-	0
69	69	CD	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
plasma	plasma	JJ	B-NP
level	level	JJ	I-NP
of	of	IN	0
its	its	PRP$	0
derivative	derivative	JJ	B-NP
Tα	Tα	NNP	I-NP
1	1	CD	0
been	been	VBN	0
proposed	proposed	VBN	0
as	as	IN	0
a	a	DT	0
marker	marker	NN	0
for	for	IN	0
the	the	DT	0
prognosis	prognosis	NN	0
of	of	IN	0
lung	lung	NN	0
cancer	cancer	NN	0
[	[	-LRB-	0
70	70	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
ligand	ligand	JJ	B-NP
blotting	blotting	JJ	I-NP
assay	assay	NN	I-NP
,	,	,	0
ProTα	ProTα	JJ	B-NP
bound	bound	NN	I-NP
only	only	RB	0
to	to	TO	0
chromatin	chromatin	VB	0
pools	pools	NNS	0
and	and	CC	0
nuclear	nuclear	JJ	0
fractions	fractions	NNS	0
where	where	WRB	0
histone	histone	JJ	B-NP
H1	H1	NN	I-NP
was	was	VBD	0
present	present	JJ	0
[	[	-LRB-	0
71	71	CD	0
72	72	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
analysis	analysis	NN	0
of	of	IN	0
the	the	DT	0
interaction	interaction	NN	0
of	of	IN	0
ProTα	ProTα	JJ	0
with	with	IN	0
H1-containing	H1-containing	CD	B-NP
chromatin	chromatin	NN	I-NP
suggests	suggests	VBZ	0
a	a	DT	0
putative	putative	JJ	B-NP
role	role	NN	I-NP
for	for	IN	0
ProTα	ProTα	JJ	0
in	in	IN	0
the	the	DT	0
stoichiometry	stoichiometry	NN	B-NP
fine-tuning	fine-tuning	NN	I-NP
and	and	CC	0
/	/	NNP	0
or	or	CC	0
mode	mode	NN	0
of	of	IN	0
interaction	interaction	NN	0
of	of	IN	0
H1	H1	CD	0
with	with	IN	0
chromatin	chromatin	NN	B-NP
[	[	-LRB-	0
73	73	CD	0
]	]	-RRB-	0
.	.	.	0
Interestingly	Interestingly	RB	0
,	,	,	0
hl-60	hl-60	NN	B-NP
cell	cell	NN	I-NP
overexpressing	overexpressing	VBP	0
ProTα	ProTα	JJ	B-NP
show	show	NN	I-NP
an	an	DT	0
enhancement	enhancement	NN	0
of	of	IN	0
accessibility	accessibility	NN	0
of	of	IN	0
micrococcal	micrococcal	JJ	B-NP
nuclease	nuclease	NN	I-NP
to	to	TO	0
chromatin	chromatin	VB	0
,	,	,	0
implying	implying	VBG	0
relaxed	relaxed	JJ	0
chromatin	chromatin	JJ	B-NP
structure	structure	NN	I-NP
for	for	IN	0
enhanced	enhanced	JJ	0
cell	cell	NN	0
cycle	cycle	NN	0
gene	gene	NN	0
expression	expression	NN	0
[	[	-LRB-	0
74	74	CD	0
]	]	-RRB-	0
.	.	.	0
A	A	DT	0
broad	broad	JJ	0
study	study	NN	0
using	using	VBG	0
several	several	JJ	0
mononuclear	mononuclear	NN	B-NP
and	and	CC	0
fibroblastic	fibroblastic	JJ	B-NP
cell	cell	NN	I-NP
line	line	NN	I-NP
has	has	VBZ	0
shown	shown	VBN	0
that	that	IN	0
ProTα	ProTα	JJ	B-NP
mRNA	mRNA	JJ	I-NP
accumulation	accumulation	NN	I-NP
is	is	VBZ	0
cell	cell	NN	B-NP
cycle	cycle	NN	I-NP
phase-dependent	phase-dependent	NN	I-NP
.	.	.	0
In	In	IN	0
the	the	DT	0
U937	U937	JJ	B-NP
monocytic	monocytic	JJ	I-NP
cell	cell	NN	I-NP
line	line	NN	I-NP
,	,	,	0
ProTα	ProTα	JJ	B-NP
mRNA	mRNA	JJ	I-NP
peaked	peaked	NN	I-NP
at	at	IN	0
the	the	DT	0
end	end	NN	0
of	of	IN	0
S	S	NNP	0
/	/	NNP	0
G2	G2	NNP	B-NP
phase	phase	NN	I-NP
and	and	CC	0
fell	fell	VBD	0
towards	towards	IN	0
the	the	DT	0
entry	entry	NN	0
into	into	IN	0
the	the	DT	0
new	new	JJ	0
G1	G1	CD	B-NP
phase	phase	NN	I-NP
.	.	.	0
More	More	RBR	0
prominent	prominent	JJ	0
mRNA	mRNA	JJ	B-NP
regulation	regulation	NN	I-NP
was	was	VBD	0
found	found	VBN	0
in	in	IN	0
the	the	DT	0
fibroblastic	fibroblastic	JJ	B-NP
cell	cell	NN	I-NP
line	line	NN	I-NP
CV1	CV1	NNP	B-NP
and	and	CC	0
NIH3T3	NIH3T3	NNP	0
,	,	,	0
with	with	IN	0
peak	peak	JJ	0
mrna	mrna	NN	B-NP
level	level	JJ	I-NP
at	at	IN	0
the	the	DT	0
end	end	NN	0
of	of	IN	0
S-phase	S-phase	JJ	B-NP
.	.	.	0
In	In	IN	0
all	all	DT	0
cases	cases	NNS	0
the	the	DT	0
expression	expression	NN	B-NP
pattern	pattern	NN	I-NP
coincided	coincided	NN	I-NP
with	with	IN	0
that	that	DT	0
of	of	IN	0
cyclin	cyclin	JJ	B-NP
B	B	NNP	I-NP
and	and	CC	0
Cdc2	Cdc2	CD	B-NP
/	/	CD	0
cyclin	cyclin	JJ	B-NP
B	B	NN	I-NP
activation	activation	NN	I-NP
[	[	-LRB-	0
75	75	CD	0
]	]	-RRB-	0
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
interesting	interesting	JJ	0
to	to	TO	0
note	note	VB	0
that	that	IN	0
Cdc2	Cdc2	NNP	B-NP
(	(	-LRB-	0
Acc	Acc	UH	B-NP
#	#	#	0
X05360	X05360	CD	0
)	)	-RRB-	0
,	,	,	0
Cdc10	Cdc10	CD	B-NP
homolog	homolog	NN	I-NP
(	(	-LRB-	0
Acc	Acc	UH	B-NP
#	#	#	0
S72008	S72008	CD	0
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
Cdc37	Cdc37	NNP	B-NP
(	(	-LRB-	0
Acc	Acc	UH	B-NP
#	#	#	0
U43077	U43077	CD	0
)	)	-RRB-	0
were	were	VBD	0
all	all	DT	0
up-regulated	up-regulated	JJ	0
in	in	IN	0
Tat	Tat	NNP	0
expressing	expressing	VBG	B-NP
cell	cell	NN	I-NP
.	.	.	0
Cdc2	Cdc2	NNP	B-NP
,	,	,	0
a	a	DT	0
cyclin-dependent	cyclin-dependent	JJ	B-NP
kinas	kinas	NNP	I-NP
catalytic	catalytic	JJ	I-NP
subunit	subunit	NN	I-NP
,	,	,	0
is	is	VBZ	0
required	required	VBN	0
for	for	IN	0
both	both	PDT	0
the	the	DT	0
G1-to-S	G1-to-S	NNP	B-NP
and	and	CC	0
g2-to-m	g2-to-m	NN	B-NP
transition	transition	NN	I-NP
.	.	.	0
In	In	IN	0
the	the	DT	0
pombe	pombe	NN	B-NP
fission	fission	NN	I-NP
yeast	yeast	NN	I-NP
schizosaccharomyce	schizosaccharomyce	NN	I-NP
,	,	,	0
the	the	DT	0
execution	execution	NN	0
of	of	IN	0
Start	Start	NNP	0
requires	requires	VBZ	0
the	the	DT	0
activity	activity	NN	0
of	of	IN	0
the	the	DT	0
Cdc2	Cdc2	JJ	B-NP
protein	protein	NN	I-NP
kinasa	kinasa	NN	I-NP
and	and	CC	0
the	the	DT	0
Cdc10	Cdc10	CD	B-NP
/	/	CD	0
Sct1	Sct1	CD	B-NP
transcription	transcription	JJ	I-NP
complex	complex	NN	I-NP
.	.	.	0
The	The	DT	0
loss	loss	NN	0
of	of	IN	0
any	any	DT	0
of	of	IN	0
these	these	DT	0
genes	genes	NNS	0
leads	leads	VBZ	0
to	to	TO	0
G1	G1	CD	0
arrest	arrest	NN	0
[	[	-LRB-	0
69	69	CD	0
]	]	-RRB-	0
.	.	.	0
Cdc37	Cdc37	NNP	B-NP
encodes	encodes	VBD	0
a	a	DT	0
50-kDa	50-kDa	JJ	0
protein	protein	NN	0
that	that	IN	0
targets	targets	NNS	0
intrinsically	intrinsically	VBP	0
unstable	unstable	JJ	0
oncoprotein	oncoprotein	NN	B-NP
kinases	kinases	VBP	0
including	including	VBG	B-NP
Cdk4	Cdk4	NNP	I-NP
,	,	,	0
Raf-1	Raf-1	NNP	B-NP
,	,	,	0
and	and	CC	0
v-src	v-src	JJ	B-NP
to	to	TO	0
the	the	DT	0
molecular	molecular	JJ	B-NP
chaperone	chaperone	JJ	I-NP
Hsp90	Hsp90	NN	I-NP
,	,	,	0
an	an	DT	0
interaction	interaction	NN	0
that	that	WDT	0
is	is	VBZ	0
thought	thought	VBN	0
to	to	TO	0
be	be	VB	0
important	important	JJ	0
for	for	IN	0
the	the	DT	0
signaling	signaling	VBG	B-NP
pathway	pathway	NN	I-NP
establishment	establishment	NN	I-NP
.	.	.	0
Cdc37	Cdc37	NNP	B-NP
expression	expression	NN	I-NP
may	may	MD	0
not	not	RB	0
only	only	RB	0
be	be	VB	0
required	required	VBN	0
to	to	TO	0
support	support	VB	0
proliferation	proliferation	NN	B-NP
in	in	IN	0
cells	cells	NNS	0
that	that	WDT	0
are	are	VBP	0
developmentally	developmentally	VBN	0
programmed	programmed	VBN	0
to	to	TO	0
proliferate	proliferate	VB	0
,	,	,	0
but	but	CC	0
may	may	MD	0
also	also	RB	0
be	be	VB	0
required	required	VBN	0
in	in	IN	0
cells	cells	NNS	0
that	that	WDT	0
are	are	VBP	0
inappropriately	inappropriately	RB	0
induced	induced	VBN	0
to	to	TO	0
initiate	initiate	VB	0
proliferation	proliferation	NN	B-NP
by	by	IN	0
oncogene	oncogene	NN	B-NP
.	.	.	0
For	For	IN	0
instance	instance	NN	0
,	,	,	0
mmtv-cdc37	mmtv-cdc37	NN	B-NP
transgenic	transgenic	NN	I-NP
mouse	mouse	NN	I-NP
develop	develop	FW	0
mammary	mammary	NN	B-NP
gland	gland	NN	I-NP
tumor	tumor	NN	I-NP
at	at	IN	0
a	a	DT	0
rate	rate	NN	0
comparable	comparable	JJ	0
to	to	TO	0
that	that	WDT	0
observed	observed	VBD	0
previously	previously	RB	0
in	in	IN	0
mmtv-cyclin	mmtv-cyclin	NN	B-NP
d1	d1	NN	I-NP
mouse	mouse	NN	I-NP
,	,	,	0
indicating	indicating	VBG	0
that	that	IN	0
Cdc37	Cdc37	NNP	B-NP
can	can	MD	0
function	function	VB	0
as	as	IN	0
an	an	DT	0
oncogene	oncogene	NN	B-NP
in	in	IN	0
mice	mice	NNS	0
and	and	CC	0
suggests	suggests	VBZ	0
that	that	IN	0
the	the	DT	0
protein	protein	NN	B-NP
kinase	kinase	NNS	I-NP
pathway	pathway	NN	I-NP
establishment	establishment	NN	I-NP
mediated	mediated	VBN	0
by	by	IN	0
Cdc37-Hsp90	Cdc37-Hsp90	NNP	B-NP
can	can	MD	0
be	be	VB	0
a	a	DT	0
rate-limiting	rate-limiting	JJ	0
event	event	NN	0
in	in	IN	0
transformation	transformation	NN	B-NP
[	[	-LRB-	0
76	76	CD	0
]	]	-RRB-	0
.	.	.	0
Also	Also	RB	0
,	,	,	0
analysis	analysis	NN	0
of	of	IN	0
proteins	proteins	NNS	0
that	that	IN	0
co-immunoprecipitated	co-immunoprecipitated	JJ	B-NP
with	with	IN	0
Cdk6	Cdk6	NNP	B-NP
and	and	CC	0
Cdk4	Cdk4	NNP	B-NP
has	has	VBZ	0
shown	shown	VBN	0
complexes	complexes	NNS	0
containing	containing	VBG	0
both	both	DT	0
Hsp90	Hsp90	NNP	B-NP
and	and	CC	0
Cdc37	Cdc37	NNP	B-NP
[	[	-LRB-	0
77	77	CD	0
78	78	CD	0
79	79	CD	0
]	]	-RRB-	0
.	.	.	0
Cdc37	Cdc37	NNP	B-NP
also	also	RB	0
promotes	promotes	VBZ	0
the	the	DT	0
production	production	NN	0
of	of	IN	0
Cak1	Cak1	CD	B-NP
.	.	.	0
Cak1	Cak1	NNP	B-NP
in	in	IN	0
yeast	yeast	NN	0
is	is	VBZ	0
the	the	DT	0
human	human	JJ	0
containing	containing	VBG	B-NP
cdk7	cdk7	NN	I-NP
cak	cak	NN	I-NP
trimeric	trimeric	NN	I-NP
enzyme	enzyme	NN	I-NP
homolog	homolog	NN	I-NP
,	,	,	0
cyclin	cyclin	VBG	0
H	H	NNP	0
,	,	,	0
and	and	CC	0
MAT1	MAT1	NNP	B-NP
.	.	.	0
Both	Both	DT	0
human	human	JJ	0
and	and	CC	0
yeast	yeast	JJ	0
Caks	Caks	JJ	B-NP
function	function	NN	I-NP
as	as	IN	0
RNA	RNA	NNP	B-NP
polymerase	polymerase	VBD	0
II	II	NNP	0
CTD	CTD	NNP	B-NP
kinase	kinase	NN	I-NP
,	,	,	0
activating	activating	VBG	B-NP
kinase	kinase	NN	I-NP
cdk	cdk	NN	I-NP
,	,	,	0
and	and	CC	0
dna	dna	NN	B-NP
damage/repair	damage/repair	NN	I-NP
enzyme	enzyme	NN	I-NP
.	.	.	0
Cdc37	Cdc37	NNP	B-NP
,	,	,	0
like	like	IN	0
its	its	PRP$	0
higher	higher	JJR	0
eukaryotic	eukaryotic	JJ	B-NP
homolog	homolog	NN	I-NP
,	,	,	0
promotes	promotes	VBZ	0
the	the	DT	0
physical	physical	JJ	B-NP
integrity	integrity	NN	I-NP
of	of	IN	0
multiple	multiple	JJ	0
protein	protein	NN	B-NP
kinas	kinas	NNP	I-NP
,	,	,	0
perhaps	perhaps	RB	0
by	by	IN	0
virtue	virtue	NN	0
of	of	IN	0
a	a	DT	0
cotranslational	cotranslational	JJ	B-NP
role	role	NN	I-NP
in	in	IN	0
protein	protein	NN	B-NP
folding	folding	NNS	0
[	[	-LRB-	0
80	80	CD	0
]	]	-RRB-	0
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
Hsp90	Hsp90	NNP	B-NP
/	/	NNP	0
Cdc37	Cdc37	NNP	B-NP
has	has	VBZ	0
recently	recently	RB	0
been	been	VBN	0
shown	shown	VBN	0
in	in	IN	0
the	the	DT	0
stabilization	stabilization	JJ	0
/	/	CD	0
folding	folding	NN	0
of	of	IN	0
Cdk9	Cdk9	CD	B-NP
as	as	IN	0
well	well	RB	0
as	as	IN	0
the	the	DT	0
assembly	assembly	NN	0
of	of	IN	0
an	an	DT	0
active	active	JJ	0
Cdk9	Cdk9	CD	B-NP
/	/	CD	0
cyclin	cyclin	CD	B-NP
T1	T1	CD	I-NP
complex	complex	JJ	0
responsible	responsible	JJ	0
for	for	IN	0
P-TEFb-mediated	P-TEFb-mediated	NNP	B-NP
Tat	Tat	NNP	I-NP
transactivation	transactivation	NN	I-NP
[	[	-LRB-	0
81	81	CD	0
]	]	-RRB-	0
.	.	.	0
Transcription	Transcription	NNP	B-NP
and	and	CC	0
chromatin	chromatin	JJ	B-NP
remodeling	remodeling	NN	I-NP
factor	factor	NN	I-NP
A	A	DT	0
highly	highly	RB	0
ordered	ordered	VBN	0
chromatin	chromatin	JJ	B-NP
structure	structure	NN	I-NP
presents	presents	VBZ	0
a	a	DT	0
gene	gene	NN	B-NP
transcription	transcription	NNS	I-NP
physical	physical	JJ	I-NP
obstacle	obstacle	NN	I-NP
;	;	:	0
presumably	presumably	RB	0
by	by	IN	0
limiting	limiting	VBG	0
the	the	DT	0
access	access	NN	0
of	of	IN	0
transcription	transcription	JJ	B-NP
factor	factor	NN	I-NP
and	and	CC	0
RNA	RNA	NNP	B-NP
polymerase	polymerase	VBD	0
II	II	NNP	0
core	core	NN	0
machinery	machinery	NN	0
to	to	TO	0
target	target	VB	0
DNA	DNA	NNP	B-NP
[	[	-LRB-	0
82	82	CD	0
83	83	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
concert	concert	NN	0
with	with	IN	0
the	the	DT	0
observation	observation	NN	0
that	that	IN	0
corepressor	corepressor	NN	B-NP
are	are	VBP	0
associated	associated	VBN	0
with	with	IN	0
hdac	hdac	NN	B-NP
activity	activity	NN	I-NP
[	[	-LRB-	0
84	84	CD	0
85	85	CD	0
]	]	-RRB-	0
,	,	,	0
it	it	PRP	0
appears	appears	VBZ	0
that	that	IN	0
the	the	DT	0
transcriptional	transcriptional	JJ	B-NP
outcome	outcome	NN	I-NP
of	of	IN	0
nuclear	nuclear	JJ	0
receptor	receptor	NN	B-NP
is	is	VBZ	0
determined	determined	VBN	0
by	by	IN	0
the	the	DT	0
balance	balance	NN	0
of	of	IN	0
histone	histone	JJ	B-NP
acetylation	acetylation	NN	I-NP
and	and	CC	0
deacetylation	deacetylation	JJ	B-NP
activity	activity	NN	I-NP
,	,	,	0
and	and	CC	0
that	that	IN	0
ligand	ligand	NN	B-NP
serve	serve	VBP	0
as	as	IN	0
a	a	DT	0
switch	switch	NN	0
to	to	TO	0
recruit	recruit	VB	0
HATs	HATs	JJ	0
with	with	IN	0
the	the	DT	0
concomitant	concomitant	JJ	0
dismissal	dismissal	NN	0
of	of	IN	0
HDACs	HDACs	JJ	0
.	.	.	0
Signal	Signal	NNP	0
transduction	transduction	VBD	0
pathways	pathways	RB	0
add	add	VB	0
another	another	DT	0
layer	layer	NN	0
of	of	IN	0
regulation	regulation	NN	0
to	to	TO	0
the	the	DT	0
functions	functions	NNS	0
of	of	IN	0
CBP	CBP	NNP	B-NP
/	/	NNP	0
p300	p300	NNP	B-NP
.	.	.	0
In	In	IN	0
the	the	DT	0
case	case	NN	0
of	of	IN	0
the	the	DT	0
POU	POU	NNP	B-NP
homeodomain	homeodomain	JJ	0
factor	factor	NN	0
Pit-1	Pit-1	NN	0
,	,	,	0
transcriptional	transcriptional	JJ	B-NP
activity	activity	NN	I-NP
is	is	VBZ	0
potentiated	potentiated	VBN	0
by	by	IN	0
mapk	mapk	NN	B-NP
pathway	pathway	NN	I-NP
[	[	-LRB-	0
86	86	CD	0
]	]	-RRB-	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
mapk	mapk	NN	B-NP
pathway	pathway	NN	I-NP
member	member	NN	I-NP
down-regulation	down-regulation	JJ	I-NP
in	in	IN	0
Tat	Tat	NNP	0
expressing	expressing	VBG	B-NP
cell	cell	NN	I-NP
,	,	,	0
as	as	RB	0
seen	seen	VBN	0
in	in	IN	0
Table	Table	NNP	0
3	3	CD	0
,	,	,	0
is	is	VBZ	0
consistent	consistent	JJ	0
with	with	IN	0
decreased	decreased	JJ	0
dna	dna	NN	B-NP
phosphorylation	phosphorylation	NN	I-NP
binding	binding	JJ	0
factors	factors	NNS	0
such	such	JJ	0
as	as	IN	0
Pit-1	Pit-1	NNP	B-NP
,	,	,	0
and	and	CC	0
overall	overall	JJ	0
lower	lower	JJR	0
DNA	DNA	NN	B-NP
binding	binding	JJ	0
activity	activity	NN	0
.	.	.	0
Here	Here	RB	0
,	,	,	0
we	we	PRP	0
describe	describe	VBP	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
src-1	src-1	NN	B-NP
coactivator	coactivator	NN	I-NP
protein	protein	NN	I-NP
(	(	-LRB-	0
Acc	Acc	UH	B-NP
#	#	#	0
AJ000882	AJ000882	CD	0
,	,	,	0
U90661	U90661	NNP	0
,	,	,	0
Table	Table	NNP	0
1	1	CD	0
)	)	-RRB-	0
and	and	CC	0
p300	p300	NNP	B-NP
(	(	-LRB-	0
Acc	Acc	UH	B-NP
#	#	#	0
U01877	U01877	CD	0
,	,	,	0
Table	Table	NNP	0
3	3	CD	0
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
their	their	PRP$	0
relation	relation	NN	0
to	to	TO	0
differentiation	differentiation	VB	B-NP
gene	gene	NN	I-NP
such	such	JJ	0
as	as	IN	0
retinoic	retinoic	JJ	B-NP
acid	acid	NN	I-NP
receptor	receptor	NN	I-NP
(	(	-LRB-	0
RAR	RAR	NNP	B-NP
/	/	NNP	I-NP
PML	PML	NNP	I-NP
,	,	,	0
Acc	Acc	NNP	B-NP
#	#	NNP	0
:	:	:	0
X06614	X06614	CD	0
,	,	,	0
Table	Table	NNP	0
1	1	CD	0
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
Leptin	Leptin	NNP	B-NP
receptor	receptor	NN	I-NP
variant	variant	JJ	I-NP
(	(	-LRB-	0
Acc	Acc	NNP	B-NP
#	#	NNP	0
:	:	:	0
U66496	U66496	CD	0
,	,	,	0
Table	Table	NNP	0
1	1	CD	0
)	)	-RRB-	0
;	;	:	0
all	all	DT	0
of	of	IN	0
which	which	WDT	0
are	are	VBP	0
down-regulated	down-regulated	JJ	0
in	in	IN	0
Tat	Tat	NNP	0
expressing	expressing	VBG	B-NP
cell	cell	NN	I-NP
(	(	-LRB-	0
Figure	Figure	NNP	0
5	5	CD	0
)	)	-RRB-	0
.	.	.	0
Over	Over	IN	0
the	the	DT	0
past	past	JJ	0
three	three	CD	0
decades	decades	NNS	0
a	a	DT	0
great	great	JJ	0
deal	deal	NN	0
of	of	IN	0
evidence	evidence	NN	0
has	has	VBZ	0
accumulated	accumulated	VBN	0
in	in	IN	0
favor	favor	NN	0
of	of	IN	0
the	the	DT	0
hypothesis	hypothesis	NN	0
that	that	IN	0
steroid	steroid	JJ	B-NP
receptor	receptor	NN	I-NP
hormones	hormones	NN	I-NP
act	act	NN	I-NP
via	via	IN	0
regulation	regulation	NN	0
of	of	IN	0
gene	gene	NN	B-NP
expression	expression	NN	I-NP
.	.	.	0
The	The	DT	0
action	action	NN	0
is	is	VBZ	0
mediated	mediated	VBN	0
by	by	IN	0
specific	specific	JJ	0
nuclear	nuclear	JJ	0
receptor	receptor	NN	B-NP
protein	protein	NN	I-NP
,	,	,	0
which	which	WDT	0
belong	belong	VBP	0
to	to	TO	0
a	a	DT	0
superfamily	superfamily	NN	0
of	of	IN	0
ligand-modulated	ligand-modulated	JJ	B-NP
transcription	transcription	JJ	I-NP
factor	factor	NN	I-NP
that	that	IN	0
regulate	regulate	JJ	0
homeostasi	homeostasi	NN	B-NP
,	,	,	0
reproduction	reproduction	NN	B-NP
,	,	,	0
development	development	NN	0
,	,	,	0
and	and	CC	0
differentiation	differentiation	NN	B-NP
[	[	-LRB-	0
87	87	CD	0
]	]	-RRB-	0
.	.	.	0
This	This	DT	0
family	family	NN	0
includes	includes	VBZ	0
receptors	receptors	VBN	0
for	for	IN	0
steroid	steroid	JJ	B-NP
hormone	hormone	NN	I-NP
,	,	,	0
thyroid	thyroid	JJ	B-NP
hormone	hormone	NN	I-NP
,	,	,	0
hormonal	hormonal	JJ	B-NP
form	form	NN	I-NP
of	of	IN	0
vitamin	vitamin	JJ	0
A	A	NN	0
and	and	CC	0
D	D	NNP	0
,	,	,	0
peroxisomal	peroxisomal	JJ	B-NP
activator	activator	NN	I-NP
,	,	,	0
and	and	CC	0
ecdysona	ecdysona	NN	B-NP
[	[	-LRB-	0
88	88	CD	0
]	]	-RRB-	0
.	.	.	0
nuclear	nuclear	JJ	B-NP
hormone	hormone	NN	I-NP
receptor	receptor	NN	I-NP
are	are	VBP	0
ligand-dependent	ligand-dependent	JJ	B-NP
transcription	transcription	JJ	I-NP
factor	factor	NN	I-NP
that	that	IN	0
regulate	regulate	JJ	0
genes	genes	NNS	0
critical	critical	JJ	0
to	to	TO	0
such	such	JJ	0
biological	biological	JJ	B-NP
process	process	NN	I-NP
as	as	IN	0
development	development	NN	0
,	,	,	0
reproduction	reproduction	NN	B-NP
,	,	,	0
and	and	CC	0
homeostasi	homeostasi	NN	B-NP
.	.	.	0
Interestingly	Interestingly	RB	0
,	,	,	0
these	these	DT	0
receptor	receptor	NN	B-NP
can	can	MD	0
function	function	VB	0
as	as	IN	0
molecular	molecular	JJ	B-NP
switch	switch	NN	I-NP
,	,	,	0
alternating	alternating	VBG	0
between	between	IN	0
states	states	NNS	0
of	of	IN	0
transcriptional	transcriptional	JJ	B-NP
repression	repression	NN	I-NP
and	and	CC	0
activation	activation	NN	B-NP
,	,	,	0
depending	depending	VBG	0
on	on	IN	0
the	the	DT	0
absence	absence	NN	B-NP
or	or	CC	0
presence	presence	NN	0
of	of	IN	0
a	a	DT	0
cognate	cognate	JJ	0
hormone	hormone	NN	0
,	,	,	0
respectively	respectively	RB	0
.	.	.	0
In	In	IN	0
the	the	DT	0
absence	absence	NN	B-NP
of	of	IN	0
cognate	cognate	JJ	0
hormone	hormone	NN	0
,	,	,	0
several	several	JJ	0
nuclear	nuclear	JJ	0
receptor	receptor	NN	B-NP
actively	actively	RB	0
repress	repress	JJ	0
target	target	NN	B-NP
gene	gene	NN	I-NP
transcription	transcription	NN	I-NP
via	via	IN	0
interaction	interaction	NN	B-NP
with	with	IN	0
the	the	DT	0
nuclear	nuclear	JJ	0
receptor	receptor	NN	B-NP
corepressors	corepressors	VBD	0
SMRT	SMRT	NNP	B-NP
and	and	CC	0
NCoR	NCoR	JJ	0
.	.	.	0
Upon	Upon	IN	0
binding	binding	VBG	0
of	of	IN	0
the	the	DT	0
hormone	hormone	NN	0
,	,	,	0
these	these	DT	0
corepressors	corepressors	JJ	0
dissociate	dissociate	NN	0
from	from	IN	0
the	the	DT	0
DNA-bound	DNA-bound	JJ	B-NP
receptor	receptor	NN	I-NP
,	,	,	0
which	which	WDT	0
subsequently	subsequently	RB	0
recruits	recruits	VBZ	0
a	a	DT	0
nuclear	nuclear	JJ	B-NP
receptor	receptor	NN	I-NP
coactivator	coactivator	NN	I-NP
(	(	-LRB-	0
nuclear	nuclear	JJ	B-NP
receptor	receptor	NN	I-NP
coactivator	coactivator	NN	I-NP
)	)	-RRB-	0
complex	complex	NN	0
.	.	.	0
Prominent	Prominent	JJ	0
among	among	IN	0
these	these	DT	0
coactivator	coactivator	NN	B-NP
is	is	VBZ	0
the	the	DT	0
steroid	steroid	NN	B-NP
receptor	receptor	NN	I-NP
coactivator	coactivator	NN	I-NP
(	(	-LRB-	0
steroid	steroid	NN	B-NP
receptor	receptor	NN	I-NP
coactivator	coactivator	NN	I-NP
)	)	-RRB-	0
family	family	NN	0
,	,	,	0
which	which	WDT	0
consists	consists	VBZ	0
of	of	IN	0
SRC-1	SRC-1	NNP	B-NP
,	,	,	0
TIF2	TIF2	NNP	B-NP
/	/	NNP	0
GRIP1	GRIP1	NNP	B-NP
,	,	,	0
and	and	CC	0
RAC3	RAC3	NNP	B-NP
/	/	NNP	0
ACTR	ACTR	NNP	B-NP
/	/	NNP	I-NP
pCIP	pCIP	NNP	I-NP
/	/	NNP	I-NP
AIB-1	AIB-1	NNP	I-NP
.	.	.	0
These	These	DT	0
cofactors	cofactors	JJ	0
interact	interact	NN	0
with	with	IN	0
nuclear	nuclear	JJ	0
receptor	receptor	NN	B-NP
in	in	IN	0
a	a	DT	0
ligand-dependent	ligand-dependent	JJ	B-NP
manner	manner	NN	I-NP
and	and	CC	0
enhance	enhance	VB	0
transcriptional	transcriptional	JJ	B-NP
activation	activation	NN	I-NP
via	via	IN	0
histone	histone	NN	B-NP
acetylation	acetylation	NN	I-NP
/	/	NN	I-NP
methylation	methylation	NN	I-NP
and	and	CC	0
recruitment	recruitment	NN	0
of	of	IN	0
additional	additional	JJ	0
cofactors	cofactors	JJ	0
such	such	JJ	0
as	as	IN	0
CBP	CBP	NNP	B-NP
/	/	NNP	0
p300	p300	NNP	B-NP
[	[	-LRB-	0
89	89	CD	0
]	]	-RRB-	0
.	.	.	0
CBP	CBP	NNP	B-NP
/	/	NNP	0
p300	p300	NNP	B-NP
has	has	VBZ	0
been	been	VBN	0
implicated	implicated	VBN	0
in	in	IN	0
the	the	DT	0
functions	functions	NNS	0
of	of	IN	0
a	a	DT	0
large	large	JJ	0
number	number	NN	0
of	of	IN	0
regulated	regulated	JJ	0
transcription	transcription	JJ	B-NP
factor	factor	NN	I-NP
based	based	VBN	0
primarily	primarily	RB	0
on	on	IN	0
physical	physical	JJ	B-NP
interaction	interaction	NN	I-NP
and	and	CC	0
the	the	DT	0
ability	ability	NN	B-NP
to	to	TO	0
potentiate	potentiate	VB	0
transcription	transcription	VBN	B-NP
when	when	WRB	0
overexpressed	overexpressed	NN	B-NP
[	[	-LRB-	0
90	90	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
the	the	DT	0
case	case	NN	0
of	of	IN	0
nuclear	nuclear	JJ	0
receptor	receptor	NN	B-NP
,	,	,	0
the	the	DT	0
interaction	interaction	NN	0
with	with	IN	0
CBP	CBP	NNP	B-NP
/	/	NNP	0
p300	p300	NNP	B-NP
is	is	VBZ	0
ligand-dependent	ligand-dependent	JJ	B-NP
and	and	CC	0
relies	relies	VBZ	0
on	on	IN	0
the	the	DT	0
conserved	conserved	JJ	0
nuclear	nuclear	JJ	0
receptor	receptor	NN	B-NP
functional	functional	NN	I-NP
domain	domain	NN	I-NP
,	,	,	0
activation	activation	NN	B-NP
function	function	NN	I-NP
2	2	NN	I-NP
(	(	-LRB-	0
activation	activation	JJ	B-NP
function	function	NN	I-NP
2	2	CD	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
vivo	vivo	JJ	B-NP
study	study	NN	I-NP
have	have	VBP	0
supported	supported	VBN	0
the	the	DT	0
conclusion	conclusion	NN	0
that	that	IN	0
CBP	CBP	NNP	B-NP
/	/	NNP	0
p300	p300	NNP	B-NP
are	are	VBP	0
components	components	NNS	0
of	of	IN	0
the	the	DT	0
transcription	transcription	NN	B-NP
hormonal-regulation	hormonal-regulation	JJ	I-NP
in	in	IN	0
fibroblasts	fibroblasts	VBG	0
isolated	isolated	VBN	0
from	from	IN	0
a	a	DT	0
p300-	p300-	NNP	B-NP
/	/	NNP	I-NP
-	-	:	I-NP
mouse	mouse	NN	I-NP
;	;	:	0
and	and	CC	0
loss	loss	NN	0
of	of	IN	0
the	the	DT	0
p300	p300	JJ	B-NP
gene	gene	NN	I-NP
severely	severely	RB	0
affects	affects	VBZ	0
retinoic	retinoic	JJ	B-NP
acid	acid	NN	I-NP
(	(	-LRB-	I-NP
RA	RA	NNP	I-NP
)	)	-RRB-	I-NP
-dependent	-dependent	JJ	I-NP
transcription	transcription	NN	I-NP
[	[	-LRB-	0
91	91	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
a	a	DT	0
separate	separate	JJ	0
study	study	NN	0
using	using	VBG	0
hammerhead	hammerhead	JJ	B-NP
ribozyme	ribozyme	NN	I-NP
that	that	WDT	0
specifically	specifically	RB	0
cleave	cleave	JJ	0
CBP	CBP	NNP	B-NP
or	or	CC	0
p300	p300	NNP	B-NP
mRNA	mRNA	NNP	I-NP
,	,	,	0
Kawasaki	Kawasaki	NNP	0
et	et	FW	0
al	al	FW	0
[	[	-LRB-	0
92	92	CD	0
]	]	-RRB-	0
reported	reported	VBD	0
that	that	DT	0
reduced	reduced	JJ	0
cellular	cellular	JJ	0
CBP	CBP	NNP	B-NP
or	or	CC	0
p300	p300	CD	B-NP
level	level	JJ	I-NP
resulted	resulted	VBD	0
in	in	IN	0
compromised	compromised	JJ	0
expression	expression	NN	0
of	of	IN	0
endogenous	endogenous	JJ	B-NP
ra-inducible	ra-inducible	NN	I-NP
gene	gene	NN	I-NP
such	such	JJ	0
as	as	IN	0
p21	p21	NNP	B-NP
/	/	NNP	0
Waf1	Waf1	NNP	B-NP
and	and	CC	0
p27	p27	CD	B-NP
cdk	cdk	CD	I-NP
inhibitor	inhibitor	NN	I-NP
.	.	.	0
Along	Along	IN	0
this	this	DT	0
line	line	NN	0
,	,	,	0
Tat	Tat	NNP	0
expressing	expressing	VBG	B-NP
cell	cell	NN	I-NP
have	have	VBP	0
lower	lower	JJR	0
levels	levels	NNS	0
of	of	IN	0
p21	p21	CD	B-NP
/	/	CD	0
Waf1	Waf1	CD	B-NP
presumably	presumably	RB	0
due	due	JJ	0
to	to	TO	0
inactivation	inactivation	VB	0
of	of	IN	0
p53	p53	NN	B-NP
and	and	CC	0
a	a	DT	0
lack	lack	NN	0
of	of	IN	0
p300	p300	CD	B-NP
/	/	CD	0
RA-	RA-	JJ	B-NP
induced	induced	JJ	I-NP
gene	gene	NN	I-NP
expression	expression	NN	I-NP
.	.	.	0
Consistent	Consistent	JJ	0
with	with	IN	0
this	this	DT	0
interpretation	interpretation	NN	B-NP
,	,	,	0
CBP	CBP	NNP	B-NP
and	and	CC	0
ligand-induced	ligand-induced	NNP	B-NP
ra	ra	NNP	I-NP
p300	p300	CD	I-NP
harbor	harbor	NN	I-NP
transcriptional	transcriptional	NN	I-NP
activation	activation	NN	I-NP
or	or	CC	0
ER	ER	NNP	B-NP
function	function	NN	I-NP
on	on	IN	0
a	a	DT	0
chromatinized	chromatinized	JJ	B-NP
template	template	NN	I-NP
[	[	-LRB-	0
93	93	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
ncoa	ncoa	NN	B-NP
family	family	NN	I-NP
member	member	NN	I-NP
constitute	constitute	VBP	0
SRC-1	SRC-1	CD	B-NP
/	/	CD	0
NcoA-1	NcoA-1	CD	B-NP
[	[	-LRB-	0
89	89	CD	0
]	]	-RRB-	0
,	,	,	0
TIF2	TIF2	CD	B-NP
/	/	CD	0
GRIP1	GRIP1	CD	B-NP
/	/	CD	0
NcoA-2	NcoA-2	CD	B-NP
,	,	,	0
[	[	-LRB-	0
94	94	CD	0
95	95	CD	0
]	]	-RRB-	0
and	and	CC	0
pCIP	pCIP	NNP	B-NP
/	/	NNP	I-NP
ACTR	ACTR	NNP	I-NP
/	/	NNP	0
AIB1	AIB1	NNP	B-NP
[	[	-LRB-	0
96	96	CD	0
97	97	CD	0
98	98	CD	0
]	]	-RRB-	0
proteins	proteins	NNS	0
,	,	,	0
which	which	WDT	0
interact	interact	VBZ	0
with	with	IN	0
liganded	liganded	JJ	B-NP
RA	RA	NNP	I-NP
receptor	receptor	NN	I-NP
(	(	-LRB-	0
ra	ra	NNP	B-NP
receptor	receptor	NN	I-NP
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
CBP	CBP	NNP	B-NP
/	/	NNP	0
p300	p300	NNP	B-NP
.	.	.	0
Overexpression	Overexpression	NNP	B-NP
of	of	IN	0
these	these	DT	0
ncoa	ncoa	NN	B-NP
factor	factor	NN	I-NP
enhances	enhances	VBZ	0
ligand-induced	ligand-induced	JJ	B-NP
transactivation	transactivation	NN	I-NP
of	of	IN	0
several	several	JJ	0
nuclear	nuclear	JJ	0
receptor	receptor	NN	B-NP
[	[	-LRB-	0
99	99	CD	0
]	]	-RRB-	0
.	.	.	0
A	A	DT	0
weak	weak	JJ	0
intrinsic	intrinsic	JJ	B-NP
HAT	HAT	NNP	I-NP
activity	activity	NN	I-NP
has	has	VBZ	0
been	been	VBN	0
reported	reported	VBN	0
in	in	IN	0
SRC-1	SRC-1	NNP	B-NP
/	/	NNP	0
NCoA-1	NCoA-1	NNP	B-NP
and	and	CC	0
pCIP	pCIP	NNP	B-NP
/	/	NNP	I-NP
ACTR	ACTR	NNP	I-NP
/	/	NNP	0
AIB1	AIB1	NNP	B-NP
,	,	,	0
suggesting	suggesting	VBG	0
that	that	IN	0
chromatin	chromatin	JJ	B-NP
remodeling	remodeling	NN	I-NP
may	may	MD	0
also	also	RB	0
be	be	VB	0
a	a	DT	0
function	function	NN	0
of	of	IN	0
these	these	DT	0
ncoa	ncoa	NN	B-NP
factor	factor	NN	I-NP
[	[	-LRB-	0
99	99	CD	0
100	100	CD	0
]	]	-RRB-	0
;	;	:	0
although	although	IN	0
they	they	PRP	0
do	do	VBP	0
not	not	RB	0
appear	appear	VB	0
to	to	TO	0
contain	contain	VB	0
regions	regions	NNS	0
homologous	homologous	VBP	0
to	to	TO	0
the	the	DT	0
HAT	HAT	NNP	0
domains	domains	NN	0
of	of	IN	0
CBP	CBP	NNP	B-NP
/	/	NNP	0
p300	p300	NNP	B-NP
or	or	CC	0
p	p	JJ	0
/	/	NNP	0
CAF	CAF	NNP	0
.	.	.	0
Structure-function	Structure-function	JJ	B-NP
analysis	analysis	NN	I-NP
of	of	IN	0
the	the	DT	0
NCoA	NCoA	NN	B-NP
have	have	VBP	0
revealed	revealed	VBN	0
multiple	multiple	JJ	0
copies	copies	NNS	0
of	of	IN	0
a	a	DT	0
signature	signature	NN	B-NP
motif	motif	NN	I-NP
,	,	,	0
LXXLL	LXXLL	NNP	B-NP
,	,	,	0
with	with	IN	0
conserved	conserved	JJ	0
spacing	spacing	NN	0
that	that	WDT	0
is	is	VBZ	0
required	required	VBN	0
for	for	IN	0
interaction	interaction	NN	0
with	with	IN	0
nuclear	nuclear	JJ	0
receptor	receptor	NN	B-NP
and	and	CC	0
CBP	CBP	NNP	B-NP
/	/	NNP	0
p300	p300	NNP	B-NP
[	[	-LRB-	0
99	99	CD	0
101	101	CD	0
]	]	-RRB-	0
.	.	.	0
Intriguingly	Intriguingly	NNP	0
,	,	,	0
different	different	JJ	0
lxxll	lxxll	NN	B-NP
motif	motif	NN	I-NP
are	are	VBP	0
required	required	VBN	0
for	for	IN	0
peroxisome	peroxisome	NN	B-NP
proliferator	proliferator	NN	I-NP
activated	activated	VBN	I-NP
receptor	receptor	NN	I-NP
γ,	γ,	NN	I-NP
(	(	-LRB-	0
Peroxisome	Peroxisome	NN	B-NP
Proliferator	Proliferator	NN	I-NP
activated	activated	FW	0
receptor	receptor	FW	0
γ	γ	FW	0
,	,	,	0
a	a	DT	0
gene	gene	NN	0
down-regulated	down-regulated	NN	0
in	in	IN	0
Tat	Tat	NNP	0
expressing	expressing	VBG	B-NP
cell	cell	NN	I-NP
;	;	:	0
Acc	Acc	RB	0
#	#	#	0
L07592	L07592	CD	0
,	,	,	0
Table	Table	NNP	0
1	1	CD	0
)	)	-RRB-	0
function	function	NN	0
in	in	IN	0
response	response	NN	0
to	to	TO	0
different	different	JJ	0
classes	classes	NNS	0
of	of	IN	0
ligand	ligand	NN	B-NP
,	,	,	0
suggesting	suggesting	VBG	0
distinct	distinct	JJ	0
configuration	configuration	NN	B-NP
of	of	IN	0
assembled	assembled	JJ	0
complexes	complexes	NNS	0
.	.	.	0
Taken	Taken	VBN	0
together	together	RB	0
,	,	,	0
through	through	IN	0
the	the	DT	0
use	use	NN	0
of	of	IN	0
microarray	microarray	JJ	B-NP
technology	technology	NN	I-NP
,	,	,	0
we	we	PRP	0
have	have	VBP	0
described	described	VBN	0
one	one	CD	0
of	of	IN	0
the	the	DT	0
first	first	JJ	0
observation	observation	NN	B-NP
about	about	IN	0
how	how	WRB	0
Tat	Tat	NNP	0
is	is	VBZ	0
able	able	JJ	0
to	to	TO	0
control	control	VB	0
various	various	JJ	0
host	host	NN	0
cellular	cellular	JJ	B-NP
machinery	machinery	NN	I-NP
.	.	.	0
Although	Although	IN	0
our	our	PRP$	0
data	data	NN	0
is	is	VBZ	0
consistent	consistent	JJ	0
with	with	IN	0
most	most	JJS	0
of	of	IN	0
the	the	DT	0
cited	cited	JJ	0
literature	literature	NN	0
on	on	IN	0
the	the	DT	0
effects	effects	NNS	0
of	of	IN	0
Tat	Tat	NNP	0
in	in	IN	0
infected	infected	JJ	0
host	host	NN	0
and	and	CC	0
uninfected	uninfected	JJ	B-NP
bystander	bystander	JJ	I-NP
cell	cell	NN	I-NP
,	,	,	0
we	we	PRP	0
caution	caution	VBP	0
that	that	IN	0
the	the	DT	0
transcriptional	transcriptional	JJ	B-NP
profiling	profiling	NN	I-NP
in	in	IN	0
chronically	chronically	RB	0
infected	infected	JJ	0
cells	cells	NNS	0
such	such	JJ	0
as	as	IN	0
ACH2	ACH2	NNP	B-NP
or	or	CC	0
H9	H9	NNP	0
/	/	NNP	0
Tat	Tat	NNP	0
cells	cells	NNS	0
may	may	MD	0
not	not	RB	0
necessarily	necessarily	RB	0
be	be	VB	0
representative	representative	NN	B-NP
of	of	IN	0
the	the	DT	0
pattern	pattern	NN	0
of	of	IN	0
expression	expression	NN	0
observed	observed	VBD	0
in	in	IN	0
most	most	JJS	0
cells	cells	NNS	0
infected	infected	VBN	0
by	by	IN	0
other	other	JJ	0
group	group	NN	0
M	M	NNP	0
,	,	,	0
N	N	NNP	0
,	,	,	0
or	or	CC	0
O	O	NNP	B-NP
HIV-1	HIV-1	NNP	I-NP
isolates	isolates	VBZ	0
.	.	.	0
We	We	PRP	0
recently	recently	RB	0
extended	extended	VBN	0
our	our	PRP$	0
observation	observation	NN	B-NP
by	by	IN	0
utilizing	utilizing	JJ	0
other	other	JJ	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
infected	infected	JJ	0
cells	cells	NNS	0
which	which	WDT	0
normally	normally	RB	0
express	express	VB	0
Tat	Tat	NNP	0
(	(	-LRB-	0
U1	U1	NNP	0
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
exogenous	exogenous	NNS	B-NP
addition	addition	NN	I-NP
purified	purified	FW	0
Tat	Tat	FW	0
to	to	TO	0
uninfected	uninfected	VB	0
PBMCs	PBMCs	JJ	0
.	.	.	0
preliminary	preliminary	JJ	B-NP
result	result	NN	I-NP
using	using	VBG	0
western	western	JJ	0
blots	blots	NN	0
supports	supports	VBZ	0
the	the	DT	0
idea	idea	NN	0
that	that	IN	0
genes	genes	NNS	0
which	which	WDT	0
were	were	VBD	0
altered	altered	VBN	0
in	in	IN	0
H9	H9	NNP	0
/	/	NNP	0
Tat	Tat	NNP	0
system	system	NN	0
also	also	RB	0
showed	showed	VBD	0
a	a	DT	0
similar	similar	JJ	0
level	level	NN	0
of	of	IN	0
change	change	NN	0
in	in	IN	0
few	few	JJ	0
of	of	IN	0
the	the	DT	0
tested	tested	JJ	0
genes	genes	NNS	0
(	(	-LRB-	0
Figure	Figure	NNP	0
3C	3C	NNP	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
notion	notion	NN	0
of	of	IN	0
consistency	consistency	NN	0
was	was	VBD	0
further	further	RB	0
confirmed	confirmed	VBD	0
using	using	VBG	0
the	the	DT	0
IL-8	IL-8	JJ	B-NP
activation	activation	NN	I-NP
by	by	IN	0
Tat	Tat	NNP	0
.	.	.	0
Interleukin-8	Interleukin-8	NNP	B-NP
(	(	-LRB-	0
IL-8	IL-8	NNP	0
)	)	-RRB-	0
belongs	belongs	VBZ	0
to	to	TO	0
the	the	DT	0
CXC	CXC	NNP	0
chemokine	chemokine	JJ	B-NP
family	family	NN	I-NP
and	and	CC	0
is	is	VBZ	0
secreted	secreted	VBN	0
by	by	IN	0
several	several	JJ	0
different	different	JJ	0
cell	cell	NN	0
types	types	NNS	0
,	,	,	0
including	including	VBG	B-NP
monocyte	monocyte	NN	I-NP
,	,	,	0
neutrophil	neutrophil	NN	B-NP
,	,	,	0
endothelial	endothelial	JJ	B-NP
cell	cell	NN	I-NP
,	,	,	0
fibroblast	fibroblast	NN	B-NP
,	,	,	0
and	and	CC	0
t	t	NN	B-NP
lymphocyte	lymphocyte	NN	I-NP
.	.	.	0
IL-8	IL-8	NNP	B-NP
production	production	NN	I-NP
(	(	-LRB-	0
induced	induced	VBN	0
by	by	IN	0
several	several	JJ	0
stimuli	stimuli	NNS	0
,	,	,	0
including	including	VBG	B-NP
IL-1	IL-1	NNP	I-NP
,	,	,	0
TNF-	TNF-	NNP	B-NP
,	,	,	0
and	and	CC	0
phorbol	phorbol	NN	B-NP
myristate	myristate	NN	I-NP
acetate	acetate	NN	I-NP
)	)	-RRB-	0
is	is	VBZ	0
primarily	primarily	RB	0
regulated	regulated	VBN	0
at	at	IN	0
the	the	DT	0
transcriptional	transcriptional	JJ	B-NP
level	level	NN	I-NP
.	.	.	0
IL-8	IL-8	NNP	B-NP
is	is	VBZ	0
a	a	DT	0
potent	potent	JJ	0
granulocyte	granulocyte	NN	B-NP
chemotactic	chemotactic	JJ	I-NP
factor	factor	NN	I-NP
and	and	CC	0
t	t	NN	B-NP
lymphocyte	lymphocyte	NN	I-NP
,	,	,	0
and	and	CC	0
is	is	VBZ	0
found	found	VBN	0
in	in	IN	0
hiv-infected	hiv-infected	NN	B-NP
individual	individual	JJ	I-NP
.	.	.	0
The	The	DT	0
CXC	CXC	FW	0
chemokine	chemokine	NN	B-NP
IL-8	IL-8	NN	I-NP
does	does	VBZ	0
not	not	RB	0
bind	bind	VBN	0
to	to	TO	0
CCR5	CCR5	CD	B-NP
.	.	.	0
It	It	PRP	0
has	has	VBZ	0
previously	previously	RB	0
been	been	VBN	0
shown	shown	VBN	0
that	that	IN	0
mrna	mrna	NN	B-NP
induction	induction	NN	I-NP
il-8	il-8	NN	I-NP
was	was	VBD	0
seen	seen	VBN	0
less	less	RBR	0
then	then	RB	0
1	1	CD	0
h	h	NN	0
after	after	IN	0
Tat	Tat	NNP	0
(	(	-LRB-	0
72aa	72aa	NNP	0
)	)	-RRB-	0
stimulation	stimulation	NN	0
,	,	,	0
and	and	CC	0
levels	levels	NNS	0
remained	remained	VBD	0
elevated	elevated	VBN	0
for	for	IN	0
up	up	RB	0
to	to	TO	0
24	24	CD	0
h	h	NN	0
,	,	,	0
leading	leading	VBG	0
to	to	TO	0
IL-8	IL-8	CD	B-NP
protein	protein	NN	I-NP
production	production	NN	I-NP
[	[	-LRB-	0
102	102	CD	0
]	]	-RRB-	0
.	.	.	0
Along	Along	IN	0
these	these	DT	0
lines	lines	NNS	0
,	,	,	0
we	we	PRP	0
have	have	VBP	0
previously	previously	RB	0
shown	shown	VBN	0
that	that	IN	0
the	the	DT	0
IL-8	IL-8	JJ	B-NP
gene	gene	NN	I-NP
is	is	VBZ	0
expressed	expressed	VBN	0
in	in	IN	0
a	a	DT	0
cell	cell	NN	B-NP
cycle-dependent	cycle-dependent	JJ	I-NP
manner	manner	NN	I-NP
in	in	IN	0
cells	cells	NNS	0
that	that	WDT	0
express	express	VBP	0
the	the	DT	0
Tat	Tat	JJ	B-NP
protein	protein	NN	I-NP
,	,	,	0
and	and	CC	0
the	the	DT	0
induction	induction	NN	B-NP
is	is	VBZ	0
during	during	IN	0
the	the	DT	0
cell	cell	NN	B-NP
cycle	cycle	NN	I-NP
		NN	I-NP
phase	phase	NN	I-NP
and	and	CC	0
regulated	regulated	VBN	0
by	by	IN	0
stable	stable	JJ	0
NF-kB	NF-kB	JJ	B-NP
binding	binding	NN	I-NP
to	to	TO	0
the	the	DT	0
IL-8	IL-8	JJ	B-NP
promoter	promoter	NN	I-NP
[	[	-LRB-	0
103	103	CD	0
]	]	-RRB-	0
.	.	.	0
When	When	WRB	0
looking	looking	VBG	0
for	for	IN	0
IL-8	IL-8	CD	B-NP
at	at	IN	0
the	the	DT	0
G1	G1	NNP	0
/	/	NNP	0
S	S	NNP	B-NP
border	border	NN	I-NP
,	,	,	0
we	we	PRP	0
found	found	VBD	0
that	that	IN	0
all	all	DT	0
Tat	Tat	NNP	0
containing	containing	VBG	B-NP
cell	cell	NN	I-NP
,	,	,	0
including	including	VBG	B-NP
pbmc	pbmc	NN	I-NP
that	that	WDT	0
were	were	VBD	0
treated	treated	VBN	0
with	with	IN	0
exogenous	exogenous	JJ	B-NP
Tat	Tat	NNP	I-NP
showed	showed	VBD	0
an	an	DT	0
il-8	il-8	NN	B-NP
up-regulation	up-regulation	JJ	I-NP
in	in	IN	0
the	the	DT	0
supernatant	supernatant	NN	B-NP
(	(	-LRB-	0
Figure	Figure	NNP	0
4	4	CD	0
)	)	-RRB-	0
,	,	,	0
further	further	RB	0
implying	implying	VBG	0
that	that	IN	0
results	results	NNS	0
obtained	obtained	VBN	0
from	from	IN	0
the	the	DT	0
H9	H9	NNP	0
/	/	NNP	0
Tat	Tat	NNP	0
system	system	NN	0
may	may	MD	0
infact	infact	RB	0
be	be	VB	0
of	of	IN	0
general	general	JJ	0
physiological	physiological	JJ	B-NP
relevance	relevance	NN	I-NP
in	in	IN	0
vivo	vivo	NN	B-NP
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
throughout	throughout	IN	0
the	the	DT	0
current	current	JJ	0
study	study	NN	0
we	we	PRP	0
came	came	VBD	0
across	across	IN	0
some	some	DT	0
technical	technical	JJ	B-NP
finding	finding	NN	I-NP
that	that	WDT	0
were	were	VBD	0
critical	critical	JJ	0
in	in	IN	0
the	the	DT	0
confirmation	confirmation	NN	B-NP
of	of	IN	0
most	most	JJS	0
of	of	IN	0
our	our	PRP$	0
results	results	NNS	0
.	.	.	0
For	For	IN	0
instance	instance	NN	0
,	,	,	0
few	few	JJ	0
genes	genes	NNS	0
did	did	VBD	0
not	not	RB	0
correlate	correlate	VBN	0
in	in	IN	0
their	their	PRP$	0
activation	activation	NN	B-NP
or	or	CC	0
suppression	suppression	JJ	B-NP
level	level	JJ	I-NP
when	when	WRB	0
comparing	comparing	VBG	B-NP
fold	fold	JJ	I-NP
change	change	NN	I-NP
between	between	IN	0
microarray	microarray	NN	B-NP
and	and	CC	0
protein	protein	NN	B-NP
level	level	JJ	I-NP
using	using	VBG	0
western	western	JJ	0
blot	blot	JJ	0
analysis	analysis	NN	0
.	.	.	0
We	We	PRP	0
suspect	suspect	VBP	0
this	this	DT	0
is	is	VBZ	0
because	because	IN	0
many	many	JJ	0
genes	genes	NNS	0
that	that	WDT	0
are	are	VBP	0
transcribed	transcribed	NNS	0
may	may	MD	0
not	not	RB	0
necessarily	necessarily	RB	0
be	be	VB	0
translated	translated	VBN	0
,	,	,	0
due	due	JJ	0
to	to	TO	0
their	their	PRP$	0
cell	cell	NN	0
cycle	cycle	NN	0
stage	stage	NN	0
,	,	,	0
5	5	CD	0
'	'	POS	0
stem	stem	NN	0
and	and	CC	0
loop	loop	JJ	B-NP
rna	rna	NN	I-NP
structure	structure	NN	I-NP
,	,	,	0
varying	varying	VBG	B-NP
half-life	half-life	NN	I-NP
of	of	IN	0
proteins	proteins	NNS	0
and	and	CC	0
mRNAs	mRNAs	JJ	0
,	,	,	0
and	and	CC	0
a	a	DT	0
host	host	NN	0
of	of	IN	0
other	other	JJ	0
unknown	unknown	JJ	0
variables	variables	NNS	0
.	.	.	0
Also	Also	RB	0
,	,	,	0
specific	specific	JJ	0
changes	changes	NNS	0
that	that	WDT	0
occur	occur	VBP	0
in	in	IN	0
a	a	DT	0
cell	cell	NN	0
may	may	MD	0
not	not	RB	0
be	be	VB	0
required	required	VBN	0
in	in	IN	0
redundant	redundant	JJ	0
pathways	pathways	NN	0
that	that	IN	0
score	score	NN	0
for	for	IN	0
a	a	DT	0
specific	specific	JJ	0
function	function	NN	0
.	.	.	0
This	This	DT	0
is	is	VBZ	0
commonly	commonly	RB	0
seen	seen	VBN	0
in	in	IN	0
the	the	DT	0
differences	differences	NNS	0
between	between	IN	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
infected	infected	JJ	0
or	or	CC	0
Tat	Tat	NNP	0
expressing	expressing	NN	0
in	in	IN	0
vitro	vitro	JJ	B-NP
cell	cell	NN	I-NP
line	line	NN	I-NP
and	and	CC	0
AIDS	AIDS	NNP	0
patients	patients	NNS	0
pbmc	pbmc	NN	B-NP
sample	sample	NN	I-NP
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
other	other	JJ	0
microarray	microarray	NN	B-NP
would	would	MD	0
have	have	VB	0
to	to	TO	0
be	be	VB	0
performed	performed	VBN	0
on	on	IN	0
purified	purified	JJ	0
infected	infected	JJ	0
PBMCs	PBMCs	JJ	0
to	to	TO	0
confirm	confirm	VB	0
most	most	JJS	0
of	of	IN	0
the	the	DT	0
changes	changes	NNS	0
observed	observed	VBD	0
in	in	IN	0
Tables	Tables	NNP	0
1	1	CD	0
,	,	,	0
2	2	CD	0
,	,	,	0
and	and	CC	0
3	3	CD	0
.	.	.	0
Unfortunately	Unfortunately	RB	0
,	,	,	0
to	to	TO	0
date	date	VB	0
this	this	DT	0
particular	particular	JJ	0
issue	issue	NN	0
is	is	VBZ	0
not	not	RB	0
feasibly	feasibly	JJ	B-NP
addressable	addressable	NN	I-NP
,	,	,	0
since	since	IN	0
it	it	PRP	0
is	is	VBZ	0
not	not	RB	0
possible	possible	JJ	0
to	to	TO	0
isolate	isolate	VB	0
a	a	DT	0
homogenous	homogenous	JJ	B-NP
population	population	NN	I-NP
of	of	IN	0
infected	infected	JJ	0
T-	T-	JJ	0
or	or	CC	0
monocytic	monocytic	NN	B-NP
cell	cell	NN	I-NP
from	from	IN	0
AIDS	AIDS	NNP	0
patients	patients	NNS	0
.	.	.	0
Also	Also	RB	0
,	,	,	0
protein	protein	NN	B-NP
expression	expression	NN	I-NP
confirmatory	confirmatory	JJ	I-NP
test	test	NN	I-NP
would	would	MD	0
have	have	VB	0
to	to	TO	0
be	be	VB	0
done	done	VBN	0
with	with	IN	0
both	both	DT	0
hydrophilic	hydrophilic	NN	B-NP
and	and	CC	0
hydrophobic	hydrophobic	JJ	B-NP
extraction	extraction	JJ	I-NP
buffer	buffer	NN	I-NP
.	.	.	0
For	For	IN	0
instance	instance	NN	0
,	,	,	0
we	we	PRP	0
have	have	VBP	0
observed	observed	VBN	0
that	that	IN	0
PCNA	PCNA	NNP	B-NP
protein	protein	NN	I-NP
,	,	,	0
which	which	WDT	0
is	is	VBZ	0
up-regulated	up-regulated	JJ	0
in	in	IN	0
Tat	Tat	NNP	0
expressing	expressing	VBG	B-NP
cell	cell	NN	I-NP
,	,	,	0
extract	extract	VB	0
best	best	JJS	0
with	with	IN	0
hydrophobic	hydrophobic	JJ	B-NP
buffer	buffer	NN	I-NP
from	from	IN	0
the	the	DT	0
nucleus	nucleus	NN	B-NP
,	,	,	0
presumably	presumably	RB	0
due	due	JJ	0
to	to	TO	0
its	its	PRP$	0
binding	binding	JJ	0
to	to	TO	0
DNA	DNA	NNP	B-NP
replication	replication	JJ	I-NP
machinery	machinery	NN	I-NP
(	(	-LRB-	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
Future	Future	JJ	0
experiments	experiments	NNS	0
will	will	MD	0
address	address	VB	0
issues	issues	NNS	0
related	related	VBN	0
to	to	TO	0
differences	differences	NNS	0
between	between	IN	0
various	various	JJ	0
hiv-1	hiv-1	NN	B-NP
tat	tat	NN	I-NP
clade	clade	NN	I-NP
,	,	,	0
host	host	NN	B-NP
expression	expression	NN	I-NP
level	level	JJ	I-NP
between	between	IN	0
T-	T-	JJ	0
and	and	CC	0
monocytic	monocytic	NN	B-NP
cell	cell	NN	I-NP
,	,	,	0
and	and	CC	0
its	its	PRP$	0
effect	effect	NN	0
at	at	IN	0
various	various	JJ	0
stages	stages	NNS	0
of	of	IN	0
the	the	DT	0
cell	cell	NN	B-NP
cycle	cycle	NN	I-NP
.	.	.	0
Conclusions	Conclusions	NNP	0
Expression	Expression	NNP	B-NP
profiling	profiling	NN	I-NP
from	from	IN	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
or	or	CC	0
Tat	Tat	NNP	0
expressing	expressing	VBG	B-NP
cell	cell	NN	I-NP
holds	holds	VBZ	0
great	great	JJ	0
promise	promise	NN	0
for	for	IN	0
rapid	rapid	JJ	B-NP
functional	functional	JJ	I-NP
analysis	analysis	NN	I-NP
.	.	.	0
Here	Here	RB	0
,	,	,	0
we	we	PRP	0
have	have	VBP	0
described	described	VBN	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
Tat	Tat	NNP	0
and	and	CC	0
its	its	PRP$	0
alterations	alterations	NN	0
with	with	IN	0
the	the	DT	0
host	host	NN	0
cellular	cellular	JJ	B-NP
gene	gene	NN	I-NP
expression	expression	NN	I-NP
.	.	.	0
We	We	PRP	0
observed	observed	VBD	0
that	that	IN	0
more	more	JJR	0
than	than	IN	0
2	2	CD	0
/	/	CD	0
3	3	CD	0
of	of	IN	0
the	the	DT	0
cellular	cellular	JJ	B-NP
gene	gene	NN	I-NP
tested	tested	VBD	0
were	were	VBD	0
down-regulated	down-regulated	JJ	0
by	by	IN	0
Tat	Tat	NNP	0
.	.	.	0
These	These	DT	0
genes	genes	NNS	0
belong	belong	VBP	0
to	to	TO	0
receptor	receptor	NN	B-NP
,	,	,	0
co-receptor	co-receptor	NNP	B-NP
,	,	,	0
and	and	CC	0
co-activator	co-activator	JJ	B-NP
pathway	pathway	NN	I-NP
that	that	WDT	0
are	are	VBP	0
part	part	NN	0
of	of	IN	0
serine	serine	NN	B-NP
/	/	NN	I-NP
threonine	threonine	NN	I-NP
receptor	receptor	NN	I-NP
tyrosine	tyrosine	NN	I-NP
kinase	kinase	NN	I-NP
,	,	,	0
Ras	Ras	NNP	B-NP
/	/	NNP	I-NP
Raf	Raf	NNP	I-NP
/	/	NNP	I-NP
MEK	MEK	NNP	I-NP
/	/	NNP	I-NP
ERK	ERK	NNP	I-NP
(	(	-LRB-	0
mitogen	mitogen	NN	B-NP
activated	activated	VBN	I-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
)	)	-RRB-	0
cascade	cascade	NN	0
,	,	,	0
which	which	WDT	0
control	control	VBP	0
proliferative	proliferative	VBN	0
and	and	CC	0
/	/	NNP	0
or	or	CC	0
differentiation	differentiation	JJ	B-NP
signal	signal	JJ	I-NP
.	.	.	0
We	We	PRP	0
also	also	RB	0
observed	observed	VBD	0
a	a	DT	0
great	great	JJ	0
deal	deal	NN	0
of	of	IN	0
increase	increase	NN	0
in	in	IN	0
the	the	DT	0
host	host	NN	B-NP
cell	cell	NN	I-NP
translation	translation	NN	I-NP
apparatus	apparatus	NN	I-NP
with	with	IN	0
the	the	DT	0
possible	possible	JJ	0
aim	aim	NN	0
of	of	IN	0
optimizing	optimizing	JJ	B-NP
viral	viral	JJ	I-NP
mRNA	mRNA	JJ	I-NP
translation	translation	NN	I-NP
prior	prior	RB	I-NP
to	to	TO	0
viral	viral	JJ	B-NP
maturation	maturation	NN	I-NP
and	and	CC	0
release	release	NN	0
.	.	.	0
Therefore	Therefore	RB	0
,	,	,	0
HIV-1	HIV-1	NNP	B-NP
accessory	accessory	NN	I-NP
doubly	doubly	FW	0
spliced	spliced	VBN	B-NP
message	message	NN	I-NP
such	such	JJ	0
as	as	IN	0
Tat	Tat	NNP	0
,	,	,	0
may	may	MD	0
control	control	VB	0
the	the	DT	0
host	host	NN	B-NP
gene	gene	NN	I-NP
expression	expression	NN	I-NP
in	in	IN	0
latently	latently	JJ	B-NP
infected	infected	JJ	I-NP
cell	cell	NN	I-NP
,	,	,	0
and	and	CC	0
determine	determine	VB	0
not	not	RB	0
only	only	RB	0
viral	viral	JJ	B-NP
transcription	transcription	NN	I-NP
,	,	,	0
but	but	CC	0
also	also	RB	0
the	the	DT	0
fate	fate	NN	0
of	of	IN	0
post-transcriptional	post-transcriptional	JJ	B-NP
event	event	NN	I-NP
.	.	.	0
Materials	Materials	NNS	0
and	and	CC	0
method	method	NN	0
Cell	Cell	NNP	B-NP
culture	culture	NN	I-NP
ACH	ACH	NNP	I-NP
2	2	CD	0
cells	cells	NNS	0
are	are	VBP	0
infected	infected	VBD	B-NP
cd4	cd4	NN	I-NP
lymphocytic	lymphocytic	CD	I-NP
cell	cell	NN	I-NP
human	human	JJ	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
,	,	,	0
with	with	IN	0
an	an	DT	0
integrated	integrated	JJ	0
chromatinized	chromatinized	JJ	B-NP
dna	dna	NN	I-NP
wild-type	wild-type	JJ	I-NP
single-copy	single-copy	JJ	I-NP
.	.	.	0
The	The	DT	0
CEM	CEM	NNP	B-NP
T	T	NN	I-NP
cell	cell	NN	I-NP
(	(	-LRB-	0
12D7	12D7	NNP	B-NP
)	)	-RRB-	0
is	is	VBZ	0
the	the	DT	0
parental	parental	JJ	0
cell	cell	NN	0
for	for	IN	0
ACH	ACH	NNP	B-NP
2	2	CD	0
cells	cells	NNS	0
.	.	.	0
ach2	ach2	NN	B-NP
cell	cell	NN	I-NP
line	line	NN	I-NP
has	has	VBZ	0
a	a	DT	0
single	single	JJ	0
copy	copy	NN	0
of	of	IN	0
LAI	LAI	NNP	B-NP
strain	strain	NN	I-NP
proviral	proviral	NN	I-NP
sequence	sequence	NN	I-NP
.	.	.	0
The	The	DT	0
TAR	TAR	NNP	0
has	has	VBZ	0
a	a	DT	0
point	point	NN	B-NP
mutation	mutation	NN	I-NP
at	at	IN	0
(	(	-LRB-	0
C37	C37	NNP	B-NP
-	-	:	0
>	>	CD	0
T	T	NN	0
)	)	-RRB-	0
,	,	,	0
which	which	WDT	0
no	no	RB	0
longer	longer	JJR	0
responds	responds	NNS	0
(	(	-LRB-	0
efficiently	efficiently	LS	0
)	)	-RRB-	0
to	to	TO	0
Tat	Tat	NNP	0
.	.	.	0
However	However	RB	0
,	,	,	0
the	the	DT	0
cell	cell	NN	0
line	line	NN	0
is	is	VBZ	0
fully	fully	RB	0
capable	capable	JJ	0
of	of	IN	0
making	making	VBG	0
infectious	infectious	JJ	B-NP
virus	virus	NN	I-NP
in	in	IN	0
presence	presence	NN	0
of	of	IN	0
TNF	TNF	NNP	B-NP
,	,	,	0
PHA	PHA	NNP	B-NP
,	,	,	0
PMA	PMA	NNP	B-NP
,	,	,	0
and	and	CC	0
a	a	DT	0
host	host	NN	0
of	of	IN	0
other	other	JJ	0
stimuli	stimuli	NNS	0
.	.	.	0
H9	H9	NNP	0
and	and	CC	0
H9	H9	NNP	0
/	/	NNP	0
Tat	Tat	NNP	0
cells	cells	NNS	0
are	are	VBP	0
both	both	DT	0
CD4+	CD4+	NNP	B-NP
lymphocytic	lymphocytic	NN	B-NP
cell	cell	NN	I-NP
,	,	,	0
where	where	WRB	0
h9	h9	NN	B-NP
cell	cell	NN	I-NP
carry	carry	VBP	0
a	a	DT	0
control	control	NN	0
integrated	integrated	JJ	0
vector	vector	NN	B-NP
without	without	IN	0
the	the	DT	0
Tat	Tat	JJ	0
open	open	JJ	0
reading	reading	NN	0
frame	frame	NN	0
,	,	,	0
and	and	CC	0
H9	H9	NNP	0
/	/	NNP	0
Tat	Tat	NNP	0
cells	cells	NNS	0
carry	carry	VBP	0
integrated	integrated	VBN	B-NP
Tat	Tat	JJ	I-NP
expression	expression	NN	I-NP
vector	vector	NN	I-NP
.	.	.	0
Both	Both	DT	0
cell	cell	NN	0
lines	lines	NNS	0
were	were	VBD	0
a	a	DT	0
generous	generous	JJ	0
gift	gift	NN	0
of	of	IN	0
george	george	NNP	B-NP
pavlaki	pavlaki	NN	I-NP
(	(	-LRB-	0
NCI	NCI	NNP	B-NP
,	,	,	0
NIH	NIH	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
U1	U1	NNP	0
is	is	VBZ	0
a	a	DT	0
monocytic	monocytic	JJ	B-NP
clone	clone	NN	I-NP
harboring	harboring	VBD	0
two	two	CD	0
copies	copies	NNS	0
of	of	IN	0
the	the	DT	0
viral	viral	JJ	B-NP
genome	genome	NN	I-NP
from	from	IN	0
parental	parental	JJ	0
u973	u973	NN	B-NP
cell	cell	NN	I-NP
.	.	.	0
All	All	DT	0
cells	cells	NNS	0
were	were	VBD	0
cultured	cultured	VBN	0
at	at	IN	0
37°C	37°C	NNP	0
up	up	RB	0
to	to	TO	0
10	10	CD	0
5cells	5cells	CD	0
per	per	IN	0
ml	ml	NN	0
in	in	IN	0
rpmi-1640	rpmi-1640	NN	B-NP
medium	medium	JJ	I-NP
,	,	,	0
containing	containing	VBG	0
10	10	CD	0
%	%	NN	0
Fetal	Fetal	NNP	B-NP
Bovine	Bovine	NNP	I-NP
Serum	Serum	NNP	I-NP
(	(	-LRB-	0
fetal	fetal	JJ	B-NP
bovine	bovine	JJ	I-NP
serum	serum	NN	I-NP
)	)	-RRB-	0
treated	treated	VBN	0
with	with	IN	0
a	a	DT	0
mixture	mixture	NN	0
of	of	IN	0
1	1	CD	0
%	%	NN	0
streptomycin	streptomycin	NNS	0
and	and	CC	0
penicillin	penicillin	JJ	0
antibiotics	antibiotics	NN	0
,	,	,	0
and	and	CC	0
1	1	CD	0
%	%	NN	0
L-glutamine	L-glutamine	NN	B-NP
(	(	-LRB-	0
Gibco	Gibco	NNP	B-NP
/	/	NNP	I-NP
BRL	BRL	NNP	I-NP
)	)	-RRB-	0
.	.	.	0
Phytohemagglutinin-activated	Phytohemagglutinin-activated	NNP	B-NP
PBMC	PBMC	NNP	I-NP
were	were	VBD	0
kept	kept	VBN	0
in	in	IN	0
culture	culture	NN	0
for	for	IN	0
2	2	CD	0
days	days	NNS	0
prior	prior	RB	0
to	to	TO	0
tat	tat	NN	B-NP
protein	protein	NN	I-NP
addition	addition	NN	I-NP
.	.	.	0
Isolation	Isolation	NNP	0
and	and	CC	0
treatment	treatment	NN	0
of	of	IN	0
PBMC	PBMC	NNP	B-NP
were	were	VBD	0
performed	performed	VBN	0
by	by	IN	0
following	following	VBG	0
the	the	DT	0
guidelines	guidelines	NNS	0
of	of	IN	0
the	the	DT	0
Centers	Centers	NNPS	0
for	for	IN	0
Disease	Disease	NNP	B-NP
Control	Control	NNP	I-NP
.	.	.	0
Approximately	Approximately	RB	0
5	5	CD	0
×	×	CD	0
10	10	CD	0
6PBMC	6PBMC	CD	0
were	were	VBD	0
used	used	VBN	0
for	for	IN	0
treatment	treatment	NN	0
of	of	IN	0
wild	wild	JJ	0
type	type	NN	0
and	and	CC	0
K41A	K41A	NNP	0
Tat	Tat	NNP	0
mutant	mutant	NNS	0
(	(	-LRB-	0
100	100	CD	0
ng	ng	CD	B-NP
/	/	CD	I-NP
ml	ml	CD	I-NP
)	)	-RRB-	0
proteins	proteins	NNS	0
.	.	.	0
After	After	IN	0
an	an	DT	0
initial	initial	JJ	0
incubation	incubation	NN	0
for	for	IN	0
one	one	CD	0
hr	hr	NN	B-NP
with	with	IN	0
Tat	Tat	NNP	0
proteins	proteins	NNS	0
,	,	,	0
cells	cells	NNS	0
were	were	VBD	0
washed	washed	VBN	0
and	and	CC	0
cultured	cultured	NN	0
in	in	IN	0
complete	complete	JJ	0
media	media	NNS	0
for	for	IN	0
24	24	CD	0
hr	hr	NN	B-NP
,	,	,	0
prior	prior	RB	0
to	to	TO	0
western	western	JJ	0
blots.	blots.	CD	0
pCEP4	pCEP4	CD	B-NP
,	,	,	0
etat	etat	NN	B-NP
cell	cell	NN	I-NP
were	were	VBD	0
HeLa	HeLa	JJ	B-NP
cells	cells	NNS	0
stably	stably	VBP	0
transfected	transfected	VBN	0
with	with	IN	0
either	either	RB	0
a	a	DT	0
backbone	backbone	NN	B-NP
control	control	NN	I-NP
plasmid	plasmid	NN	I-NP
(	(	-LRB-	0
pCEP4	pCEP4	NNP	B-NP
;	;	:	0
Invitrogen	Invitrogen	LS	B-NP
)	)	-RRB-	0
or	or	CC	0
a	a	DT	0
expressing	expressing	VBG	B-NP
tat	tat	NN	I-NP
plasmid	plasmid	NN	I-NP
(	(	-LRB-	0
1-86	1-86	NNP	0
)	)	-RRB-	0
with	with	IN	0
a	a	DT	0
epitope	epitope	JJ	B-NP
tag	tag	NN	I-NP
c-terminal	c-terminal	NN	I-NP
(	(	-LRB-	0
eTat	eTat	NNP	B-NP
)	)	-RRB-	0
[	[	-LRB-	0
103	103	CD	0
]	]	-RRB-	0
.	.	.	0
HeLa	HeLa	JJ	B-NP
cell	cell	NN	0
lines	lines	NNS	0
containing	containing	VBG	0
either	either	RB	0
the	the	DT	0
control	control	NN	0
or	or	CC	0
eTat	eTat	JJ	B-NP
plasmid	plasmid	NN	I-NP
were	were	VBD	0
selected	selected	VBN	0
by	by	IN	0
single-cell	single-cell	JJ	B-NP
dilution	dilution	NN	I-NP
.	.	.	0
Both	Both	DT	0
cell	cell	NN	0
types	types	NNS	0
were	were	VBD	0
selected	selected	VBN	0
and	and	CC	0
maintained	maintained	VBN	0
under	under	IN	0
200	200	CD	0
hygromycin	hygromycin	NN	B-NP
μg	μg	NN	I-NP
per	per	FW	0
ml	ml	FW	0
.	.	.	0
Verification	Verification	NN	B-NP
of	of	IN	0
Tat	Tat	NNP	0
transcriptional	transcriptional	JJ	B-NP
activity	activity	NN	I-NP
was	was	VBD	0
achieved	achieved	VBN	0
by	by	IN	0
reporter	reporter	NN	B-NP
plasmid	plasmid	NN	I-NP
electroporation	electroporation	NN	I-NP
as	as	IN	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
103	103	CD	0
]	]	-RRB-	0
.	.	.	0
cell	cell	NN	B-NP
cycle	cycle	NN	I-NP
analysis	analysis	NN	I-NP
hela	hela	NN	I-NP
cell	cell	NN	I-NP
were	were	VBD	0
blocked	blocked	VBN	0
with	with	IN	0
hydroxyureum	hydroxyureum	NN	B-NP
(	(	-LRB-	0
Hu	Hu	NNP	0
)	)	-RRB-	0
(	(	-LRB-	0
2	2	CD	0
mM	mM	NN	0
)	)	-RRB-	0
for	for	IN	0
14	14	CD	0
h	h	NNS	0
.	.	.	0
Following	Following	VBG	0
the	the	DT	0
block	block	NN	0
,	,	,	0
cells	cells	NNS	0
were	were	VBD	0
released	released	VBN	0
by	by	IN	0
being	being	VBG	0
washed	washed	VBN	0
twice	twice	RB	0
with	with	IN	0
phosphate-buffered	phosphate-buffered	JJ	B-NP
saline	saline	NN	I-NP
(	(	-LRB-	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
)	)	-RRB-	0
and	and	CC	0
by	by	IN	0
the	the	DT	0
addition	addition	NN	B-NP
of	of	IN	0
complete	complete	JJ	0
medium	medium	NN	0
.	.	.	0
All	All	DT	0
suspension	suspension	NN	B-NP
cell	cell	NN	I-NP
were	were	VBD	0
treated	treated	VBN	0
with	with	IN	0
1	1	CD	0
%	%	NN	0
serum	serum	NN	B-NP
for	for	IN	0
48	48	CD	0
hr	hr	NN	B-NP
prior	prior	RB	0
to	to	TO	0
addition	addition	NN	B-NP
of	of	IN	0
Hu	Hu	NNP	0
.	.	.	0
supernatant	supernatant	NN	B-NP
were	were	VBD	0
collected	collected	VBN	0
and	and	CC	0
analyzed	analyzed	VBD	0
by	by	IN	0
an	an	DT	0
IL-8	IL-8	NNP	B-NP
ELISA	ELISA	NNP	I-NP
according	according	VBG	0
to	to	TO	0
the	the	DT	0
manufacturer	manufacturer	NN	0
's	's	POS	0
instruction	instruction	NN	B-NP
(	(	-LRB-	0
Biosource	Biosource	NNP	B-NP
International	International	NNP	0
)	)	-RRB-	0
.	.	.	0
For	For	IN	0
controls	controls	NNS	0
,	,	,	0
each	each	DT	0
sample	sample	NN	0
,	,	,	0
approximately	approximately	RB	0
1	1	CD	0
×	×	CD	0
10	10	CD	0
6cells	6cells	CD	0
was	was	VBD	0
processed	processed	VBN	0
for	for	IN	0
cell	cell	NN	0
sorting	sorting	NN	0
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
washed	washed	VBN	0
with	with	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
and	and	CC	0
fixed	fixed	VBN	B-NP
by	by	IN	0
addition	addition	NN	B-NP
of	of	IN	0
500	500	CD	0
μl	μl	NN	B-NP
of	of	IN	0
70	70	CD	0
%	%	NN	0
ethanol	ethanol	NN	B-NP
.	.	.	0
For	For	IN	0
fluorescence-activated	fluorescence-activated	JJ	B-NP
cell	cell	NN	I-NP
sort	sort	NN	I-NP
(	(	-LRB-	0
fluorescence	fluorescence	NN	B-NP
activated	activated	VBN	I-NP
cell	cell	NN	I-NP
sorting	sorting	VBG	I-NP
)	)	-RRB-	0
analysis	analysis	NN	0
,	,	,	0
cells	cells	NNS	0
were	were	VBD	0
stained	stained	VBN	0
with	with	IN	0
a	a	DT	0
cocktail	cocktail	NN	0
of	of	IN	0
propidium	propidium	JJ	B-NP
iodida	iodida	NN	I-NP
(	(	-LRB-	0
propidium	propidium	NN	B-NP
iodide	iodide	NN	I-NP
)	)	-RRB-	0
buffer	buffer	NN	B-NP
(	(	-LRB-	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
with	with	IN	0
Ca2+	Ca2+	NNP	B-NP
and	and	CC	0
Mg2+	Mg2+	NNP	B-NP
,	,	,	0
RNase	RNase	NNP	B-NP
A	A	NNP	0
[	[	-LRB-	0
10	10	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	CD	I-NP
]	]	-RRB-	0
,	,	,	0
NP-40	NP-40	NNP	B-NP
[	[	-LRB-	0
0.1	0.1	CD	0
%	%	NN	0
]	]	-RRB-	0
,	,	,	0
and	and	CC	0
PI	PI	NNP	0
[	[	-LRB-	0
50	50	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	CD	I-NP
]	]	CD	0
)	)	-RRB-	0
followed	followed	VBD	0
by	by	IN	0
cell-sorting	cell-sorting	JJ	0
analysis	analysis	NN	0
.	.	.	0
FACS	FACS	NNP	B-NP
data	data	NN	I-NP
acquired	acquired	VBD	0
were	were	VBD	0
analyzed	analyzed	VBN	0
by	by	IN	0
ModFit	ModFit	NNP	B-NP
LT	LT	NNP	I-NP
software	software	NN	I-NP
(	(	-LRB-	0
Verity	Verity	NNP	0
Software	Software	NNP	0
House	House	NNP	0
,	,	,	0
Inc.	Inc.	NNP	0
)	)	-RRB-	0
.	.	.	0
Cell	Cell	NN	B-NP
extract	extract	NN	I-NP
preparation	preparation	NN	I-NP
and	and	CC	0
immunoblotting	immunoblotting	VBG	0
All	All	DT	0
cells	cells	NNS	0
were	were	VBD	0
cultured	cultured	VBN	0
to	to	TO	0
growth	growth	NN	B-NP
mid-log	mid-log	JJ	I-NP
phase	phase	NN	I-NP
,	,	,	0
washed	washed	VBN	0
with	with	IN	0
phosphate	phosphate	NN	B-NP
buffered	buffered	NN	I-NP
saline	saline	JJ	I-NP
without	without	IN	0
Ca	Ca	NNP	B-NP
2+and	2+and	NNP	0
Mg	Mg	NNP	B-NP
2+	2+	NNP	0
,	,	,	0
and	and	CC	0
lysed	lysed	NN	B-NP
in	in	IN	0
a	a	DT	0
buffer	buffer	NN	B-NP
containing	containing	VBG	0
50	50	CD	0
mM	mM	JJ	B-NP
Tris-HCl	Tris-HCl	NN	I-NP
(	(	-LRB-	0
pH	pH	NNP	B-NP
7.5	7.5	CD	0
)	)	-RRB-	0
,	,	,	0
120	120	CD	0
mM	mM	JJ	B-NP
NaCl	NaCl	NN	I-NP
,	,	,	0
5	5	CD	0
mM	mM	JJ	B-NP
EDTA	EDTA	NNP	I-NP
,	,	,	0
50	50	CD	0
mM	mM	JJ	B-NP
NaF	NaF	NN	I-NP
,	,	,	0
0.2	0.2	CD	0
mM	mM	JJ	0
Na	Na	NNP	0
3	3	CD	0
VO	VO	CD	B-NP
4	4	CD	0
,	,	,	0
1	1	CD	0
mM	mM	JJ	B-NP
DTT	DTT	NNP	I-NP
,	,	,	0
0.5	0.5	CD	0
%	%	NN	0
NP-40	NP-40	NN	B-NP
and	and	CC	0
protease	protease	JJ	B-NP
inhibitor	inhibitor	NN	I-NP
(	(	-LRB-	0
protease	protease	NN	B-NP
inhibitor	inhibitor	NN	I-NP
cocktail	cocktail	NN	I-NP
tablet	tablet	NN	I-NP
,	,	,	0
Boehringer	Boehringer	NNP	0
Mannheim	Mannheim	NNP	0
,	,	,	0
one	one	CD	0
tablet	tablet	NN	0
per	per	IN	0
50	50	CD	0
ml	ml	CD	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
lysate	lysate	NN	B-NP
was	was	VBD	0
incubated	incubated	VBN	0
on	on	IN	0
ice	ice	NN	0
for	for	IN	0
15	15	CD	0
min	min	NN	B-NP
,	,	,	0
and	and	CC	0
microcentrifuged	microcentrifuged	NN	0
at	at	IN	0
4°C	4°C	CD	0
for	for	IN	0
10	10	CD	0
min	min	NN	B-NP
.	.	.	0
Total	Total	JJ	B-NP
cellular	cellular	JJ	I-NP
protein	protein	NN	I-NP
was	was	VBD	0
separated	separated	VBN	0
on	on	IN	0
4-20	4-20	CD	0
%	%	NN	0
tris-glycine	tris-glycine	NN	B-NP
gel	gel	NN	I-NP
(	(	-LRB-	0
Novex	Novex	NNP	B-NP
,	,	,	0
Inc.	Inc.	NNP	0
)	)	-RRB-	0
and	and	CC	0
transferred	transferred	VBN	0
to	to	TO	0
a	a	DT	0
polvinylidene	polvinylidene	JJ	B-NP
difluorida	difluorida	NN	I-NP
(	(	-LRB-	0
polvinylidene	polvinylidene	NN	B-NP
difluoride	difluoride	NN	I-NP
)	)	-RRB-	0
membranes	membranes	NNS	0
(	(	-LRB-	0
immobilon-p	immobilon-p	NN	B-NP
transfer	transfer	NN	I-NP
membrane	membrane	NN	I-NP
;	;	:	0
Millipore	Millipore	NNP	B-NP
Corp.	Corp.	NNP	0
)	)	-RRB-	0
overnight	overnight	JJ	0
at	at	IN	0
0.08	0.08	NNP	0
A.	A.	NNP	0
Following	Following	VBG	0
the	the	DT	0
transfer	transfer	NN	0
,	,	,	0
blots	blots	NN	0
were	were	VBD	0
blocked	blocked	VBN	0
with	with	IN	0
5	5	CD	0
%	%	NN	0
non-fat	non-fat	JJ	B-NP
dry	dry	JJ	0
milk	milk	NN	0
in	in	IN	0
50	50	CD	0
ml	ml	NN	0
of	of	IN	0
TNE	TNE	NNP	B-NP
50	50	CD	0
(	(	-LRB-	0
100	100	CD	0
mM	mM	JJ	B-NP
Tris-Cl	Tris-Cl	NN	I-NP
[	[	-LRB-	0
pH	pH	NNP	B-NP
8.0	8.0	NNP	0
]	]	-RRB-	0
,	,	,	0
50	50	CD	0
mM	mM	JJ	B-NP
NaCl	NaCl	NN	I-NP
,	,	,	0
1	1	CD	0
mM	mM	JJ	B-NP
EDTA	EDTA	NNP	I-NP
)	)	-RRB-	0
plus	plus	CC	0
0.1	0.1	CD	0
%	%	NN	0
NP-40	NP-40	NN	B-NP
.	.	.	0
Membranes	Membranes	NNP	0
were	were	VBD	0
probed	probed	VBN	0
with	with	IN	0
a	a	DT	0
1	1	CD	0
:	:	:	0
200-1	200-1	CD	0
:	:	:	0
1000	1000	CD	0
dilution	dilution	NN	0
of	of	IN	0
antibody	antibody	NN	B-NP
at	at	IN	0
4°C	4°C	CD	0
overnight	overnight	JJ	0
,	,	,	0
followed	followed	VBN	0
by	by	IN	0
three	three	CD	0
washes	washes	NN	0
with	with	IN	0
TNE	TNE	NNP	B-NP
50	50	CD	0
plus	plus	CC	0
0.1	0.1	CD	0
%	%	NN	0
NP-40	NP-40	NN	B-NP
.	.	.	0
All	All	DT	0
antibody	antibody	NN	B-NP
used	used	VBN	0
in	in	IN	0
this	this	DT	0
study	study	NN	0
were	were	VBD	0
purchased	purchased	VBN	0
from	from	IN	0
Santa	Santa	NNP	0
Cruz	Cruz	NNP	0
Biotechnology	Biotechnology	NNP	0
.	.	.	0
The	The	DT	0
next	next	JJ	0
day	day	NN	0
,	,	,	0
blots	blots	NN	0
were	were	VBD	0
incubated	incubated	VBN	0
with	with	IN	0
10	10	CD	0
ml	ml	NN	0
of	of	IN	0
125I-protein	125I-protein	NNP	0
G	G	NNP	0
(	(	-LRB-	0
Amersham	Amersham	NNP	B-NP
,	,	,	0
50	50	CD	0
μl	μl	CD	B-NP
/	/	CD	0
10	10	CD	0
ml	ml	JJ	B-NP
solution	solution	NN	I-NP
)	)	-RRB-	0
in	in	IN	0
TNE	TNE	NNP	B-NP
50	50	CD	0
plus	plus	CC	0
0.1	0.1	CD	0
%	%	NN	0
NP-40	NP-40	NN	B-NP
for	for	IN	0
2	2	CD	0
hr	hr	NN	B-NP
at	at	IN	0
4°C	4°C	CD	0
.	.	.	0
Finally	Finally	RB	0
,	,	,	0
blots	blots	NN	0
were	were	VBD	0
washed	washed	VBN	0
twice	twice	RB	0
in	in	IN	0
TNE	TNE	NNP	B-NP
50	50	CD	0
plus	plus	CC	0
0.1	0.1	CD	0
%	%	NN	0
NP-40	NP-40	NN	B-NP
and	and	CC	0
placed	placed	VBN	0
on	on	IN	0
a	a	DT	0
PhosphorImager	PhosphorImager	JJ	B-NP
cassette	cassette	NN	I-NP
for	for	IN	0
further	further	JJ	0
analysis	analysis	NN	0
.	.	.	0
total	total	JJ	B-NP
rna	rna	NN	I-NP
purification	purification	VBD	I-NP
cell	cell	NN	I-NP
were	were	VBD	0
grown	grown	VBN	0
to	to	TO	0
growth	growth	NN	B-NP
mid-log	mid-log	JJ	I-NP
phase	phase	NN	I-NP
(	(	-LRB-	0
5.0	5.0	CD	0
×	×	CD	0
10	10	CD	0
6	6	CD	0
)	)	-RRB-	0
,	,	,	0
pelleted	pelleted	NN	0
,	,	,	0
and	and	CC	0
washed	washed	VBD	0
twice	twice	RB	0
with	with	IN	0
cold	cold	JJ	0
d-pb	d-pb	NN	B-NP
without	without	IN	0
Ca	Ca	NNP	B-NP
2+	2+	NNP	0
/	/	NNP	0
Mg	Mg	NNP	B-NP
2+	2+	NNP	0
.	.	.	0
Total	Total	JJ	B-NP
RNA	RNA	NNP	I-NP
was	was	VBD	0
extracted	extracted	VBN	0
on	on	IN	0
ice	ice	NN	0
using	using	VBG	0
Trizol	Trizol	NNP	B-NP
Reagent	Reagent	NNP	I-NP
(	(	-LRB-	0
Life	Life	NNP	0
Technologies	Technologies	NNPS	0
,	,	,	0
Inc.	Inc.	NNP	0
)	)	-RRB-	0
.	.	.	0
Purified	Purified	NNP	B-NP
RNA	RNA	NNP	I-NP
was	was	VBD	0
then	then	RB	0
analyzed	analyzed	VBN	0
on	on	IN	0
a	a	DT	0
1	1	CD	0
%	%	NN	0
agarose	agarose	NN	B-NP
gel	gel	NN	I-NP
for	for	IN	0
quality	quality	NN	0
and	and	CC	0
quantity	quantity	NN	B-NP
prior	prior	RB	I-NP
to	to	TO	0
each	each	DT	0
experiment	experiment	NN	0
.	.	.	0
Glass	Glass	NNP	0
slide	slide	NN	0
microarray	microarray	VBD	0
Gene	Gene	NNP	B-NP
expression	expression	NN	I-NP
analysis	analysis	NN	I-NP
was	was	VBD	0
performed	performed	VBN	0
using	using	VBG	0
Micromax™	Micromax™	CD	B-NP
:	:	:	0
Human	Human	NNP	B-NP
cDNA	cDNA	NNP	I-NP
Microarray	Microarray	NNP	I-NP
System	System	NNP	I-NP
I	I	NNP	I-NP
(	(	-LRB-	0
cat	cat	JJ	0
#	#	#	0
MPS101	MPS101	CD	B-NP
,	,	,	0
nen	nen	NN	B-NP
life	life	NN	I-NP
science	science	NN	I-NP
product	product	NN	I-NP
)	)	-RRB-	0
.	.	.	0
On	On	IN	0
a	a	DT	0
glass	glass	NN	B-NP
microarray	microarray	NN	I-NP
slide	slide	NN	I-NP
,	,	,	0
2400	2400	CD	0
know	know	VBP	0
human	human	JJ	0
genes	genes	NNS	0
were	were	VBD	0
arrayed	arrayed	VBN	0
into	into	IN	0
4	4	CD	0
separate	separate	JJ	0
grids	grids	NNS	0
(	(	-LRB-	0
A	A	NNP	0
,	,	,	0
B	B	NNP	0
,	,	,	0
C	C	NNP	0
,	,	,	0
D	D	NNP	0
)	)	-RRB-	0
,	,	,	0
containing	containing	VBG	0
600	600	CD	0
genes	genes	NNS	0
each	each	DT	0
(	(	-LRB-	0
gene	gene	NN	B-NP
description	description	NN	I-NP
and	and	CC	0
location	location	NN	0
on	on	IN	0
microarrays	microarrays	JJ	B-NP
available	available	JJ	I-NP
at	at	IN	0
NEN	NEN	NNP	B-NP
website	website	NN	I-NP
:	:	:	0
www.nenlifesci.com	www.nenlifesci.com	CD	B-NP
)	)	-RRB-	0
.	.	.	0
All	All	DT	0
human	human	JJ	0
genes	genes	NNS	0
were	were	VBD	0
~2200	~2200	CD	0
bp	bp	JJ	B-NP
cdna	cdna	NN	I-NP
,	,	,	0
and	and	CC	0
were	were	VBD	0
characterized	characterized	VBN	0
from	from	IN	0
50+	50+	CD	0
human	human	JJ	0
cdna	cdna	NN	B-NP
library	library	NN	I-NP
(	(	-LRB-	0
AlphaGene	AlphaGene	NNP	B-NP
,	,	,	0
Inc.	Inc.	NNP	0
,	,	,	0
Woburn	Woburn	NNP	B-NP
,	,	,	0
MA	MA	NNP	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
addition	addition	NN	0
to	to	TO	0
the	the	DT	0
human	human	JJ	0
genes	genes	NNS	0
,	,	,	0
three	three	CD	0
plant	plant	NN	0
control	control	NN	0
genes	genes	NNS	0
were	were	VBD	0
spotted	spotted	VBN	0
on	on	IN	0
each	each	DT	0
grid	grid	NN	0
and	and	CC	0
were	were	VBD	0
utilized	utilized	VBN	0
to	to	TO	0
balance	balance	VB	0
the	the	DT	0
Cyanine-3	Cyanine-3	NNP	B-NP
(	(	-LRB-	0
cyanine	cyanine	NN	B-NP
3	3	NN	I-NP
)	)	-RRB-	0
and	and	CC	0
Cyanine-5	Cyanine-5	NNP	B-NP
(	(	-LRB-	0
cyanine	cyanine	NN	B-NP
5	5	NN	I-NP
)	)	-RRB-	0
fluorescence	fluorescence	JJ	B-NP
signal	signal	JJ	I-NP
.	.	.	0
A	A	DT	0
total	total	NN	0
of	of	IN	0
8	8	CD	0
μg	μg	CD	B-NP
each	each	DT	0
of	of	IN	0
H9	H9	NNP	0
(	(	-LRB-	0
control	control	NN	B-NP
sample	sample	NN	I-NP
)	)	-RRB-	0
and	and	CC	0
H9	H9	NNP	0
/	/	NNP	0
Tat	Tat	NNP	0
(	(	-LRB-	0
test	test	NN	B-NP
sample	sample	NN	I-NP
)	)	-RRB-	0
mrna	mrna	NN	B-NP
were	were	VBD	0
reverse	reverse	JJ	B-NP
transcribed	transcribed	NN	I-NP
into	into	IN	0
Biotin	Biotin	NNP	B-NP
and	and	CC	0
Dinitrophenyl	Dinitrophenyl	NNP	B-NP
(	(	-LRB-	0
dinitrophenyl	dinitrophenyl	NN	B-NP
)	)	-RRB-	0
labeled	labeled	VBD	0
cDNA	cDNA	JJ	0
,	,	,	0
respectively	respectively	RB	0
.	.	.	0
After	After	IN	0
cDNA	cDNA	JJ	B-NP
quality	quality	NN	I-NP
and	and	CC	0
quantities	quantities	NNS	0
were	were	VBD	0
analyzed	analyzed	VBN	0
,	,	,	0
both	both	DT	0
cdna	cdna	NN	B-NP
were	were	VBD	0
then	then	RB	0
pooled	pooled	VBN	0
and	and	CC	0
simultaneously	simultaneously	RB	0
hybridized	hybridized	JJ	0
overnight	overnight	JJ	0
at	at	IN	0
65°C	65°C	CD	0
onto	onto	IN	0
the	the	DT	0
glass	glass	NN	B-NP
microarray	microarray	NN	I-NP
.	.	.	0
The	The	DT	0
next	next	JJ	0
day	day	NN	0
,	,	,	0
the	the	DT	0
microarray	microarray	JJ	B-NP
slide	slide	NN	I-NP
was	was	VBD	0
serially	serially	VBN	0
washed	washed	VBN	0
in	in	IN	0
0.5×	0.5×	NNP	0
SSC	SSC	NNP	B-NP
(	(	-LRB-	0
Sodium	Sodium	NNP	B-NP
Citrate-Sodium	Citrate-Sodium	NNP	I-NP
Chloride	Chloride	NNP	I-NP
)	)	-RRB-	0
+	+	CD	0
0.01	0.01	CD	0
%	%	NN	0
sd	sd	NN	B-NP
(	(	-LRB-	0
Sodium	Sodium	NNP	B-NP
Dodecyl	Dodecyl	NNP	I-NP
Sulfate	Sulfate	NNP	I-NP
)	)	-RRB-	0
,	,	,	0
0.06×	0.06×	NNP	0
SSC	SSC	NNP	B-NP
+	+	CD	0
0.01	0.01	CD	0
%	%	NN	0
sd	sd	NN	B-NP
,	,	,	0
and	and	CC	0
0.06×	0.06×	NNP	0
SSC	SSC	NNP	B-NP
.	.	.	0
Next	Next	JJ	B-NP
,	,	,	0
the	the	DT	0
Tyramide	Tyramide	NNP	B-NP
Signal	Signal	NNP	I-NP
Amplification	Amplification	NNP	I-NP
(	(	-LRB-	0
TSA™	TSA™	NNP	B-NP
)	)	-RRB-	0
was	was	VBD	0
then	then	RB	0
used	used	VBN	0
to	to	TO	0
amplify	amplify	VB	0
the	the	DT	0
cyanine	cyanine	NN	B-NP
3	3	NN	I-NP
and	and	CC	0
cyanine	cyanine	NN	B-NP
5	5	NN	I-NP
signals	signals	VBZ	0
using	using	VBG	0
antibody-enzyme	antibody-enzyme	JJ	B-NP
conjugates	conjugates	NN	0
,	,	,	0
α-DNP-Horseradish	α-DNP-Horseradish	JJ	B-NP
peroxidasa	peroxidasa	NN	I-NP
(	(	-LRB-	0
horseradish	horseradish	NN	B-NP
peroxidase	peroxidase	NN	I-NP
)	)	-RRB-	0
and	and	CC	0
α-Streptavidin-HRP	α-Streptavidin-HRP	JJ	B-NP
with	with	IN	0
linked	linked	VBD	B-NP
cy-3	cy-3	NN	I-NP
tyramide	tyramide	NN	I-NP
and	and	CC	0
cyanine	cyanine	NN	B-NP
5	5	NN	I-NP
.	.	.	0
Screening	Screening	NNP	0
and	and	CC	0
data	data	NN	0
analysis	analysis	NN	0
was	was	VBD	0
performed	performed	VBN	0
by	by	IN	0
NEN.	NEN.	NN	B-NP
cem	cem	NN	B-NP
cdna	cdna	NN	I-NP
filter	filter	NN	I-NP
hybridization	hybridization	NN	I-NP
gene	gene	NN	I-NP
expression	expression	NN	I-NP
and	and	CC	0
ACH2	ACH2	NNP	B-NP
were	were	VBD	0
performed	performed	VBN	0
using	using	VBG	0
Atlas	Atlas	NNP	B-NP
Human	Human	NNP	I-NP
cDNA	cDNA	NNP	I-NP
Expression	Expression	NNP	I-NP
Array	Array	NNP	I-NP
(	(	-LRB-	0
Clontech	Clontech	NNP	0
Laboratories	Laboratories	NNPS	0
Inc.	Inc.	NNP	0
,	,	,	0
Palo	Palo	NNP	B-NP
Alto	Alto	NNP	I-NP
,	,	,	0
CA	CA	NNP	B-NP
)	)	-RRB-	0
according	according	VBG	0
to	to	TO	0
the	the	DT	0
manufacturer	manufacturer	NN	0
's	's	POS	0
directions	directions	NNS	0
.	.	.	0
One	One	CD	0
μg	μg	NN	B-NP
of	of	IN	0
poly	poly	VBG	0
A	A	DT	0
+RNA	+RNA	CD	0
each	each	DT	0
was	was	VBD	0
DNase	DNase	JJ	0
I	I	PRP	0
treated	treated	VBD	0
,	,	,	0
purified	purified	VBZ	0
using	using	VBG	0
a	a	DT	0
CHROMA	CHROMA	NNP	B-NP
SPIN-200	SPIN-200	NNP	I-NP
column	column	NN	I-NP
,	,	,	0
and	and	CC	0
reverse	reverse	VB	0
transcribed	transcribed	VBN	0
into	into	IN	0
32P-labeled	32P-labeled	NNP	0
cDNA	cDNA	NNP	0
.	.	.	0
The	The	DT	0
CHROMA	CHROMA	NNP	B-NP
SPIN-200	SPIN-200	NNP	I-NP
column	column	NN	I-NP
was	was	VBD	0
used	used	VBN	0
to	to	TO	0
purify	purify	VB	0
the	the	DT	0
32P-labeled	32P-labeled	JJ	0
cDNA	cDNA	NN	0
from	from	IN	0
unincorporated	unincorporated	JJ	0
32P-labeled	32P-labeled	NNP	0
dNTPs	dNTPs	NNP	0
and	and	CC	0
small	small	JJ	0
(	(	-LRB-	0
<	<	SYM	0
0.1	0.1	CD	0
kb	kb	CD	B-NP
)	)	-RRB-	0
cdna	cdna	NN	B-NP
fragment	fragment	NN	I-NP
.	.	.	0
Each	Each	DT	0
sample	sample	NN	0
was	was	VBD	0
then	then	RB	0
hybridized	hybridized	VBN	0
to	to	TO	0
a	a	DT	0
human	human	JJ	0
cDNA	cDNA	JJ	B-NP
expression	expression	NN	I-NP
array	array	NN	I-NP
overnight	overnight	RB	0
with	with	IN	0
continuous	continuous	JJ	B-NP
agitation	agitation	NN	I-NP
at	at	IN	0
68°C	68°C	CD	0
.	.	.	0
The	The	DT	0
next	next	JJ	0
day	day	NN	0
,	,	,	0
the	the	DT	0
array	array	NN	0
was	was	VBD	0
washed	washed	VBN	0
three	three	CD	0
times	times	NNS	0
with	with	IN	0
gentle	gentle	JJ	0
agitation	agitation	NN	B-NP
,	,	,	0
first	first	JJ	0
wash	wash	NN	0
with	with	IN	0
2×	2×	NNP	0
SSC	SSC	NNP	B-NP
+	+	CD	0
1	1	CD	0
%	%	NN	0
sd	sd	NN	B-NP
and	and	CC	0
the	the	DT	0
last	last	JJ	0
two	two	CD	0
washes	washes	NN	0
with	with	IN	0
0.1×	0.1×	NNP	0
SSC	SSC	NNP	B-NP
+	+	CD	0
0.5	0.5	CD	0
%	%	NN	0
sd	sd	NN	B-NP
at	at	IN	0
37°C	37°C	CD	0
.	.	.	0
Array	Array	NN	0
was	was	VBD	0
exposed	exposed	VBN	0
to	to	TO	0
a	a	DT	0
PhosphorImager	PhosphorImager	JJ	B-NP
Cassette	Cassette	NNP	I-NP
and	and	CC	0
analyzed	analyzed	VBD	0
using	using	VBG	0
ImageQuant	ImageQuant	JJ	B-NP
software	software	NN	I-NP
.	.	.	0
Northern	Northern	JJ	0
blots	blots	JJ	0
Total	Total	JJ	B-NP
cellular	cellular	JJ	I-NP
RNA	RNA	NNP	I-NP
was	was	VBD	0
extracted	extracted	VBN	0
using	using	VBG	0
the	the	DT	0
RNAzol	RNAzol	JJ	B-NP
reagent	reagent	NN	I-NP
(	(	-LRB-	0
Gibco	Gibco	NNP	B-NP
/	/	NNP	I-NP
BRL	BRL	NNP	I-NP
)	)	-RRB-	0
.	.	.	0
Total	Total	JJ	B-NP
RNA	RNA	NNP	I-NP
(	(	-LRB-	0
20	20	CD	0
μg	μg	CD	B-NP
)	)	-RRB-	0
was	was	VBD	0
isolated	isolated	VBN	0
from	from	IN	0
various	various	JJ	0
cells	cells	NNS	0
and	and	CC	0
ran	ran	VBD	0
on	on	IN	0
a	a	DT	0
1	1	CD	0
%	%	NN	0
formaldehyde-agarose	formaldehyde-agarose	JJ	B-NP
gel	gel	JJ	I-NP
overnight	overnight	JJ	0
at	at	IN	0
75	75	CD	0
V	V	NNP	0
,	,	,	0
transferred	transferred	VBN	0
onto	onto	IN	0
a	a	DT	0
0.2	0.2	CD	0
μm	μm	NN	B-NP
nitrocellulose	nitrocellulose	NN	I-NP
membrane	membrane	NN	I-NP
(	(	-LRB-	0
Millipore	Millipore	NNP	B-NP
Inc.	Inc.	NNP	0
)	)	-RRB-	0
,	,	,	0
UV	UV	NNP	B-NP
cross-linked	cross-linked	NNP	0
,	,	,	0
and	and	CC	0
hybridized	hybridized	JJ	0
overnight	overnight	JJ	0
at	at	IN	0
42°C	42°C	CD	0
with	with	IN	0
32P-end-labeled	32P-end-labeled	CD	0
40	40	CD	0
including	including	VBG	B-NP
p21	p21	CD	I-NP
mer	mer	CD	I-NP
oligo	oligo	CD	I-NP
probe	probe	NN	I-NP
/	/	CD	0
Waf1	Waf1	CD	B-NP
,	,	,	0
C-myc	C-myc	NNP	B-NP
,	,	,	0
Pro-thymosin	Pro-thymosin	NNP	B-NP
,	,	,	0
Actin	Actin	NNP	B-NP
,	,	,	0
Tat	Tat	NNP	0
,	,	,	0
and	and	CC	0
Ubiquitin	Ubiquitin	NNP	B-NP
(	(	-LRB-	0
Loftstrand	Loftstrand	NNP	B-NP
,	,	,	0
Gaithersburg	Gaithersburg	NNP	B-NP
,	,	,	0
Md.	Md.	NNP	0
)	)	-RRB-	0
.	.	.	0
Next	Next	JJ	0
day	day	NN	0
,	,	,	0
membranes	membranes	NN	0
were	were	VBD	0
washed	washed	VBN	0
two	two	CD	0
times	times	NNS	0
for	for	IN	0
15	15	CD	0
min	min	CD	B-NP
each	each	DT	0
,	,	,	0
with	with	IN	0
10	10	CD	0
ml	ml	NN	0
of	of	IN	0
0.2	0.2	CD	0
%	%	NN	0
SDS-2XSSC	SDS-2XSSC	NN	B-NP
at	at	IN	0
37°C	37°C	NNP	0
,	,	,	0
exposed	exposed	VBN	0
,	,	,	0
and	and	CC	0
counted	counted	VBN	0
on	on	IN	0
PhosphorImager	PhosphorImager	NNP	B-NP
Cassette	Cassette	NNP	I-NP
.	.	.	0
Viral	Viral	JJ	B-NP
infection	infection	NN	I-NP
and	and	CC	0
ELISA	ELISA	NNP	B-NP
assay	assay	VBD	0
Both	Both	DT	0
H9	H9	NNP	0
and	and	CC	0
H9	H9	NNP	0
/	/	NNP	0
Tat	Tat	NNP	0
cells	cells	NNS	0
were	were	VBD	0
infected	infected	VBN	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
10	10	CD	0
polybrene	polybrene	NN	B-NP
ug	ug	NN	I-NP
.	.	.	0
For	For	IN	0
pbmc	pbmc	NN	B-NP
infection	infection	NN	I-NP
,	,	,	0
PHA	PHA	NNP	B-NP
activated	activated	JJ	0
peripheral	peripheral	JJ	B-NP
blood	blood	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
mononuclear	mononuclear	NN	I-NP
cell	cell	NN	I-NP
were	were	VBD	0
kept	kept	VBN	0
in	in	IN	0
culture	culture	NN	0
for	for	IN	0
2	2	CD	0
days	days	NNS	0
prior	prior	RB	0
to	to	TO	0
each	each	DT	0
infection	infection	NN	B-NP
.	.	.	0
Isolation	Isolation	NNP	0
and	and	CC	0
treatment	treatment	NN	0
of	of	IN	0
peripheral	peripheral	JJ	B-NP
blood	blood	NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
mononuclear	mononuclear	NN	I-NP
cell	cell	NN	I-NP
were	were	VBD	0
performed	performed	VBN	0
by	by	IN	0
following	following	VBG	0
guidelines	guidelines	NNS	0
from	from	IN	0
the	the	DT	0
CDC	CDC	NNP	B-NP
(	(	-LRB-	0
Isolation	Isolation	NNP	0
,	,	,	0
culture	culture	NN	0
,	,	,	0
and	and	CC	0
hiv	hiv	NN	B-NP
identification	identification	NN	I-NP
,	,	,	0
Procedural	Procedural	NNP	B-NP
Guide	Guide	NNP	I-NP
,	,	,	0
July	July	NNP	0
1991	1991	CD	0
,	,	,	0
Atlanta	Atlanta	NNP	B-NP
,	,	,	0
GA	GA	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
Approximately	Approximately	RB	0
2	2	CD	0
×	×	CD	0
10	10	CD	0
6of	6of	CD	B-NP
H9	H9	CD	I-NP
or	or	CC	0
H9	H9	NNP	0
/	/	NNP	0
Tat	Tat	NNP	0
cells	cells	NNS	0
,	,	,	0
and	and	CC	0
5	5	CD	0
×	×	CD	0
10	10	CD	0
6PBMC	6PBMC	CD	0
cells	cells	NNS	0
were	were	VBD	0
infected	infected	VBN	0
with	with	IN	0
either	either	RB	0
an	an	DT	0
HXB-2	HXB-2	NNP	B-NP
(	(	-LRB-	0
CXCR4	CXCR4	NNP	B-NP
,	,	,	0
T-tropic	T-tropic	NNP	B-NP
)	)	-RRB-	0
,	,	,	0
or	or	CC	0
BaL	BaL	NNP	B-NP
(	(	-LRB-	0
CCR5	CCR5	NNP	B-NP
,	,	,	0
Macrophage-tropic	Macrophage-tropic	NNP	B-NP
)	)	-RRB-	0
at	at	IN	0
5	5	CD	0
p24	p24	NN	B-NP
gag	gag	NN	I-NP
antigen	antigen	NN	I-NP
ng	ng	NN	I-NP
/	/	FW	0
HIV-1	HIV-1	NN	B-NP
strain	strain	NN	I-NP
.	.	.	0
Both	Both	DT	0
viral	viral	JJ	0
isolates	isolates	NN	0
were	were	VBD	0
obtained	obtained	VBN	0
from	from	IN	0
the	the	DT	0
NIH	NIH	NNP	B-NP
AIDS	AIDS	NNP	0
research	research	NN	0
and	and	CC	0
reference	reference	NN	B-NP
reagent	reagent	NN	I-NP
program	program	NN	I-NP
.	.	.	0
After	After	IN	0
8	8	CD	0
infection	infection	NN	B-NP
hr	hr	NN	I-NP
,	,	,	0
cells	cells	NNS	0
were	were	VBD	0
washed	washed	VBN	0
and	and	CC	0
fresh	fresh	JJ	0
media	media	NNS	0
was	was	VBD	0
added	added	VBN	0
.	.	.	0
Samples	Samples	NNS	0
were	were	VBD	0
collected	collected	VBN	0
every	every	DT	0
3	3	CD	0
rdday	rdday	NN	B-NP
and	and	CC	0
stored	stored	VBD	0
at	at	IN	0
-20	-20	NNP	0
C	C	NNP	0
for	for	IN	0
p24	p24	NN	B-NP
gag	gag	NN	I-NP
ELISA	ELISA	NNP	I-NP
.	.	.	0
Media	Media	NNS	0
from	from	IN	0
human	human	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
immunodeficiency	immunodeficiency	NN	I-NP
virus	virus	NN	I-NP
type	type	NN	I-NP
1	1	NN	I-NP
infected	infected	JJ	0
cells	cells	NNS	0
were	were	VBD	0
centrifuged	centrifuged	VBN	0
to	to	TO	0
pellet	pellet	VB	0
the	the	DT	0
cells	cells	NNS	0
and	and	CC	0
supernatant	supernatant	NN	B-NP
were	were	VBD	0
collected	collected	VBN	0
,	,	,	0
and	and	CC	0
diluted	diluted	VBN	0
to	to	TO	0
1	1	CD	0
:	:	:	0
100	100	CD	0
to	to	TO	0
1	1	CD	0
:	:	:	0
1000	1000	CD	0
in	in	IN	0
RPMI	RPMI	NNP	B-NP
1640	1640	CD	0
prior	prior	JJ	0
to	to	TO	0
ELISA	ELISA	NNP	B-NP
.	.	.	0
The	The	DT	0
p24	p24	JJ	B-NP
gag	gag	JJ	I-NP
antigen	antigen	NN	I-NP
level	level	NN	I-NP
was	was	VBD	0
analyzed	analyzed	VBN	0
by	by	IN	0
HIVAG™-1	HIVAG™-1	NNP	0
Monoclonal	Monoclonal	NNP	0
antibody	antibody	NN	0
Kit	Kit	NNP	0
(	(	-LRB-	0
Abbott	Abbott	NNP	0
Laboratories	Laboratories	NNPS	0
,	,	,	0
Diagnostics	Diagnostics	NNP	B-NP
Division	Division	NNP	I-NP
)	)	-RRB-	0
.	.	.	0
Authors	Authors	NNP	0
'	'	POS	0
cf	cf	NN	B-NP
contribution	contribution	NN	I-NP
,	,	,	0
and	and	CC	0
f	f	NN	B-NP
carried	carried	VBD	0
out	out	RP	0
the	the	DT	0
ACH2	ACH2	NNP	B-NP
and	and	CC	0
H9	H9	NNP	0
/	/	NNP	0
tat	tat	NN	B-NP
microarray	microarray	NN	I-NP
.	.	.	0
LD	LD	NNP	B-NP
,	,	,	0
CE	CE	NNP	B-NP
,	,	,	0
IZ	IZ	NNP	B-NP
,	,	,	0
CGL	CGL	NNP	B-NP
,	,	,	0
and	and	CC	0
KW	KW	NNP	B-NP
aided	aided	VBD	0
in	in	IN	0
westerns	westerns	NN	0
,	,	,	0
northern	northern	JJ	B-NP
,	,	,	0
p24	p24	NNP	B-NP
and	and	CC	0
elisa	elisa	NNP	B-NP
assay	assay	NN	I-NP
.	.	.	0
AM	AM	NNP	0
,	,	,	0
KK	KK	NNP	B-NP
,	,	,	0
SB	SB	NNP	B-NP
,	,	,	0
AP	AP	NNP	B-NP
,	,	,	0
and	and	CC	0
FK	FK	NNP	B-NP
aided	aided	VBD	0
in	in	IN	0
data	data	NN	0
interpretation	interpretation	NN	0
,	,	,	0
bioinformatic	bioinformatic	NN	B-NP
,	,	,	0
literature	literature	NN	B-NP
search	search	NN	I-NP
and	and	CC	0
writing	writing	VBG	0
the	the	DT	0
manuscript	manuscript	NN	0
.	.	.	0
